id	sid	tid	token	lemma	pos
ajlm-1644	1	1	abstract	abstract	ADJ
ajlm-1644	1	2	introduction	introduction	NOUN
ajlm-1644	1	3	methods	method	NOUN
ajlm-1644	1	4	results	result	VERB
ajlm-1644	1	5	discussion	discussion	NOUN
ajlm-1644	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1644	1	7	references	reference	NOUN
ajlm-1644	1	8	about	about	ADP
ajlm-1644	1	9	the	the	DET
ajlm-1644	1	10	author(s	author(s	NOUN
ajlm-1644	1	11	)	)	PUNCT
ajlm-1644	1	12	benard	benard	PROPN
ajlm-1644	1	13	m.	m.	PROPN
ajlm-1644	1	14	mutua	mutua	PROPN
ajlm-1644	1	15	department	department	PROPN
ajlm-1644	1	16	of	of	ADP
ajlm-1644	1	17	medical	medical	PROPN
ajlm-1644	1	18	laboratory	laboratory	NOUN
ajlm-1644	1	19	sciences	sciences	PROPN
ajlm-1644	1	20	,	,	PUNCT
ajlm-1644	1	21	school	school	NOUN
ajlm-1644	1	22	of	of	ADP
ajlm-1644	1	23	public	public	ADJ
ajlm-1644	1	24	health	health	NOUN
ajlm-1644	1	25	biomedical	biomedical	ADJ
ajlm-1644	1	26	sciences	sciences	PROPN
ajlm-1644	1	27	and	and	CCONJ
ajlm-1644	1	28	technology	technology	NOUN
ajlm-1644	1	29	,	,	PUNCT
ajlm-1644	1	30	masinde	masinde	VERB
ajlm-1644	1	31	muliro	muliro	PROPN
ajlm-1644	1	32	university	university	PROPN
ajlm-1644	1	33	of	of	ADP
ajlm-1644	1	34	science	science	NOUN
ajlm-1644	1	35	and	and	CCONJ
ajlm-1644	1	36	technology	technology	NOUN
ajlm-1644	1	37	,	,	PUNCT
ajlm-1644	1	38	kakamega	kakamega	PROPN
ajlm-1644	1	39	,	,	PUNCT
ajlm-1644	1	40	kenya	kenya	PROPN
ajlm-1644	1	41	george	george	PROPN
ajlm-1644	1	42	sowayi	sowayi	PROPN
ajlm-1644	1	43	department	department	PROPN
ajlm-1644	1	44	of	of	ADP
ajlm-1644	1	45	medical	medical	PROPN
ajlm-1644	1	46	laboratory	laboratory	NOUN
ajlm-1644	1	47	sciences	sciences	PROPN
ajlm-1644	1	48	,	,	PUNCT
ajlm-1644	1	49	school	school	NOUN
ajlm-1644	1	50	of	of	ADP
ajlm-1644	1	51	public	public	ADJ
ajlm-1644	1	52	health	health	NOUN
ajlm-1644	1	53	biomedical	biomedical	ADJ
ajlm-1644	1	54	sciences	sciences	PROPN
ajlm-1644	1	55	and	and	CCONJ
ajlm-1644	1	56	technology	technology	NOUN
ajlm-1644	1	57	,	,	PUNCT
ajlm-1644	1	58	masinde	masinde	VERB
ajlm-1644	1	59	muliro	muliro	PROPN
ajlm-1644	1	60	university	university	PROPN
ajlm-1644	1	61	of	of	ADP
ajlm-1644	1	62	science	science	NOUN
ajlm-1644	1	63	and	and	CCONJ
ajlm-1644	1	64	technology	technology	NOUN
ajlm-1644	1	65	,	,	PUNCT
ajlm-1644	1	66	kakamega	kakamega	PROPN
ajlm-1644	1	67	,	,	PUNCT
ajlm-1644	1	68	kenya	kenya	PROPN
ajlm-1644	1	69	patrick	patrick	PROPN
ajlm-1644	1	70	okoth	okoth	PROPN
ajlm-1644	1	71	department	department	PROPN
ajlm-1644	1	72	of	of	ADP
ajlm-1644	1	73	biological	biological	ADJ
ajlm-1644	1	74	sciences	science	NOUN
ajlm-1644	1	75	,	,	PUNCT
ajlm-1644	1	76	school	school	NOUN
ajlm-1644	1	77	of	of	ADP
ajlm-1644	1	78	natural	natural	ADJ
ajlm-1644	1	79	and	and	CCONJ
ajlm-1644	1	80	applied	applied	ADJ
ajlm-1644	1	81	sciences	science	NOUN
ajlm-1644	1	82	,	,	PUNCT
ajlm-1644	1	83	masinde	masinde	VERB
ajlm-1644	1	84	muliro	muliro	PROPN
ajlm-1644	1	85	university	university	PROPN
ajlm-1644	1	86	of	of	ADP
ajlm-1644	1	87	science	science	NOUN
ajlm-1644	1	88	and	and	CCONJ
ajlm-1644	1	89	technology	technology	NOUN
ajlm-1644	1	90	,	,	PUNCT
ajlm-1644	1	91	kakamega	kakamega	PROPN
ajlm-1644	1	92	,	,	PUNCT
ajlm-1644	1	93	kenya	kenya	PROPN
ajlm-1644	1	94	citation	citation	PROPN
ajlm-1644	1	95	mutua	mutua	PROPN
ajlm-1644	1	96	bm	bm	PROPN
ajlm-1644	1	97	,	,	PUNCT
ajlm-1644	1	98	sowayi	sowayi	VERB
ajlm-1644	1	99	g	g	NOUN
ajlm-1644	1	100	,	,	PUNCT
ajlm-1644	1	101	okoth	okoth	ADJ
ajlm-1644	1	102	p.	p.	NOUN
ajlm-1644	1	103	red	red	ADJ
ajlm-1644	1	104	cell	cell	NOUN
ajlm-1644	1	105	distribution	distribution	NOUN
ajlm-1644	1	106	width	width	NOUN
ajlm-1644	1	107	as	as	ADP
ajlm-1644	1	108	a	a	DET
ajlm-1644	1	109	surrogate	surrogate	ADJ
ajlm-1644	1	110	marker	marker	NOUN
ajlm-1644	1	111	of	of	ADP
ajlm-1644	1	112	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	1	113	in	in	ADP
ajlm-1644	1	114	western	western	ADJ
ajlm-1644	1	115	kenya	kenya	PROPN
ajlm-1644	1	116	.	.	PUNCT
ajlm-1644	2	1	afr	afr	PROPN
ajlm-1644	2	2	j	j	PROPN
ajlm-1644	2	3	lab	lab	PROPN
ajlm-1644	2	4	med	med	PROPN
ajlm-1644	2	5	.	.	PUNCT
ajlm-1644	3	1	2022;11(1	2022;11(1	NUM
ajlm-1644	3	2	)	)	PUNCT
ajlm-1644	3	3	,	,	PUNCT
ajlm-1644	3	4	a1644	a1644	PROPN
ajlm-1644	3	5	.	.	PROPN
ajlm-1644	3	6	https://doi.org/10.4102/ajlm.v11i1.1644	https://doi.org/10.4102/ajlm.v11i1.1644	X
ajlm-1644	3	7	project	project	NOUN
ajlm-1644	3	8	research	research	NOUN
ajlm-1644	3	9	registration	registration	NOUN
ajlm-1644	3	10	:	:	PUNCT
ajlm-1644	3	11	project	project	NOUN
ajlm-1644	3	12	number	number	NOUN
ajlm-1644	3	13	:	:	PUNCT
ajlm-1644	3	14	407653	407653	NUM
ajlm-1644	3	15	original	original	ADJ
ajlm-1644	3	16	research	research	NOUN
ajlm-1644	3	17	red	red	ADJ
ajlm-1644	3	18	cell	cell	NOUN
ajlm-1644	3	19	distribution	distribution	NOUN
ajlm-1644	3	20	width	width	NOUN
ajlm-1644	3	21	as	as	ADP
ajlm-1644	3	22	a	a	DET
ajlm-1644	3	23	surrogate	surrogate	ADJ
ajlm-1644	3	24	marker	marker	NOUN
ajlm-1644	3	25	of	of	ADP
ajlm-1644	3	26	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	3	27	in	in	ADP
ajlm-1644	3	28	western	western	ADJ
ajlm-1644	3	29	kenya	kenya	PROPN
ajlm-1644	3	30	benard	benard	PROPN
ajlm-1644	3	31	m.	m.	PROPN
ajlm-1644	3	32	mutua	mutua	PROPN
ajlm-1644	3	33	,	,	PUNCT
ajlm-1644	3	34	george	george	PROPN
ajlm-1644	3	35	sowayi	sowayi	PROPN
ajlm-1644	3	36	,	,	PUNCT
ajlm-1644	3	37	patrick	patrick	PROPN
ajlm-1644	3	38	okoth	okoth	PROPN
ajlm-1644	3	39	received	receive	VERB
ajlm-1644	3	40	:	:	PUNCT
ajlm-1644	3	41	09	09	NUM
ajlm-1644	3	42	june	june	PROPN
ajlm-1644	3	43	2021	2021	NUM
ajlm-1644	3	44	;	;	PUNCT
ajlm-1644	3	45	accepted	accept	VERB
ajlm-1644	3	46	:	:	PUNCT
ajlm-1644	3	47	11	11	NUM
ajlm-1644	3	48	feb	feb	X
ajlm-1644	3	49	.	.	PROPN
ajlm-1644	3	50	2022	2022	NUM
ajlm-1644	3	51	;	;	PUNCT
ajlm-1644	3	52	published	publish	VERB
ajlm-1644	3	53	:	:	PUNCT
ajlm-1644	3	54	29	29	NUM
ajlm-1644	3	55	apr	apr	NOUN
ajlm-1644	3	56	.	.	PUNCT
ajlm-1644	4	1	2022	2022	NUM
ajlm-1644	4	2	copyright	copyright	NOUN
ajlm-1644	4	3	:	:	PUNCT
ajlm-1644	4	4	©	©	PROPN
ajlm-1644	4	5	2022	2022	NUM
ajlm-1644	4	6	.	.	PUNCT
ajlm-1644	5	1	the	the	DET
ajlm-1644	5	2	author(s	author(s	PROPN
ajlm-1644	5	3	)	)	PUNCT
ajlm-1644	5	4	.	.	PUNCT
ajlm-1644	6	1	licensee	licensee	NOUN
ajlm-1644	6	2	:	:	PUNCT
ajlm-1644	6	3	aosis	aosis	NOUN
ajlm-1644	6	4	.	.	PUNCT
ajlm-1644	7	1	this	this	PRON
ajlm-1644	7	2	is	be	AUX
ajlm-1644	7	3	an	an	DET
ajlm-1644	7	4	open	open	ADJ
ajlm-1644	7	5	access	access	NOUN
ajlm-1644	7	6	article	article	NOUN
ajlm-1644	7	7	distributed	distribute	VERB
ajlm-1644	7	8	under	under	ADP
ajlm-1644	7	9	the	the	DET
ajlm-1644	7	10	terms	term	NOUN
ajlm-1644	7	11	of	of	ADP
ajlm-1644	7	12	the	the	DET
ajlm-1644	7	13	creative	creative	ADJ
ajlm-1644	7	14	commons	common	NOUN
ajlm-1644	7	15	attribution	attribution	NOUN
ajlm-1644	7	16	license	license	NOUN
ajlm-1644	7	17	,	,	PUNCT
ajlm-1644	7	18	which	which	PRON
ajlm-1644	7	19	permits	permit	VERB
ajlm-1644	7	20	unrestricted	unrestricted	ADJ
ajlm-1644	7	21	use	use	NOUN
ajlm-1644	7	22	,	,	PUNCT
ajlm-1644	7	23	distribution	distribution	NOUN
ajlm-1644	7	24	,	,	PUNCT
ajlm-1644	7	25	and	and	CCONJ
ajlm-1644	7	26	reproduction	reproduction	NOUN
ajlm-1644	7	27	in	in	ADP
ajlm-1644	7	28	any	any	DET
ajlm-1644	7	29	medium	medium	NOUN
ajlm-1644	7	30	,	,	PUNCT
ajlm-1644	7	31	provided	provide	VERB
ajlm-1644	7	32	the	the	DET
ajlm-1644	7	33	original	original	ADJ
ajlm-1644	7	34	work	work	NOUN
ajlm-1644	7	35	is	be	AUX
ajlm-1644	7	36	properly	properly	ADV
ajlm-1644	7	37	cited	cite	VERB
ajlm-1644	7	38	.	.	PUNCT
ajlm-1644	8	1	abstract	abstract	ADJ
ajlm-1644	8	2	background	background	NOUN
ajlm-1644	8	3	:	:	PUNCT
ajlm-1644	8	4	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	8	5	are	be	AUX
ajlm-1644	8	6	inherited	inherit	VERB
ajlm-1644	8	7	haemoglobin	haemoglobin	NOUN
ajlm-1644	8	8	disorders	disorder	NOUN
ajlm-1644	8	9	that	that	PRON
ajlm-1644	8	10	result	result	VERB
ajlm-1644	8	11	in	in	ADP
ajlm-1644	8	12	anaemia	anaemia	NOUN
ajlm-1644	8	13	characterised	characterise	VERB
ajlm-1644	8	14	by	by	ADP
ajlm-1644	8	15	erythrocyte	erythrocyte	NOUN
ajlm-1644	8	16	anisopoikilocytosis	anisopoikilocytosis	NOUN
ajlm-1644	8	17	.	.	PUNCT
ajlm-1644	9	1	red	red	ADJ
ajlm-1644	9	2	cell	cell	NOUN
ajlm-1644	9	3	distribution	distribution	NOUN
ajlm-1644	9	4	width	width	NOUN
ajlm-1644	9	5	(	(	PUNCT
ajlm-1644	9	6	rdw	rdw	ADJ
ajlm-1644	9	7	)	)	PUNCT
ajlm-1644	9	8	measures	measure	NOUN
ajlm-1644	9	9	anisopoikiloytosis	anisopoikiloytosis	NOUN
ajlm-1644	10	1	and	and	CCONJ
ajlm-1644	10	2	is	be	AUX
ajlm-1644	10	3	readily	readily	ADV
ajlm-1644	10	4	reported	report	VERB
ajlm-1644	10	5	by	by	ADP
ajlm-1644	10	6	haematology	haematology	NOUN
ajlm-1644	10	7	analysers	analyser	NOUN
ajlm-1644	10	8	as	as	ADP
ajlm-1644	10	9	a	a	DET
ajlm-1644	10	10	complete	complete	ADJ
ajlm-1644	10	11	blood	blood	NOUN
ajlm-1644	10	12	count	count	NOUN
ajlm-1644	10	13	parameter	parameter	NOUN
ajlm-1644	10	14	.	.	PUNCT
ajlm-1644	11	1	the	the	DET
ajlm-1644	11	2	utility	utility	NOUN
ajlm-1644	11	3	of	of	ADP
ajlm-1644	11	4	rdw	rdw	NOUN
ajlm-1644	11	5	as	as	ADP
ajlm-1644	11	6	a	a	DET
ajlm-1644	11	7	diagnostic	diagnostic	ADJ
ajlm-1644	11	8	marker	marker	NOUN
ajlm-1644	11	9	of	of	ADP
ajlm-1644	11	10	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	11	11	in	in	ADP
ajlm-1644	11	12	kenya	kenya	PROPN
ajlm-1644	11	13	remains	remain	VERB
ajlm-1644	11	14	undetermined	undetermined	ADJ
ajlm-1644	11	15	and	and	CCONJ
ajlm-1644	11	16	undocumented	undocumented	ADJ
ajlm-1644	11	17	.	.	PUNCT
ajlm-1644	12	1	objective	objective	NOUN
ajlm-1644	12	2	:	:	PUNCT
ajlm-1644	12	3	this	this	DET
ajlm-1644	12	4	study	study	NOUN
ajlm-1644	12	5	aimed	aim	VERB
ajlm-1644	12	6	to	to	PART
ajlm-1644	12	7	determine	determine	VERB
ajlm-1644	12	8	the	the	DET
ajlm-1644	12	9	diagnostic	diagnostic	ADJ
ajlm-1644	12	10	efficacy	efficacy	NOUN
ajlm-1644	12	11	of	of	ADP
ajlm-1644	12	12	rdw	rdw	PROPN
ajlm-1644	12	13	in	in	ADP
ajlm-1644	12	14	discriminating	discriminate	VERB
ajlm-1644	12	15	haemoglobinopathy	haemoglobinopathy	ADJ
ajlm-1644	12	16	and	and	CCONJ
ajlm-1644	12	17	haemoglobinopathy	haemoglobinopathy	ADV
ajlm-1644	12	18	-	-	PUNCT
ajlm-1644	12	19	free	free	ADJ
ajlm-1644	12	20	cases	case	NOUN
ajlm-1644	12	21	in	in	ADP
ajlm-1644	12	22	kenya	kenya	PROPN
ajlm-1644	12	23	.	.	PUNCT
ajlm-1644	13	1	methods	method	NOUN
ajlm-1644	13	2	:	:	PUNCT
ajlm-1644	13	3	the	the	DET
ajlm-1644	13	4	case	case	NOUN
ajlm-1644	13	5	-	-	PUNCT
ajlm-1644	13	6	control	control	NOUN
ajlm-1644	13	7	study	study	NOUN
ajlm-1644	13	8	used	use	VERB
ajlm-1644	13	9	randomly	randomly	ADV
ajlm-1644	13	10	selected	select	VERB
ajlm-1644	13	11	haematology	haematology	NOUN
ajlm-1644	13	12	analyser	analyser	NOUN
ajlm-1644	13	13	outputs	output	NOUN
ajlm-1644	13	14	for	for	ADP
ajlm-1644	13	15	haemoglobinopathy	haemoglobinopathy	ADV
ajlm-1644	13	16	-	-	PUNCT
ajlm-1644	13	17	free	free	ADJ
ajlm-1644	13	18	(	(	PUNCT
ajlm-1644	13	19	241	241	NUM
ajlm-1644	13	20	,	,	PUNCT
ajlm-1644	13	21	49.4	49.4	NUM
ajlm-1644	13	22	%	%	NOUN
ajlm-1644	13	23	)	)	PUNCT
ajlm-1644	13	24	and	and	CCONJ
ajlm-1644	13	25	haemoglobinopathy	haemoglobinopathy	ADJ
ajlm-1644	13	26	cases	case	NOUN
ajlm-1644	13	27	(	(	PUNCT
ajlm-1644	13	28	247	247	NUM
ajlm-1644	13	29	,	,	PUNCT
ajlm-1644	13	30	50.1	50.1	NUM
ajlm-1644	13	31	%	%	NOUN
ajlm-1644	13	32	)	)	PUNCT
ajlm-1644	13	33	aged	aged	ADJ
ajlm-1644	13	34	1	1	NUM
ajlm-1644	13	35	month	month	NOUN
ajlm-1644	13	36	to	to	ADP
ajlm-1644	13	37	66	66	NUM
ajlm-1644	13	38	years	year	NOUN
ajlm-1644	13	39	old	old	ADJ
ajlm-1644	13	40	tested	test	VERB
ajlm-1644	13	41	in	in	ADP
ajlm-1644	13	42	the	the	DET
ajlm-1644	13	43	aga	aga	PROPN
ajlm-1644	13	44	khan	khan	PROPN
ajlm-1644	13	45	hospital	hospital	PROPN
ajlm-1644	13	46	,	,	PUNCT
ajlm-1644	13	47	kisumu	kisumu	PROPN
ajlm-1644	13	48	,	,	PUNCT
ajlm-1644	13	49	and	and	CCONJ
ajlm-1644	13	50	its	its	PRON
ajlm-1644	13	51	satellite	satellite	NOUN
ajlm-1644	13	52	centres	centre	NOUN
ajlm-1644	13	53	in	in	ADP
ajlm-1644	13	54	western	western	ADJ
ajlm-1644	13	55	kenya	kenya	PROPN
ajlm-1644	13	56	from	from	ADP
ajlm-1644	13	57	01	01	NUM
ajlm-1644	13	58	january	january	PROPN
ajlm-1644	13	59	2015	2015	NUM
ajlm-1644	13	60	to	to	ADP
ajlm-1644	13	61	31	31	NUM
ajlm-1644	13	62	december	december	PROPN
ajlm-1644	13	63	2020	2020	NUM
ajlm-1644	13	64	.	.	PUNCT
ajlm-1644	14	1	results	result	NOUN
ajlm-1644	14	2	were	be	AUX
ajlm-1644	14	3	verified	verify	VERB
ajlm-1644	14	4	using	use	VERB
ajlm-1644	14	5	high	high	ADJ
ajlm-1644	14	6	performance	performance	NOUN
ajlm-1644	14	7	liquid	liquid	NOUN
ajlm-1644	14	8	chromatography	chromatography	NOUN
ajlm-1644	14	9	.	.	PUNCT
ajlm-1644	15	1	the	the	DET
ajlm-1644	15	2	receiver	receiver	NOUN
ajlm-1644	15	3	operating	operate	VERB
ajlm-1644	15	4	characteristic	characteristic	NOUN
ajlm-1644	15	5	(	(	PUNCT
ajlm-1644	15	6	roc	roc	PROPN
ajlm-1644	15	7	)	)	PUNCT
ajlm-1644	15	8	curve	curve	NOUN
ajlm-1644	15	9	was	be	AUX
ajlm-1644	15	10	used	use	VERB
ajlm-1644	15	11	to	to	PART
ajlm-1644	15	12	evaluate	evaluate	VERB
ajlm-1644	15	13	the	the	DET
ajlm-1644	15	14	diagnostic	diagnostic	ADJ
ajlm-1644	15	15	power	power	NOUN
ajlm-1644	15	16	of	of	ADP
ajlm-1644	15	17	rdw	rdw	NOUN
ajlm-1644	15	18	as	as	ADP
ajlm-1644	15	19	a	a	DET
ajlm-1644	15	20	biomarker	biomarker	NOUN
ajlm-1644	15	21	for	for	ADP
ajlm-1644	15	22	sickle	sickle	NOUN
ajlm-1644	15	23	cell	cell	NOUN
ajlm-1644	15	24	disease	disease	NOUN
ajlm-1644	15	25	(	(	PUNCT
ajlm-1644	15	26	scd	scd	NOUN
ajlm-1644	15	27	)	)	PUNCT
ajlm-1644	15	28	and	and	CCONJ
ajlm-1644	15	29	sickle	sickle	NOUN
ajlm-1644	15	30	cell	cell	NOUN
ajlm-1644	15	31	trait	trait	NOUN
ajlm-1644	15	32	phenotypes	phenotype	NOUN
ajlm-1644	15	33	and	and	CCONJ
ajlm-1644	15	34	β	β	NOUN
ajlm-1644	15	35	-	-	NOUN
ajlm-1644	15	36	thalassaemia	thalassaemia	NOUN
ajlm-1644	15	37	.	.	PUNCT
ajlm-1644	16	1	results	result	NOUN
ajlm-1644	16	2	:	:	PUNCT
ajlm-1644	16	3	the	the	DET
ajlm-1644	16	4	rdw	rdw	NOUN
ajlm-1644	16	5	showed	show	VERB
ajlm-1644	16	6	diagnostic	diagnostic	ADJ
ajlm-1644	16	7	significance	significance	NOUN
ajlm-1644	16	8	in	in	ADP
ajlm-1644	16	9	scd	scd	NOUN
ajlm-1644	16	10	phenotypes	phenotype	NOUN
ajlm-1644	16	11	at	at	ADP
ajlm-1644	16	12	21.1	21.1	NUM
ajlm-1644	16	13	roc	roc	PROPN
ajlm-1644	16	14	curve	curve	NOUN
ajlm-1644	16	15	coordinate	coordinate	NOUN
ajlm-1644	16	16	with	with	ADP
ajlm-1644	16	17	67.7	67.7	NUM
ajlm-1644	16	18	%	%	NOUN
ajlm-1644	16	19	sensitivity	sensitivity	NOUN
ajlm-1644	16	20	,	,	PUNCT
ajlm-1644	16	21	90.0	90.0	NUM
ajlm-1644	16	22	%	%	NOUN
ajlm-1644	16	23	specificity	specificity	NOUN
ajlm-1644	16	24	,	,	PUNCT
ajlm-1644	16	25	0.789	0.789	NUM
ajlm-1644	16	26	accuracy	accuracy	NOUN
ajlm-1644	16	27	,	,	PUNCT
ajlm-1644	16	28	70.5	70.5	NUM
ajlm-1644	16	29	%	%	NOUN
ajlm-1644	16	30	positive	positive	ADJ
ajlm-1644	16	31	predictive	predictive	ADJ
ajlm-1644	16	32	validity	validity	NOUN
ajlm-1644	16	33	,	,	PUNCT
ajlm-1644	16	34	88.8	88.8	NUM
ajlm-1644	16	35	%	%	NOUN
ajlm-1644	16	36	negative	negative	ADJ
ajlm-1644	16	37	predictive	predictive	ADJ
ajlm-1644	16	38	validity	validity	NOUN
ajlm-1644	16	39	,	,	PUNCT
ajlm-1644	16	40	6.77	6.77	NUM
ajlm-1644	16	41	positive	positive	ADJ
ajlm-1644	16	42	likelihood	likelihood	NOUN
ajlm-1644	16	43	ratio	ratio	NOUN
ajlm-1644	16	44	,	,	PUNCT
ajlm-1644	16	45	0.36	0.36	NUM
ajlm-1644	16	46	negative	negative	ADJ
ajlm-1644	16	47	likelihood	likelihood	NOUN
ajlm-1644	16	48	ratio	ratio	NOUN
ajlm-1644	16	49	and	and	CCONJ
ajlm-1644	16	50	18.94	18.94	NUM
ajlm-1644	16	51	(	(	PUNCT
ajlm-1644	16	52	11.4–31.4	11.4–31.4	NUM
ajlm-1644	16	53	)	)	PUNCT
ajlm-1644	16	54	odds	odd	NOUN
ajlm-1644	16	55	ratio	ratio	NOUN
ajlm-1644	16	56	.	.	PUNCT
ajlm-1644	17	1	conclusion	conclusion	NOUN
ajlm-1644	17	2	:	:	PUNCT
ajlm-1644	17	3	an	an	DET
ajlm-1644	17	4	rdw	rdw	NOUN
ajlm-1644	17	5	of	of	ADP
ajlm-1644	17	6	21.1	21.1	NUM
ajlm-1644	17	7	%	%	NOUN
ajlm-1644	17	8	is	be	AUX
ajlm-1644	17	9	potentially	potentially	ADV
ajlm-1644	17	10	a	a	DET
ajlm-1644	17	11	predictor	predictor	NOUN
ajlm-1644	17	12	of	of	ADP
ajlm-1644	17	13	scd	scd	PROPN
ajlm-1644	17	14	haemoglobin	haemoglobin	PROPN
ajlm-1644	17	15	phenotypes	phenotype	NOUN
ajlm-1644	17	16	and	and	CCONJ
ajlm-1644	17	17	should	should	AUX
ajlm-1644	17	18	be	be	AUX
ajlm-1644	17	19	included	include	VERB
ajlm-1644	17	20	in	in	ADP
ajlm-1644	17	21	the	the	DET
ajlm-1644	17	22	haematology	haematology	NOUN
ajlm-1644	17	23	screening	screen	VERB
ajlm-1644	17	24	algorithm	algorithm	NOUN
ajlm-1644	17	25	as	as	ADP
ajlm-1644	17	26	a	a	DET
ajlm-1644	17	27	critical	critical	ADJ
ajlm-1644	17	28	value	value	NOUN
ajlm-1644	17	29	,	,	PUNCT
ajlm-1644	17	30	above	above	ADP
ajlm-1644	17	31	which	which	PRON
ajlm-1644	17	32	suspected	suspect	VERB
ajlm-1644	17	33	cases	case	NOUN
ajlm-1644	17	34	qualify	qualify	VERB
ajlm-1644	17	35	to	to	PART
ajlm-1644	17	36	be	be	AUX
ajlm-1644	17	37	investigated	investigate	VERB
ajlm-1644	17	38	for	for	ADP
ajlm-1644	17	39	scd	scd	PROPN
ajlm-1644	17	40	.	.	PUNCT
ajlm-1644	18	1	keywords	keyword	NOUN
ajlm-1644	18	2	:	:	PUNCT
ajlm-1644	18	3	red	red	ADJ
ajlm-1644	18	4	cell	cell	NOUN
ajlm-1644	18	5	distribution	distribution	NOUN
ajlm-1644	18	6	width	width	NOUN
ajlm-1644	18	7	;	;	PUNCT
ajlm-1644	18	8	surrogate	surrogate	ADJ
ajlm-1644	18	9	marker	marker	NOUN
ajlm-1644	18	10	;	;	PUNCT
ajlm-1644	18	11	biomarker	biomarker	NOUN
ajlm-1644	18	12	;	;	PUNCT
ajlm-1644	18	13	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	18	14	;	;	PUNCT
ajlm-1644	18	15	patients	patient	NOUN
ajlm-1644	18	16	;	;	PUNCT
ajlm-1644	18	17	western	western	ADJ
ajlm-1644	18	18	kenya	kenya	PROPN
ajlm-1644	18	19	.	.	PUNCT
ajlm-1644	19	1	introduction	introduction	NOUN
ajlm-1644	19	2	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	19	3	,	,	PUNCT
ajlm-1644	19	4	thalassaemia	thalassaemia	NOUN
ajlm-1644	19	5	syndromes	syndrome	NOUN
ajlm-1644	19	6	,	,	PUNCT
ajlm-1644	19	7	and	and	CCONJ
ajlm-1644	19	8	structural	structural	ADJ
ajlm-1644	19	9	haemoglobinopathy	haemoglobinopathy	ADJ
ajlm-1644	19	10	variants	variant	NOUN
ajlm-1644	19	11	–	–	PUNCT
ajlm-1644	19	12	haemoglobin	haemoglobin	PROPN
ajlm-1644	19	13	s	s	PROPN
ajlm-1644	19	14	,	,	PUNCT
ajlm-1644	19	15	haemoglobin	haemoglobin	NOUN
ajlm-1644	19	16	e	e	PROPN
ajlm-1644	19	17	,	,	PUNCT
ajlm-1644	19	18	haemoglobin	haemoglobin	PROPN
ajlm-1644	19	19	c	c	PROPN
ajlm-1644	19	20	–	–	PUNCT
ajlm-1644	19	21	are	be	AUX
ajlm-1644	19	22	hereditary	hereditary	ADJ
ajlm-1644	19	23	haemoglobin	haemoglobin	NOUN
ajlm-1644	19	24	disorders	disorder	NOUN
ajlm-1644	19	25	resulting	result	VERB
ajlm-1644	19	26	from	from	ADP
ajlm-1644	19	27	mutations	mutation	NOUN
ajlm-1644	19	28	in	in	ADP
ajlm-1644	19	29	genes	gene	NOUN
ajlm-1644	19	30	encoding	encode	VERB
ajlm-1644	19	31	the	the	DET
ajlm-1644	19	32	haemoglobin	haemoglobin	NOUN
ajlm-1644	19	33	polypeptide	polypeptide	ADJ
ajlm-1644	19	34	chain	chain	NOUN
ajlm-1644	19	35	.	.	PUNCT
ajlm-1644	20	1	these	these	DET
ajlm-1644	20	2	structural	structural	ADJ
ajlm-1644	20	3	haemoglobin	haemoglobin	NOUN
ajlm-1644	20	4	disorders	disorder	NOUN
ajlm-1644	20	5	result	result	VERB
ajlm-1644	20	6	in	in	ADP
ajlm-1644	20	7	functionally	functionally	ADV
ajlm-1644	20	8	impaired	impair	VERB
ajlm-1644	20	9	molecules	molecule	NOUN
ajlm-1644	20	10	;	;	PUNCT
ajlm-1644	20	11	impairment	impairment	NOUN
ajlm-1644	20	12	includes	include	VERB
ajlm-1644	20	13	inefficient	inefficient	ADJ
ajlm-1644	20	14	oxygen	oxygen	NOUN
ajlm-1644	20	15	supply	supply	NOUN
ajlm-1644	20	16	and	and	CCONJ
ajlm-1644	20	17	susceptibility	susceptibility	NOUN
ajlm-1644	20	18	to	to	ADP
ajlm-1644	20	19	destruction	destruction	NOUN
ajlm-1644	20	20	by	by	ADP
ajlm-1644	20	21	the	the	DET
ajlm-1644	20	22	victim	victim	NOUN
ajlm-1644	20	23	’s	’s	PART
ajlm-1644	20	24	reticuloendothelial	reticuloendothelial	ADJ
ajlm-1644	20	25	system	system	NOUN
ajlm-1644	20	26	,	,	PUNCT
ajlm-1644	20	27	with	with	ADP
ajlm-1644	20	28	consequential	consequential	ADJ
ajlm-1644	20	29	fatal	fatal	ADJ
ajlm-1644	20	30	or	or	CCONJ
ajlm-1644	20	31	life	life	NOUN
ajlm-1644	20	32	-	-	PUNCT
ajlm-1644	20	33	threatening	threaten	VERB
ajlm-1644	20	34	severe	severe	ADJ
ajlm-1644	20	35	anaemia	anaemia	NOUN
ajlm-1644	20	36	and	and	CCONJ
ajlm-1644	20	37	hypoxia.1,2	hypoxia.1,2	PROPN
ajlm-1644	20	38	the	the	DET
ajlm-1644	20	39	world	world	PROPN
ajlm-1644	20	40	health	health	PROPN
ajlm-1644	20	41	organization	organization	NOUN
ajlm-1644	20	42	reports	report	VERB
ajlm-1644	20	43	that	that	SCONJ
ajlm-1644	20	44	approximately	approximately	ADV
ajlm-1644	20	45	7	7	NUM
ajlm-1644	20	46	%	%	NOUN
ajlm-1644	20	47	of	of	ADP
ajlm-1644	20	48	the	the	DET
ajlm-1644	20	49	global	global	ADJ
ajlm-1644	20	50	population	population	NOUN
ajlm-1644	20	51	carry	carry	VERB
ajlm-1644	20	52	an	an	DET
ajlm-1644	20	53	inherited	inherit	VERB
ajlm-1644	20	54	haemoglobin	haemoglobin	NOUN
ajlm-1644	20	55	disorder	disorder	NOUN
ajlm-1644	20	56	gene	gene	NOUN
ajlm-1644	20	57	and	and	CCONJ
ajlm-1644	20	58	that	that	SCONJ
ajlm-1644	20	59	about	about	ADV
ajlm-1644	20	60	300	300	NUM
ajlm-1644	20	61	000	000	NUM
ajlm-1644	20	62	infants	infant	NOUN
ajlm-1644	20	63	are	be	AUX
ajlm-1644	20	64	born	bear	VERB
ajlm-1644	20	65	with	with	ADP
ajlm-1644	20	66	severe	severe	ADJ
ajlm-1644	20	67	haemoglobin	haemoglobin	NOUN
ajlm-1644	20	68	disorders	disorder	NOUN
ajlm-1644	20	69	annually	annually	ADV
ajlm-1644	20	70	,	,	PUNCT
ajlm-1644	20	71	with	with	ADP
ajlm-1644	20	72	over	over	ADP
ajlm-1644	20	73	200	200	NUM
ajlm-1644	20	74	000	000	NUM
ajlm-1644	20	75	being	be	AUX
ajlm-1644	20	76	born	bear	VERB
ajlm-1644	20	77	in	in	ADP
ajlm-1644	20	78	the	the	DET
ajlm-1644	20	79	sub	sub	ADJ
ajlm-1644	20	80	-	-	ADJ
ajlm-1644	20	81	saharan	saharan	ADJ
ajlm-1644	20	82	african	african	ADJ
ajlm-1644	20	83	countries.1,3	countries.1,3	PROPN
ajlm-1644	20	84	if	if	SCONJ
ajlm-1644	20	85	proper	proper	ADJ
ajlm-1644	20	86	measures	measure	NOUN
ajlm-1644	20	87	are	be	AUX
ajlm-1644	20	88	not	not	PART
ajlm-1644	20	89	put	put	VERB
ajlm-1644	20	90	in	in	ADP
ajlm-1644	20	91	place	place	NOUN
ajlm-1644	20	92	,	,	PUNCT
ajlm-1644	20	93	it	it	PRON
ajlm-1644	20	94	is	be	AUX
ajlm-1644	20	95	estimated	estimate	VERB
ajlm-1644	20	96	that	that	SCONJ
ajlm-1644	20	97	between	between	ADP
ajlm-1644	20	98	2010	2010	NUM
ajlm-1644	20	99	and	and	CCONJ
ajlm-1644	20	100	2050	2050	NUM
ajlm-1644	20	101	,	,	PUNCT
ajlm-1644	20	102	14	14	NUM
ajlm-1644	20	103	282	282	NUM
ajlm-1644	20	104	000	000	NUM
ajlm-1644	20	105	babies	baby	NOUN
ajlm-1644	20	106	will	will	AUX
ajlm-1644	20	107	be	be	AUX
ajlm-1644	20	108	born	bear	VERB
ajlm-1644	20	109	with	with	ADP
ajlm-1644	20	110	sickle	sickle	NOUN
ajlm-1644	20	111	cell	cell	NOUN
ajlm-1644	20	112	disease	disease	NOUN
ajlm-1644	20	113	(	(	PUNCT
ajlm-1644	20	114	scd	scd	NOUN
ajlm-1644	20	115	)	)	PUNCT
ajlm-1644	20	116	,	,	PUNCT
ajlm-1644	20	117	of	of	ADP
ajlm-1644	20	118	which	which	PRON
ajlm-1644	20	119	82	82	NUM
ajlm-1644	20	120	%	%	NOUN
ajlm-1644	20	121	will	will	AUX
ajlm-1644	20	122	be	be	AUX
ajlm-1644	20	123	born	bear	VERB
ajlm-1644	20	124	in	in	ADP
ajlm-1644	20	125	sub	sub	ADJ
ajlm-1644	20	126	-	-	ADJ
ajlm-1644	20	127	saharan	saharan	ADJ
ajlm-1644	20	128	african	african	ADJ
ajlm-1644	20	129	countries.4	countries.4	PROPN
ajlm-1644	20	130	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	20	131	are	be	AUX
ajlm-1644	20	132	neglected	neglect	VERB
ajlm-1644	20	133	but	but	CCONJ
ajlm-1644	20	134	increasing	increase	VERB
ajlm-1644	20	135	global	global	ADJ
ajlm-1644	20	136	health	health	NOUN
ajlm-1644	20	137	problems	problem	NOUN
ajlm-1644	20	138	;	;	PUNCT
ajlm-1644	20	139	children	child	NOUN
ajlm-1644	20	140	with	with	ADP
ajlm-1644	20	141	scd	scd	PROPN
ajlm-1644	20	142	who	who	PRON
ajlm-1644	20	143	live	live	VERB
ajlm-1644	20	144	in	in	ADP
ajlm-1644	20	145	sub	sub	ADJ
ajlm-1644	20	146	-	-	ADJ
ajlm-1644	20	147	saharan	saharan	ADJ
ajlm-1644	20	148	africa	africa	PROPN
ajlm-1644	20	149	have	have	VERB
ajlm-1644	20	150	an	an	DET
ajlm-1644	20	151	estimated	estimate	VERB
ajlm-1644	20	152	high	high	ADJ
ajlm-1644	20	153	mortality	mortality	NOUN
ajlm-1644	20	154	rate	rate	NOUN
ajlm-1644	20	155	of	of	ADP
ajlm-1644	20	156	50	50	NUM
ajlm-1644	20	157	%	%	NOUN
ajlm-1644	20	158	–	–	PUNCT
ajlm-1644	20	159	80	80	NUM
ajlm-1644	20	160	%	%	NOUN
ajlm-1644	20	161	by	by	ADP
ajlm-1644	20	162	age	age	NOUN
ajlm-1644	20	163	5.1,5,6,7,8,9,10,11	5.1,5,6,7,8,9,10,11	NUM
ajlm-1644	20	164	parents	parent	NOUN
ajlm-1644	20	165	who	who	PRON
ajlm-1644	20	166	are	be	AUX
ajlm-1644	20	167	carriers	carrier	NOUN
ajlm-1644	20	168	of	of	ADP
ajlm-1644	20	169	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	20	170	have	have	VERB
ajlm-1644	20	171	a	a	DET
ajlm-1644	20	172	25	25	NUM
ajlm-1644	20	173	%	%	NOUN
ajlm-1644	20	174	risk	risk	NOUN
ajlm-1644	20	175	of	of	ADP
ajlm-1644	20	176	genetically	genetically	ADV
ajlm-1644	20	177	transferring	transfer	VERB
ajlm-1644	20	178	potentially	potentially	ADV
ajlm-1644	20	179	severe	severe	ADJ
ajlm-1644	20	180	disorders	disorder	NOUN
ajlm-1644	20	181	to	to	ADP
ajlm-1644	20	182	offspring	offspring	NOUN
ajlm-1644	20	183	,	,	PUNCT
ajlm-1644	20	184	thus	thus	ADV
ajlm-1644	20	185	making	make	VERB
ajlm-1644	20	186	prevention	prevention	NOUN
ajlm-1644	20	187	and	and	CCONJ
ajlm-1644	20	188	control	control	NOUN
ajlm-1644	20	189	of	of	ADP
ajlm-1644	20	190	these	these	DET
ajlm-1644	20	191	disorders	disorder	NOUN
ajlm-1644	20	192	difficult	difficult	ADJ
ajlm-1644	20	193	.	.	PUNCT
ajlm-1644	21	1	therefore	therefore	ADV
ajlm-1644	21	2	,	,	PUNCT
ajlm-1644	21	3	due	due	ADP
ajlm-1644	21	4	to	to	ADP
ajlm-1644	21	5	the	the	DET
ajlm-1644	21	6	recessive	recessive	ADJ
ajlm-1644	21	7	character	character	NOUN
ajlm-1644	21	8	of	of	ADP
ajlm-1644	21	9	haemoglobinopathy	haemoglobinopathy	ADJ
ajlm-1644	21	10	inheritance	inheritance	NOUN
ajlm-1644	21	11	,	,	PUNCT
ajlm-1644	21	12	researchers	researcher	NOUN
ajlm-1644	21	13	have	have	AUX
ajlm-1644	21	14	recommended	recommend	VERB
ajlm-1644	21	15	screening	screen	VERB
ajlm-1644	21	16	for	for	ADP
ajlm-1644	21	17	the	the	DET
ajlm-1644	21	18	carrier	carrier	NOUN
ajlm-1644	21	19	state	state	NOUN
ajlm-1644	21	20	in	in	ADP
ajlm-1644	21	21	potentially	potentially	ADV
ajlm-1644	21	22	susceptible	susceptible	ADJ
ajlm-1644	21	23	populations.12,13	populations.12,13	NOUN
ajlm-1644	21	24	studies	study	NOUN
ajlm-1644	21	25	have	have	AUX
ajlm-1644	21	26	shown	show	VERB
ajlm-1644	21	27	that	that	SCONJ
ajlm-1644	21	28	the	the	DET
ajlm-1644	21	29	kenyan	kenyan	ADJ
ajlm-1644	21	30	population	population	NOUN
ajlm-1644	21	31	has	have	VERB
ajlm-1644	21	32	a	a	DET
ajlm-1644	21	33	significant	significant	ADJ
ajlm-1644	21	34	burden	burden	NOUN
ajlm-1644	21	35	of	of	ADP
ajlm-1644	21	36	haemoglobin	haemoglobin	ADJ
ajlm-1644	21	37	disorders	disorder	NOUN
ajlm-1644	21	38	that	that	PRON
ajlm-1644	21	39	remains	remain	VERB
ajlm-1644	21	40	undocumented	undocumented	ADJ
ajlm-1644	21	41	as	as	ADP
ajlm-1644	21	42	with	with	ADP
ajlm-1644	21	43	many	many	ADJ
ajlm-1644	21	44	other	other	ADJ
ajlm-1644	21	45	sub	sub	ADJ
ajlm-1644	21	46	-	-	ADJ
ajlm-1644	21	47	saharan	saharan	ADJ
ajlm-1644	21	48	african	african	ADJ
ajlm-1644	21	49	countries	country	NOUN
ajlm-1644	21	50	.	.	PUNCT
ajlm-1644	22	1	non	non	ADJ
ajlm-1644	22	2	-	-	NOUN
ajlm-1644	22	3	surveillance	surveillance	NOUN
ajlm-1644	22	4	is	be	AUX
ajlm-1644	22	5	due	due	ADJ
ajlm-1644	22	6	to	to	ADP
ajlm-1644	22	7	the	the	DET
ajlm-1644	22	8	high	high	ADJ
ajlm-1644	22	9	financial	financial	ADJ
ajlm-1644	22	10	cost	cost	NOUN
ajlm-1644	22	11	of	of	ADP
ajlm-1644	22	12	haemoglobinopathy	haemoglobinopathy	ADJ
ajlm-1644	22	13	laboratory	laboratory	NOUN
ajlm-1644	22	14	tests	test	NOUN
ajlm-1644	22	15	.	.	PUNCT
ajlm-1644	23	1	these	these	DET
ajlm-1644	23	2	tests	test	NOUN
ajlm-1644	23	3	include	include	VERB
ajlm-1644	23	4	the	the	DET
ajlm-1644	23	5	world	world	PROPN
ajlm-1644	23	6	health	health	NOUN
ajlm-1644	23	7	organization	organization	NOUN
ajlm-1644	23	8	recommended	recommend	VERB
ajlm-1644	23	9	haemoglobin	haemoglobin	ADJ
ajlm-1644	23	10	electrophoresis	electrophoresis	NOUN
ajlm-1644	23	11	and	and	CCONJ
ajlm-1644	23	12	genotyping	genotype	VERB
ajlm-1644	23	13	tests	test	NOUN
ajlm-1644	23	14	for	for	ADP
ajlm-1644	23	15	population	population	NOUN
ajlm-1644	23	16	and	and	CCONJ
ajlm-1644	23	17	newborn	newborn	ADJ
ajlm-1644	23	18	screening.11,14	screening.11,14	NOUN
ajlm-1644	23	19	consequently	consequently	ADV
ajlm-1644	23	20	,	,	PUNCT
ajlm-1644	23	21	a	a	DET
ajlm-1644	23	22	simple	simple	ADJ
ajlm-1644	23	23	model	model	NOUN
ajlm-1644	23	24	to	to	PART
ajlm-1644	23	25	unmask	unmask	VERB
ajlm-1644	23	26	cases	case	NOUN
ajlm-1644	23	27	needs	need	VERB
ajlm-1644	23	28	to	to	PART
ajlm-1644	23	29	be	be	AUX
ajlm-1644	23	30	established	establish	VERB
ajlm-1644	23	31	.	.	PUNCT
ajlm-1644	24	1	laboratory	laboratory	NOUN
ajlm-1644	24	2	testing	testing	NOUN
ajlm-1644	24	3	is	be	AUX
ajlm-1644	24	4	the	the	DET
ajlm-1644	24	5	surest	sure	ADJ
ajlm-1644	24	6	way	way	NOUN
ajlm-1644	24	7	to	to	PART
ajlm-1644	24	8	diagnose	diagnose	VERB
ajlm-1644	24	9	blood	blood	NOUN
ajlm-1644	24	10	disorders	disorder	NOUN
ajlm-1644	24	11	;	;	PUNCT
ajlm-1644	24	12	however	however	ADV
ajlm-1644	24	13	,	,	PUNCT
ajlm-1644	24	14	most	most	ADV
ajlm-1644	24	15	affected	affect	VERB
ajlm-1644	24	16	children	child	NOUN
ajlm-1644	24	17	in	in	ADP
ajlm-1644	24	18	african	african	ADJ
ajlm-1644	24	19	countries	country	NOUN
ajlm-1644	24	20	continue	continue	VERB
ajlm-1644	24	21	to	to	PART
ajlm-1644	24	22	die	die	VERB
ajlm-1644	24	23	in	in	ADP
ajlm-1644	24	24	early	early	ADJ
ajlm-1644	24	25	childhood	childhood	NOUN
ajlm-1644	24	26	,	,	PUNCT
ajlm-1644	24	27	usually	usually	ADV
ajlm-1644	24	28	undiagnosed	undiagnosed	ADJ
ajlm-1644	24	29	,	,	PUNCT
ajlm-1644	24	30	due	due	ADP
ajlm-1644	24	31	to	to	ADP
ajlm-1644	24	32	the	the	DET
ajlm-1644	24	33	lack	lack	NOUN
ajlm-1644	24	34	of	of	ADP
ajlm-1644	24	35	effective	effective	ADJ
ajlm-1644	24	36	programmes	programme	NOUN
ajlm-1644	24	37	for	for	ADP
ajlm-1644	24	38	early	early	ADJ
ajlm-1644	24	39	detection	detection	NOUN
ajlm-1644	24	40	and	and	CCONJ
ajlm-1644	24	41	treatment	treatment	NOUN
ajlm-1644	24	42	.	.	PUNCT
ajlm-1644	25	1	a	a	DET
ajlm-1644	25	2	prospective	prospective	ADJ
ajlm-1644	25	3	cohort	cohort	NOUN
ajlm-1644	25	4	study	study	NOUN
ajlm-1644	25	5	in	in	ADP
ajlm-1644	25	6	the	the	DET
ajlm-1644	25	7	kilifi	kilifi	NOUN
ajlm-1644	25	8	area	area	NOUN
ajlm-1644	25	9	of	of	ADP
ajlm-1644	25	10	kenya	kenya	PROPN
ajlm-1644	25	11	documented	document	VERB
ajlm-1644	25	12	a	a	DET
ajlm-1644	25	13	50	50	NUM
ajlm-1644	25	14	%	%	NOUN
ajlm-1644	25	15	–	–	PUNCT
ajlm-1644	25	16	90	90	NUM
ajlm-1644	25	17	%	%	NOUN
ajlm-1644	25	18	mortality	mortality	NOUN
ajlm-1644	25	19	rate	rate	NOUN
ajlm-1644	25	20	in	in	ADP
ajlm-1644	25	21	children	child	NOUN
ajlm-1644	25	22	under	under	ADP
ajlm-1644	25	23	five	five	NUM
ajlm-1644	25	24	years	year	NOUN
ajlm-1644	25	25	with	with	ADP
ajlm-1644	25	26	scd	scd	PROPN
ajlm-1644	25	27	,	,	PUNCT
ajlm-1644	25	28	which	which	PRON
ajlm-1644	25	29	was	be	AUX
ajlm-1644	25	30	consistent	consistent	ADJ
ajlm-1644	25	31	with	with	ADP
ajlm-1644	25	32	the	the	DET
ajlm-1644	25	33	50	50	NUM
ajlm-1644	25	34	%	%	NOUN
ajlm-1644	25	35	–	–	PUNCT
ajlm-1644	25	36	80	80	NUM
ajlm-1644	25	37	%	%	NOUN
ajlm-1644	25	38	mortality	mortality	NOUN
ajlm-1644	25	39	rate	rate	NOUN
ajlm-1644	25	40	recorded	record	VERB
ajlm-1644	25	41	among	among	ADP
ajlm-1644	25	42	undiagnosed	undiagnosed	ADJ
ajlm-1644	25	43	and	and	CCONJ
ajlm-1644	25	44	untreated	untreated	ADJ
ajlm-1644	25	45	children	child	NOUN
ajlm-1644	25	46	across	across	ADP
ajlm-1644	25	47	africa	africa	PROPN
ajlm-1644	25	48	.	.	PUNCT
ajlm-1644	26	1	the	the	DET
ajlm-1644	26	2	authors	author	NOUN
ajlm-1644	26	3	recommended	recommend	VERB
ajlm-1644	26	4	prioritising	prioritise	VERB
ajlm-1644	26	5	scd	scd	NOUN
ajlm-1644	26	6	diagnosis	diagnosis	NOUN
ajlm-1644	26	7	and	and	CCONJ
ajlm-1644	26	8	management	management	NOUN
ajlm-1644	26	9	health	health	NOUN
ajlm-1644	26	10	research	research	NOUN
ajlm-1644	26	11	in	in	ADP
ajlm-1644	26	12	africa	africa	PROPN
ajlm-1644	26	13	.	.	PUNCT
ajlm-1644	27	1	the	the	DET
ajlm-1644	27	2	current	current	ADJ
ajlm-1644	27	3	study	study	NOUN
ajlm-1644	27	4	sought	seek	VERB
ajlm-1644	27	5	to	to	PART
ajlm-1644	27	6	determine	determine	VERB
ajlm-1644	27	7	the	the	DET
ajlm-1644	27	8	potency	potency	NOUN
ajlm-1644	27	9	of	of	ADP
ajlm-1644	27	10	red	red	ADJ
ajlm-1644	27	11	cell	cell	NOUN
ajlm-1644	27	12	distribution	distribution	NOUN
ajlm-1644	27	13	width	width	NOUN
ajlm-1644	27	14	(	(	PUNCT
ajlm-1644	27	15	rdw	rdw	NOUN
ajlm-1644	27	16	)	)	PUNCT
ajlm-1644	27	17	as	as	ADP
ajlm-1644	27	18	a	a	DET
ajlm-1644	27	19	surrogate	surrogate	ADJ
ajlm-1644	27	20	marker	marker	NOUN
ajlm-1644	27	21	for	for	ADP
ajlm-1644	27	22	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	27	23	circulating	circulate	VERB
ajlm-1644	27	24	in	in	ADP
ajlm-1644	27	25	a	a	DET
ajlm-1644	27	26	vulnerable	vulnerable	ADJ
ajlm-1644	27	27	population	population	NOUN
ajlm-1644	27	28	in	in	ADP
ajlm-1644	27	29	resource	resource	NOUN
ajlm-1644	27	30	-	-	PUNCT
ajlm-1644	27	31	poor	poor	ADJ
ajlm-1644	27	32	settings	setting	NOUN
ajlm-1644	27	33	of	of	ADP
ajlm-1644	27	34	western	western	ADJ
ajlm-1644	27	35	kenya.4,5,7,6	kenya.4,5,7,6	VERB
ajlm-1644	27	36	the	the	DET
ajlm-1644	27	37	kenyan	kenyan	ADJ
ajlm-1644	27	38	regions	region	NOUN
ajlm-1644	27	39	served	serve	VERB
ajlm-1644	27	40	by	by	ADP
ajlm-1644	27	41	the	the	DET
ajlm-1644	27	42	aga	aga	PROPN
ajlm-1644	27	43	khan	khan	PROPN
ajlm-1644	27	44	hospital	hospital	PROPN
ajlm-1644	27	45	kisumu	kisumu	PROPN
ajlm-1644	27	46	,	,	PUNCT
ajlm-1644	27	47	being	be	AUX
ajlm-1644	27	48	within	within	ADP
ajlm-1644	27	49	the	the	DET
ajlm-1644	27	50	malaria	malaria	ADJ
ajlm-1644	27	51	holoendemic	holoendemic	ADJ
ajlm-1644	27	52	region	region	NOUN
ajlm-1644	27	53	of	of	ADP
ajlm-1644	27	54	western	western	ADJ
ajlm-1644	27	55	kenya	kenya	PROPN
ajlm-1644	27	56	,	,	PUNCT
ajlm-1644	27	57	lie	lie	VERB
ajlm-1644	27	58	in	in	ADP
ajlm-1644	27	59	the	the	DET
ajlm-1644	27	60	lake	lake	PROPN
ajlm-1644	27	61	victoria	victoria	PROPN
ajlm-1644	27	62	economic	economic	PROPN
ajlm-1644	27	63	block	block	PROPN
ajlm-1644	27	64	region	region	NOUN
ajlm-1644	27	65	which	which	PRON
ajlm-1644	27	66	is	be	AUX
ajlm-1644	27	67	known	know	VERB
ajlm-1644	27	68	to	to	PART
ajlm-1644	27	69	have	have	VERB
ajlm-1644	27	70	a	a	DET
ajlm-1644	27	71	high	high	ADJ
ajlm-1644	27	72	burden	burden	NOUN
ajlm-1644	27	73	of	of	ADP
ajlm-1644	27	74	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	27	75	,	,	PUNCT
ajlm-1644	27	76	particularly	particularly	ADV
ajlm-1644	27	77	sickle	sickle	NOUN
ajlm-1644	27	78	cell	cell	NOUN
ajlm-1644	27	79	haemoglobinopathy.11,15,16	haemoglobinopathy.11,15,16	ADP
ajlm-1644	27	80	the	the	DET
ajlm-1644	27	81	need	need	NOUN
ajlm-1644	27	82	for	for	ADP
ajlm-1644	27	83	a	a	DET
ajlm-1644	27	84	less	less	ADV
ajlm-1644	27	85	costly	costly	ADJ
ajlm-1644	27	86	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	27	87	laboratory	laboratory	NOUN
ajlm-1644	27	88	testing	testing	NOUN
ajlm-1644	27	89	method	method	NOUN
ajlm-1644	27	90	in	in	ADP
ajlm-1644	27	91	western	western	ADJ
ajlm-1644	27	92	kenya	kenya	PROPN
ajlm-1644	27	93	is	be	AUX
ajlm-1644	27	94	imperative	imperative	ADJ
ajlm-1644	27	95	.	.	PUNCT
ajlm-1644	28	1	previous	previous	ADJ
ajlm-1644	28	2	studies	study	NOUN
ajlm-1644	28	3	have	have	AUX
ajlm-1644	28	4	demonstrated	demonstrate	VERB
ajlm-1644	28	5	the	the	DET
ajlm-1644	28	6	utility	utility	NOUN
ajlm-1644	28	7	of	of	ADP
ajlm-1644	28	8	rdw	rdw	NOUN
ajlm-1644	28	9	as	as	ADP
ajlm-1644	28	10	a	a	DET
ajlm-1644	28	11	discriminatory	discriminatory	ADJ
ajlm-1644	28	12	marker	marker	NOUN
ajlm-1644	28	13	of	of	ADP
ajlm-1644	28	14	iron	iron	NOUN
ajlm-1644	28	15	deficiency	deficiency	NOUN
ajlm-1644	28	16	anaemia	anaemia	NOUN
ajlm-1644	28	17	from	from	ADP
ajlm-1644	28	18	other	other	ADJ
ajlm-1644	28	19	microcytic	microcytic	ADJ
ajlm-1644	28	20	anaemias	anaemias	PROPN
ajlm-1644	28	21	while	while	SCONJ
ajlm-1644	28	22	other	other	ADJ
ajlm-1644	28	23	studies	study	NOUN
ajlm-1644	28	24	have	have	AUX
ajlm-1644	28	25	demonstrated	demonstrate	VERB
ajlm-1644	28	26	the	the	DET
ajlm-1644	28	27	ability	ability	NOUN
ajlm-1644	28	28	of	of	ADP
ajlm-1644	28	29	this	this	DET
ajlm-1644	28	30	haematological	haematological	ADJ
ajlm-1644	28	31	parameter	parameter	NOUN
ajlm-1644	28	32	to	to	PART
ajlm-1644	28	33	discriminate	discriminate	VERB
ajlm-1644	28	34	iron	iron	NOUN
ajlm-1644	28	35	deficiency	deficiency	NOUN
ajlm-1644	28	36	anaemia	anaemia	NOUN
ajlm-1644	28	37	and	and	CCONJ
ajlm-1644	28	38	thalassaemias	thalassaemia	NOUN
ajlm-1644	28	39	.	.	PUNCT
ajlm-1644	29	1	the	the	DET
ajlm-1644	29	2	haematological	haematological	ADJ
ajlm-1644	29	3	index	index	NOUN
ajlm-1644	29	4	or	or	CCONJ
ajlm-1644	29	5	parameter	parameter	NOUN
ajlm-1644	29	6	,	,	PUNCT
ajlm-1644	29	7	rdw	rdw	PROPN
ajlm-1644	29	8	,	,	PUNCT
ajlm-1644	29	9	seems	seem	VERB
ajlm-1644	29	10	able	able	ADJ
ajlm-1644	29	11	to	to	PART
ajlm-1644	29	12	discriminate	discriminate	VERB
ajlm-1644	29	13	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	29	14	generally	generally	ADV
ajlm-1644	29	15	from	from	ADP
ajlm-1644	29	16	other	other	ADJ
ajlm-1644	29	17	erythrocyte	erythrocyte	NOUN
ajlm-1644	29	18	disorders	disorder	NOUN
ajlm-1644	29	19	associated	associate	VERB
ajlm-1644	29	20	with	with	ADP
ajlm-1644	29	21	anaemia.17,18,19,20,21,22	anaemia.17,18,19,20,21,22	NOUN
ajlm-1644	29	22	this	this	PRON
ajlm-1644	29	23	makes	make	VERB
ajlm-1644	29	24	rdw	rdw	ADJ
ajlm-1644	29	25	a	a	DET
ajlm-1644	29	26	potentially	potentially	ADV
ajlm-1644	29	27	simpler	simple	ADJ
ajlm-1644	29	28	,	,	PUNCT
ajlm-1644	29	29	cheaper	cheap	ADJ
ajlm-1644	29	30	,	,	PUNCT
ajlm-1644	29	31	faster	fast	ADV
ajlm-1644	29	32	,	,	PUNCT
ajlm-1644	29	33	and	and	CCONJ
ajlm-1644	29	34	potentially	potentially	ADV
ajlm-1644	29	35	dependable	dependable	ADJ
ajlm-1644	29	36	laboratory	laboratory	NOUN
ajlm-1644	29	37	assay	assay	NOUN
ajlm-1644	29	38	method	method	NOUN
ajlm-1644	29	39	for	for	ADP
ajlm-1644	29	40	haemoglobinopathy	haemoglobinopathy	ADJ
ajlm-1644	29	41	detection	detection	NOUN
ajlm-1644	29	42	suitable	suitable	ADJ
ajlm-1644	29	43	in	in	ADP
ajlm-1644	29	44	low	low	ADJ
ajlm-1644	29	45	-	-	PUNCT
ajlm-1644	29	46	income	income	NOUN
ajlm-1644	29	47	settings	setting	NOUN
ajlm-1644	29	48	of	of	ADP
ajlm-1644	29	49	western	western	ADJ
ajlm-1644	29	50	kenya	kenya	PROPN
ajlm-1644	29	51	.	.	PUNCT
ajlm-1644	30	1	a	a	DET
ajlm-1644	30	2	sickling	sickle	VERB
ajlm-1644	30	3	test	test	NOUN
ajlm-1644	30	4	was	be	AUX
ajlm-1644	30	5	recommended	recommend	VERB
ajlm-1644	30	6	for	for	ADP
ajlm-1644	30	7	screening	screen	VERB
ajlm-1644	30	8	scd	scd	NOUN
ajlm-1644	30	9	in	in	ADP
ajlm-1644	30	10	children	child	NOUN
ajlm-1644	30	11	since	since	SCONJ
ajlm-1644	30	12	it	it	PRON
ajlm-1644	30	13	proved	prove	VERB
ajlm-1644	30	14	to	to	PART
ajlm-1644	30	15	have	have	VERB
ajlm-1644	30	16	high	high	ADJ
ajlm-1644	30	17	sensitivity	sensitivity	NOUN
ajlm-1644	30	18	and	and	CCONJ
ajlm-1644	30	19	specificity	specificity	NOUN
ajlm-1644	30	20	compared	compare	VERB
ajlm-1644	30	21	to	to	ADP
ajlm-1644	30	22	solubility	solubility	NOUN
ajlm-1644	30	23	test	test	NOUN
ajlm-1644	30	24	and	and	CCONJ
ajlm-1644	30	25	peripheral	peripheral	ADJ
ajlm-1644	30	26	blood	blood	NOUN
ajlm-1644	30	27	film	film	NOUN
ajlm-1644	30	28	in	in	ADP
ajlm-1644	30	29	a	a	DET
ajlm-1644	30	30	study	study	NOUN
ajlm-1644	30	31	done	do	VERB
ajlm-1644	30	32	in	in	ADP
ajlm-1644	30	33	uganda	uganda	PROPN
ajlm-1644	30	34	.	.	PUNCT
ajlm-1644	31	1	however	however	ADV
ajlm-1644	31	2	,	,	PUNCT
ajlm-1644	31	3	unknown	unknown	ADJ
ajlm-1644	31	4	adult	adult	NOUN
ajlm-1644	31	5	haemoglobinopathy	haemoglobinopathy	ADJ
ajlm-1644	31	6	carriers	carrier	NOUN
ajlm-1644	31	7	were	be	AUX
ajlm-1644	31	8	left	leave	VERB
ajlm-1644	31	9	out	out	ADP
ajlm-1644	31	10	by	by	ADP
ajlm-1644	31	11	the	the	DET
ajlm-1644	31	12	same	same	ADJ
ajlm-1644	31	13	study	study	NOUN
ajlm-1644	31	14	;	;	PUNCT
ajlm-1644	31	15	thus	thus	ADV
ajlm-1644	31	16	,	,	PUNCT
ajlm-1644	31	17	the	the	DET
ajlm-1644	31	18	present	present	ADJ
ajlm-1644	31	19	study	study	NOUN
ajlm-1644	31	20	sought	seek	VERB
ajlm-1644	31	21	to	to	PART
ajlm-1644	31	22	unmask	unmask	VERB
ajlm-1644	31	23	these	these	DET
ajlm-1644	31	24	carriers	carrier	NOUN
ajlm-1644	31	25	from	from	ADP
ajlm-1644	31	26	the	the	DET
ajlm-1644	31	27	general	general	ADJ
ajlm-1644	31	28	population.23	population.23	PROPN
ajlm-1644	31	29	the	the	DET
ajlm-1644	31	30	rdw	rdw	ADJ
ajlm-1644	31	31	measures	measure	NOUN
ajlm-1644	31	32	variation	variation	NOUN
ajlm-1644	31	33	in	in	ADP
ajlm-1644	31	34	red	red	ADJ
ajlm-1644	31	35	blood	blood	NOUN
ajlm-1644	31	36	cell	cell	NOUN
ajlm-1644	31	37	sizes	size	NOUN
ajlm-1644	31	38	(	(	PUNCT
ajlm-1644	31	39	anisocytosis	anisocytosis	NOUN
ajlm-1644	31	40	)	)	PUNCT
ajlm-1644	31	41	and	and	CCONJ
ajlm-1644	31	42	shapes	shape	NOUN
ajlm-1644	31	43	(	(	PUNCT
ajlm-1644	31	44	poikilocytosis	poikilocytosis	NOUN
ajlm-1644	31	45	)	)	PUNCT
ajlm-1644	31	46	in	in	ADP
ajlm-1644	31	47	cell	cell	NOUN
ajlm-1644	31	48	volume	volume	NOUN
ajlm-1644	31	49	within	within	ADP
ajlm-1644	31	50	the	the	DET
ajlm-1644	31	51	red	red	ADJ
ajlm-1644	31	52	cell	cell	NOUN
ajlm-1644	31	53	population	population	NOUN
ajlm-1644	31	54	.	.	PUNCT
ajlm-1644	32	1	these	these	PRON
ajlm-1644	32	2	are	be	AUX
ajlm-1644	32	3	erythrocyte	erythrocyte	ADJ
ajlm-1644	32	4	phenotypic	phenotypic	NOUN
ajlm-1644	32	5	features	feature	NOUN
ajlm-1644	32	6	that	that	PRON
ajlm-1644	32	7	are	be	AUX
ajlm-1644	32	8	commonly	commonly	ADV
ajlm-1644	32	9	abnormal	abnormal	ADJ
ajlm-1644	32	10	in	in	ADP
ajlm-1644	32	11	the	the	DET
ajlm-1644	32	12	presence	presence	NOUN
ajlm-1644	32	13	of	of	ADP
ajlm-1644	32	14	haemoglobinopathy.24	haemoglobinopathy.24	NOUN
ajlm-1644	32	15	the	the	DET
ajlm-1644	32	16	rdw	rdw	PROPN
ajlm-1644	32	17	is	be	AUX
ajlm-1644	32	18	one	one	NUM
ajlm-1644	32	19	of	of	ADP
ajlm-1644	32	20	the	the	DET
ajlm-1644	32	21	haematological	haematological	ADJ
ajlm-1644	32	22	indices	index	NOUN
ajlm-1644	32	23	routinely	routinely	ADV
ajlm-1644	32	24	generated	generate	VERB
ajlm-1644	32	25	by	by	ADP
ajlm-1644	32	26	automated	automate	VERB
ajlm-1644	32	27	haematology	haematology	NOUN
ajlm-1644	32	28	analysers	analyser	NOUN
ajlm-1644	32	29	in	in	ADP
ajlm-1644	32	30	clinical	clinical	ADJ
ajlm-1644	32	31	laboratory	laboratory	NOUN
ajlm-1644	32	32	assays	assay	NOUN
ajlm-1644	32	33	;	;	PUNCT
ajlm-1644	32	34	therefore	therefore	ADV
ajlm-1644	32	35	,	,	PUNCT
ajlm-1644	32	36	it	it	PRON
ajlm-1644	32	37	is	be	AUX
ajlm-1644	32	38	a	a	DET
ajlm-1644	32	39	simple	simple	ADJ
ajlm-1644	32	40	,	,	PUNCT
ajlm-1644	32	41	faster	fast	ADJ
ajlm-1644	32	42	,	,	PUNCT
ajlm-1644	32	43	cheaper	cheap	ADJ
ajlm-1644	32	44	,	,	PUNCT
ajlm-1644	32	45	and	and	CCONJ
ajlm-1644	32	46	widely	widely	ADV
ajlm-1644	32	47	used	use	VERB
ajlm-1644	32	48	test	test	NOUN
ajlm-1644	32	49	in	in	ADP
ajlm-1644	32	50	routine	routine	ADJ
ajlm-1644	32	51	practice	practice	NOUN
ajlm-1644	32	52	as	as	ADP
ajlm-1644	32	53	part	part	NOUN
ajlm-1644	32	54	of	of	ADP
ajlm-1644	32	55	a	a	DET
ajlm-1644	32	56	full	full	ADJ
ajlm-1644	32	57	haemogram	haemogram	PROPN
ajlm-1644	32	58	report	report	NOUN
ajlm-1644	32	59	.	.	PUNCT
ajlm-1644	33	1	the	the	DET
ajlm-1644	33	2	rdw	rdw	PROPN
ajlm-1644	33	3	has	have	AUX
ajlm-1644	33	4	been	be	AUX
ajlm-1644	33	5	studied	study	VERB
ajlm-1644	33	6	as	as	ADP
ajlm-1644	33	7	a	a	DET
ajlm-1644	33	8	significant	significant	ADJ
ajlm-1644	33	9	entity	entity	NOUN
ajlm-1644	33	10	in	in	ADP
ajlm-1644	33	11	various	various	ADJ
ajlm-1644	33	12	disease	disease	NOUN
ajlm-1644	33	13	pathogeneses	pathogenese	NOUN
ajlm-1644	33	14	involving	involve	VERB
ajlm-1644	33	15	erythrocyte	erythrocyte	NOUN
ajlm-1644	33	16	size	size	NOUN
ajlm-1644	33	17	and	and	CCONJ
ajlm-1644	33	18	shape	shape	NOUN
ajlm-1644	33	19	variations24,25,26	variations24,25,26	NOUN
ajlm-1644	33	20	it	it	PRON
ajlm-1644	33	21	is	be	AUX
ajlm-1644	33	22	derived	derive	VERB
ajlm-1644	33	23	and	and	CCONJ
ajlm-1644	33	24	presented	present	VERB
ajlm-1644	33	25	as	as	ADP
ajlm-1644	33	26	a	a	DET
ajlm-1644	33	27	coefficient	coefficient	NOUN
ajlm-1644	33	28	of	of	ADP
ajlm-1644	33	29	variation	variation	NOUN
ajlm-1644	33	30	.	.	PUNCT
ajlm-1644	34	1	studies	study	NOUN
ajlm-1644	34	2	have	have	AUX
ajlm-1644	34	3	shown	show	VERB
ajlm-1644	34	4	the	the	DET
ajlm-1644	34	5	potential	potential	ADJ
ajlm-1644	34	6	utility	utility	NOUN
ajlm-1644	34	7	of	of	ADP
ajlm-1644	34	8	the	the	DET
ajlm-1644	34	9	rdw	rdw	NOUN
ajlm-1644	34	10	as	as	ADP
ajlm-1644	34	11	a	a	DET
ajlm-1644	34	12	marker	marker	NOUN
ajlm-1644	34	13	for	for	ADP
ajlm-1644	34	14	laboratory	laboratory	NOUN
ajlm-1644	34	15	detection	detection	NOUN
ajlm-1644	34	16	of	of	ADP
ajlm-1644	34	17	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	34	18	,	,	PUNCT
ajlm-1644	34	19	but	but	CCONJ
ajlm-1644	34	20	there	there	PRON
ajlm-1644	34	21	is	be	VERB
ajlm-1644	34	22	a	a	DET
ajlm-1644	34	23	paucity	paucity	NOUN
ajlm-1644	34	24	of	of	ADP
ajlm-1644	34	25	data	datum	NOUN
ajlm-1644	34	26	on	on	ADP
ajlm-1644	34	27	its	its	PRON
ajlm-1644	34	28	use	use	NOUN
ajlm-1644	34	29	in	in	ADP
ajlm-1644	34	30	kenya	kenya	PROPN
ajlm-1644	34	31	.	.	PUNCT
ajlm-1644	35	1	genetic	genetic	ADJ
ajlm-1644	35	2	variation	variation	NOUN
ajlm-1644	35	3	and	and	CCONJ
ajlm-1644	35	4	environmentally	environmentally	ADV
ajlm-1644	35	5	and	and	CCONJ
ajlm-1644	35	6	socioculturally	socioculturally	ADV
ajlm-1644	35	7	imposed	impose	VERB
ajlm-1644	35	8	epigenetic	epigenetic	ADJ
ajlm-1644	35	9	changes	change	NOUN
ajlm-1644	35	10	have	have	AUX
ajlm-1644	35	11	been	be	AUX
ajlm-1644	35	12	shown	show	VERB
ajlm-1644	35	13	to	to	PART
ajlm-1644	35	14	influence	influence	VERB
ajlm-1644	35	15	gene	gene	NOUN
ajlm-1644	35	16	-	-	PUNCT
ajlm-1644	35	17	phenotype.27	phenotype.27	NOUN
ajlm-1644	35	18	it	it	PRON
ajlm-1644	35	19	is	be	AUX
ajlm-1644	35	20	uncertain	uncertain	ADJ
ajlm-1644	35	21	if	if	SCONJ
ajlm-1644	35	22	the	the	DET
ajlm-1644	35	23	rdw	rdw	ADJ
ajlm-1644	35	24	values	value	NOUN
ajlm-1644	35	25	and	and	CCONJ
ajlm-1644	35	26	their	their	PRON
ajlm-1644	35	27	relationship	relationship	NOUN
ajlm-1644	35	28	with	with	ADP
ajlm-1644	35	29	haemoglobin	haemoglobin	PROPN
ajlm-1644	35	30	phenotypes	phenotype	NOUN
ajlm-1644	35	31	on	on	ADP
ajlm-1644	35	32	populations	population	NOUN
ajlm-1644	35	33	in	in	ADP
ajlm-1644	35	34	other	other	ADJ
ajlm-1644	35	35	geographical	geographical	ADJ
ajlm-1644	35	36	settings	setting	NOUN
ajlm-1644	35	37	can	can	AUX
ajlm-1644	35	38	apply	apply	VERB
ajlm-1644	35	39	to	to	ADP
ajlm-1644	35	40	the	the	DET
ajlm-1644	35	41	kenyan	kenyan	ADJ
ajlm-1644	35	42	scenario	scenario	NOUN
ajlm-1644	35	43	,	,	PUNCT
ajlm-1644	35	44	especially	especially	ADV
ajlm-1644	35	45	the	the	DET
ajlm-1644	35	46	malaria	malaria	NOUN
ajlm-1644	35	47	holoendemic	holoendemic	PROPN
ajlm-1644	35	48	lake	lake	PROPN
ajlm-1644	35	49	victoria	victoria	PROPN
ajlm-1644	35	50	basin	basin	PROPN
ajlm-1644	35	51	.	.	PUNCT
ajlm-1644	36	1	the	the	DET
ajlm-1644	36	2	overall	overall	ADJ
ajlm-1644	36	3	goal	goal	NOUN
ajlm-1644	36	4	of	of	ADP
ajlm-1644	36	5	the	the	DET
ajlm-1644	36	6	study	study	NOUN
ajlm-1644	36	7	was	be	AUX
ajlm-1644	36	8	to	to	PART
ajlm-1644	36	9	contribute	contribute	VERB
ajlm-1644	36	10	to	to	ADP
ajlm-1644	36	11	improving	improve	VERB
ajlm-1644	36	12	the	the	DET
ajlm-1644	36	13	chances	chance	NOUN
ajlm-1644	36	14	of	of	ADP
ajlm-1644	36	15	survival	survival	NOUN
ajlm-1644	36	16	of	of	ADP
ajlm-1644	36	17	infants	infant	NOUN
ajlm-1644	36	18	and	and	CCONJ
ajlm-1644	36	19	children	child	NOUN
ajlm-1644	36	20	with	with	ADP
ajlm-1644	36	21	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	36	22	by	by	ADP
ajlm-1644	36	23	enabling	enable	VERB
ajlm-1644	36	24	financial	financial	ADJ
ajlm-1644	36	25	access	access	NOUN
ajlm-1644	36	26	to	to	ADP
ajlm-1644	36	27	timely	timely	ADJ
ajlm-1644	36	28	laboratory	laboratory	NOUN
ajlm-1644	36	29	testing	testing	NOUN
ajlm-1644	36	30	through	through	ADP
ajlm-1644	36	31	a	a	DET
ajlm-1644	36	32	dependable	dependable	ADJ
ajlm-1644	36	33	but	but	CCONJ
ajlm-1644	36	34	affordable	affordable	ADJ
ajlm-1644	36	35	assay	assay	NOUN
ajlm-1644	36	36	method	method	NOUN
ajlm-1644	36	37	.	.	PUNCT
ajlm-1644	37	1	its	its	PRON
ajlm-1644	37	2	main	main	ADJ
ajlm-1644	37	3	objective	objective	NOUN
ajlm-1644	37	4	was	be	AUX
ajlm-1644	37	5	to	to	PART
ajlm-1644	37	6	establish	establish	VERB
ajlm-1644	37	7	the	the	DET
ajlm-1644	37	8	overall	overall	ADJ
ajlm-1644	37	9	accuracy	accuracy	NOUN
ajlm-1644	37	10	of	of	ADP
ajlm-1644	37	11	the	the	DET
ajlm-1644	37	12	rdw	rdw	NOUN
ajlm-1644	37	13	as	as	ADP
ajlm-1644	37	14	a	a	DET
ajlm-1644	37	15	surrogate	surrogate	ADJ
ajlm-1644	37	16	marker	marker	NOUN
ajlm-1644	37	17	of	of	ADP
ajlm-1644	37	18	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	37	19	among	among	ADP
ajlm-1644	37	20	age	age	NOUN
ajlm-1644	37	21	-	-	PUNCT
ajlm-1644	37	22	mixed	mix	VERB
ajlm-1644	37	23	patients	patient	NOUN
ajlm-1644	37	24	.	.	PUNCT
ajlm-1644	38	1	methods	method	NOUN
ajlm-1644	38	2	ethical	ethical	ADJ
ajlm-1644	38	3	considerations	consideration	NOUN
ajlm-1644	38	4	ethical	ethical	ADJ
ajlm-1644	38	5	approval	approval	NOUN
ajlm-1644	38	6	was	be	AUX
ajlm-1644	38	7	granted	grant	VERB
ajlm-1644	38	8	by	by	ADP
ajlm-1644	38	9	the	the	DET
ajlm-1644	38	10	masinde	masinde	NOUN
ajlm-1644	38	11	muliro	muliro	PROPN
ajlm-1644	38	12	university	university	PROPN
ajlm-1644	38	13	ethical	ethical	PROPN
ajlm-1644	38	14	review	review	PROPN
ajlm-1644	38	15	committee	committee	NOUN
ajlm-1644	38	16	(	(	PUNCT
ajlm-1644	38	17	reference	reference	NOUN
ajlm-1644	38	18	mmu	mmu	PROPN
ajlm-1644	38	19	/	/	SYM
ajlm-1644	38	20	cor:403012	cor:403012	NOUN
ajlm-1644	38	21	vol	vol	NOUN
ajlm-1644	38	22	3(03	3(03	NUM
ajlm-1644	38	23	)	)	PUNCT
ajlm-1644	38	24	and	and	CCONJ
ajlm-1644	38	25	national	national	ADJ
ajlm-1644	38	26	commission	commission	PROPN
ajlm-1644	38	27	of	of	ADP
ajlm-1644	38	28	science	science	NOUN
ajlm-1644	38	29	and	and	CCONJ
ajlm-1644	38	30	technology	technology	NOUN
ajlm-1644	38	31	(	(	PUNCT
ajlm-1644	38	32	nacosti	nacosti	PROPN
ajlm-1644	38	33	)	)	PUNCT
ajlm-1644	38	34	(	(	PUNCT
ajlm-1644	38	35	ref	ref	NOUN
ajlm-1644	38	36	.	.	PUNCT
ajlm-1644	38	37	407653	407653	NUM
ajlm-1644	38	38	)	)	PUNCT
ajlm-1644	38	39	.	.	PUNCT
ajlm-1644	39	1	permission	permission	NOUN
ajlm-1644	39	2	to	to	PART
ajlm-1644	39	3	collect	collect	VERB
ajlm-1644	39	4	data	datum	NOUN
ajlm-1644	39	5	was	be	AUX
ajlm-1644	39	6	approved	approve	VERB
ajlm-1644	39	7	by	by	ADP
ajlm-1644	39	8	aga	aga	PROPN
ajlm-1644	39	9	khan	khan	PROPN
ajlm-1644	39	10	hospital	hospital	PROPN
ajlm-1644	39	11	,	,	PUNCT
ajlm-1644	39	12	kisumu	kisumu	PROPN
ajlm-1644	39	13	ethics	ethics	PROPN
ajlm-1644	39	14	committee	committee	PROPN
ajlm-1644	39	15	(	(	PUNCT
ajlm-1644	39	16	reference	reference	NOUN
ajlm-1644	39	17	adm/007/089	adm/007/089	PROPN
ajlm-1644	39	18	)	)	PUNCT
ajlm-1644	39	19	thus	thus	ADV
ajlm-1644	39	20	patients	patient	NOUN
ajlm-1644	39	21	’	'	PUNCT
ajlm-1644	39	22	consent	consent	NOUN
ajlm-1644	39	23	was	be	AUX
ajlm-1644	39	24	not	not	PART
ajlm-1644	39	25	needed	need	VERB
ajlm-1644	39	26	.	.	PUNCT
ajlm-1644	40	1	the	the	DET
ajlm-1644	40	2	raw	raw	ADJ
ajlm-1644	40	3	data	datum	NOUN
ajlm-1644	40	4	was	be	AUX
ajlm-1644	40	5	stored	store	VERB
ajlm-1644	40	6	by	by	ADP
ajlm-1644	40	7	the	the	DET
ajlm-1644	40	8	principal	principal	ADJ
ajlm-1644	40	9	investigator	investigator	NOUN
ajlm-1644	40	10	in	in	ADP
ajlm-1644	40	11	restricted	restricted	ADJ
ajlm-1644	40	12	rooms	room	NOUN
ajlm-1644	40	13	and	and	CCONJ
ajlm-1644	40	14	electronic	electronic	ADJ
ajlm-1644	40	15	data	datum	NOUN
ajlm-1644	40	16	was	be	AUX
ajlm-1644	40	17	coded	code	VERB
ajlm-1644	40	18	to	to	PART
ajlm-1644	40	19	maintain	maintain	VERB
ajlm-1644	40	20	anonymity	anonymity	NOUN
ajlm-1644	40	21	in	in	ADP
ajlm-1644	40	22	password	password	NOUN
ajlm-1644	40	23	proof	proof	NOUN
ajlm-1644	40	24	computers	computer	NOUN
ajlm-1644	40	25	.	.	PUNCT
ajlm-1644	41	1	sample	sample	NOUN
ajlm-1644	41	2	size	size	NOUN
ajlm-1644	41	3	determination	determination	NOUN
ajlm-1644	41	4	sample	sample	NOUN
ajlm-1644	41	5	size	size	NOUN
ajlm-1644	41	6	calculation	calculation	NOUN
ajlm-1644	41	7	was	be	AUX
ajlm-1644	41	8	performed	perform	VERB
ajlm-1644	41	9	using	use	VERB
ajlm-1644	41	10	cochrans	cochran	NOUN
ajlm-1644	41	11	’s	’s	PART
ajlm-1644	41	12	formula	formula	NOUN
ajlm-1644	41	13	for	for	ADP
ajlm-1644	41	14	sample	sample	NOUN
ajlm-1644	41	15	size	size	NOUN
ajlm-1644	41	16	determination	determination	NOUN
ajlm-1644	41	17	in	in	ADP
ajlm-1644	41	18	case	case	NOUN
ajlm-1644	41	19	-	-	PUNCT
ajlm-1644	41	20	control	control	NOUN
ajlm-1644	41	21	and	and	CCONJ
ajlm-1644	41	22	other	other	ADJ
ajlm-1644	41	23	comparative	comparative	ADJ
ajlm-1644	41	24	studies.28	studies.28	NOUN
ajlm-1644	41	25	assuming	assume	VERB
ajlm-1644	41	26	19	19	NUM
ajlm-1644	41	27	%	%	NOUN
ajlm-1644	41	28	prevalence	prevalence	NOUN
ajlm-1644	41	29	of	of	ADP
ajlm-1644	41	30	α	α	NOUN
ajlm-1644	41	31	-	-	NOUN
ajlm-1644	41	32	thalassaemia	thalassaemia	NOUN
ajlm-1644	41	33	and	and	CCONJ
ajlm-1644	41	34	sickle	sickle	NOUN
ajlm-1644	41	35	cell	cell	NOUN
ajlm-1644	41	36	among	among	ADP
ajlm-1644	41	37	children	child	NOUN
ajlm-1644	41	38	enrolled	enrol	VERB
ajlm-1644	41	39	in	in	ADP
ajlm-1644	41	40	a	a	DET
ajlm-1644	41	41	malaria	malaria	NOUN
ajlm-1644	41	42	vaccine	vaccine	NOUN
ajlm-1644	41	43	clinical	clinical	ADJ
ajlm-1644	41	44	trial	trial	NOUN
ajlm-1644	41	45	study	study	NOUN
ajlm-1644	41	46	done	do	VERB
ajlm-1644	41	47	at	at	ADP
ajlm-1644	41	48	kombewa	kombewa	PROPN
ajlm-1644	41	49	in	in	ADP
ajlm-1644	41	50	lake	lake	PROPN
ajlm-1644	41	51	victoria	victoria	PROPN
ajlm-1644	41	52	basin	basin	PROPN
ajlm-1644	41	53	,	,	PUNCT
ajlm-1644	41	54	western	western	ADJ
ajlm-1644	41	55	kenya	kenya	PROPN
ajlm-1644	41	56	,	,	PUNCT
ajlm-1644	41	57	a	a	DET
ajlm-1644	41	58	confidence	confidence	NOUN
ajlm-1644	41	59	level	level	NOUN
ajlm-1644	41	60	of	of	ADP
ajlm-1644	41	61	95	95	NUM
ajlm-1644	41	62	%	%	NOUN
ajlm-1644	41	63	and	and	CCONJ
ajlm-1644	41	64	a	a	DET
ajlm-1644	41	65	precision	precision	NOUN
ajlm-1644	41	66	level	level	NOUN
ajlm-1644	41	67	of	of	ADP
ajlm-1644	41	68	5	5	NUM
ajlm-1644	41	69	%	%	NOUN
ajlm-1644	41	70	,	,	PUNCT
ajlm-1644	41	71	sample	sample	NOUN
ajlm-1644	41	72	size	size	NOUN
ajlm-1644	41	73	of	of	ADP
ajlm-1644	41	74	237	237	NUM
ajlm-1644	41	75	was	be	AUX
ajlm-1644	41	76	obtained	obtain	VERB
ajlm-1644	41	77	;	;	PUNCT
ajlm-1644	41	78	since	since	SCONJ
ajlm-1644	41	79	this	this	PRON
ajlm-1644	41	80	was	be	AUX
ajlm-1644	41	81	a	a	DET
ajlm-1644	41	82	two	two	NUM
ajlm-1644	41	83	-	-	PUNCT
ajlm-1644	41	84	arm	arm	NOUN
ajlm-1644	41	85	study	study	NOUN
ajlm-1644	41	86	(	(	PUNCT
ajlm-1644	41	87	case	case	NOUN
ajlm-1644	41	88	-	-	PUNCT
ajlm-1644	41	89	control	control	NOUN
ajlm-1644	41	90	)	)	PUNCT
ajlm-1644	41	91	,	,	PUNCT
ajlm-1644	41	92	an	an	DET
ajlm-1644	41	93	equal	equal	ADJ
ajlm-1644	41	94	control	control	NOUN
ajlm-1644	41	95	of	of	ADP
ajlm-1644	41	96	237	237	NUM
ajlm-1644	41	97	was	be	AUX
ajlm-1644	41	98	needed	need	VERB
ajlm-1644	41	99	,	,	PUNCT
ajlm-1644	41	100	giving	give	VERB
ajlm-1644	41	101	a	a	DET
ajlm-1644	41	102	minimum	minimum	NOUN
ajlm-1644	41	103	required	require	VERB
ajlm-1644	41	104	sample	sample	NOUN
ajlm-1644	41	105	size	size	NOUN
ajlm-1644	41	106	of	of	ADP
ajlm-1644	41	107	474.16	474.16	NUM
ajlm-1644	41	108	study	study	NOUN
ajlm-1644	41	109	design	design	NOUN
ajlm-1644	41	110	this	this	PRON
ajlm-1644	41	111	was	be	AUX
ajlm-1644	41	112	a	a	DET
ajlm-1644	41	113	hospital	hospital	NOUN
ajlm-1644	41	114	-	-	PUNCT
ajlm-1644	41	115	based	base	VERB
ajlm-1644	41	116	cross	cross	ADJ
ajlm-1644	41	117	-	-	ADJ
ajlm-1644	41	118	sectional	sectional	ADJ
ajlm-1644	41	119	retrospective	retrospective	ADJ
ajlm-1644	41	120	comparative	comparative	ADJ
ajlm-1644	41	121	study	study	NOUN
ajlm-1644	41	122	of	of	ADP
ajlm-1644	41	123	488	488	NUM
ajlm-1644	41	124	randomly	randomly	ADV
ajlm-1644	41	125	selected	select	VERB
ajlm-1644	41	126	high	high	ADJ
ajlm-1644	41	127	performance	performance	NOUN
ajlm-1644	41	128	liquid	liquid	NOUN
ajlm-1644	41	129	chromatography	chromatography	NOUN
ajlm-1644	41	130	confirmed	confirm	VERB
ajlm-1644	41	131	haemoglobinopathy	haemoglobinopathy	ADJ
ajlm-1644	41	132	,	,	PUNCT
ajlm-1644	41	133	but	but	CCONJ
ajlm-1644	41	134	non	non	ADJ
ajlm-1644	41	135	-	-	ADJ
ajlm-1644	41	136	iron	iron	ADJ
ajlm-1644	41	137	deficiency	deficiency	NOUN
ajlm-1644	41	138	,	,	PUNCT
ajlm-1644	41	139	subjects	subject	NOUN
ajlm-1644	41	140	(	(	PUNCT
ajlm-1644	41	141	cases	case	NOUN
ajlm-1644	41	142	)	)	PUNCT
ajlm-1644	41	143	(	(	PUNCT
ajlm-1644	41	144	n	n	NOUN
ajlm-1644	41	145	=	=	SYM
ajlm-1644	41	146	247	247	NUM
ajlm-1644	41	147	,	,	PUNCT
ajlm-1644	41	148	50.1	50.1	NUM
ajlm-1644	41	149	%	%	NOUN
ajlm-1644	41	150	)	)	PUNCT
ajlm-1644	41	151	and	and	CCONJ
ajlm-1644	41	152	haemoglobinopathy	haemoglobinopathy	ADV
ajlm-1644	41	153	-	-	PUNCT
ajlm-1644	41	154	free	free	ADJ
ajlm-1644	41	155	and	and	CCONJ
ajlm-1644	41	156	non	non	ADJ
ajlm-1644	41	157	-	-	ADJ
ajlm-1644	41	158	anaemic	anaemic	ADJ
ajlm-1644	41	159	results	result	NOUN
ajlm-1644	41	160	(	(	PUNCT
ajlm-1644	41	161	control	control	NOUN
ajlm-1644	41	162	group	group	NOUN
ajlm-1644	41	163	)	)	PUNCT
ajlm-1644	41	164	(	(	PUNCT
ajlm-1644	41	165	n	n	NOUN
ajlm-1644	41	166	=	=	SYM
ajlm-1644	41	167	241	241	NUM
ajlm-1644	41	168	,	,	PUNCT
ajlm-1644	41	169	49.4	49.4	NUM
ajlm-1644	41	170	%	%	NOUN
ajlm-1644	41	171	)	)	PUNCT
ajlm-1644	41	172	with	with	ADP
ajlm-1644	41	173	corresponding	correspond	VERB
ajlm-1644	41	174	complete	complete	ADJ
ajlm-1644	41	175	blood	blood	NOUN
ajlm-1644	41	176	counts	count	NOUN
ajlm-1644	41	177	from	from	ADP
ajlm-1644	41	178	hospital	hospital	NOUN
ajlm-1644	41	179	databases	database	NOUN
ajlm-1644	41	180	for	for	ADP
ajlm-1644	41	181	the	the	DET
ajlm-1644	41	182	aga	aga	PROPN
ajlm-1644	41	183	khan	khan	PROPN
ajlm-1644	41	184	hospital	hospital	PROPN
ajlm-1644	41	185	,	,	PUNCT
ajlm-1644	41	186	kisumu	kisumu	PROPN
ajlm-1644	41	187	,	,	PUNCT
ajlm-1644	41	188	and	and	CCONJ
ajlm-1644	41	189	its	its	PRON
ajlm-1644	41	190	western	western	ADJ
ajlm-1644	41	191	kenya	kenya	PROPN
ajlm-1644	41	192	satellites	satellite	NOUN
ajlm-1644	41	193	.	.	PUNCT
ajlm-1644	42	1	data	datum	NOUN
ajlm-1644	42	2	collection	collection	NOUN
ajlm-1644	42	3	data	datum	NOUN
ajlm-1644	42	4	were	be	AUX
ajlm-1644	42	5	obtained	obtain	VERB
ajlm-1644	42	6	from	from	ADP
ajlm-1644	42	7	the	the	DET
ajlm-1644	42	8	laboratory	laboratory	NOUN
ajlm-1644	42	9	database	database	NOUN
ajlm-1644	42	10	on	on	ADP
ajlm-1644	42	11	patients	patient	NOUN
ajlm-1644	42	12	examined	examine	VERB
ajlm-1644	42	13	at	at	ADP
ajlm-1644	42	14	the	the	DET
ajlm-1644	42	15	hospital	hospital	NOUN
ajlm-1644	42	16	’s	’s	PART
ajlm-1644	42	17	haematology	haematology	NOUN
ajlm-1644	42	18	laboratory	laboratory	NOUN
ajlm-1644	42	19	for	for	ADP
ajlm-1644	42	20	the	the	DET
ajlm-1644	42	21	past	past	ADJ
ajlm-1644	42	22	five	five	NUM
ajlm-1644	42	23	years	year	NOUN
ajlm-1644	42	24	from	from	ADP
ajlm-1644	42	25	01	01	NUM
ajlm-1644	42	26	january	january	PROPN
ajlm-1644	42	27	2015	2015	NUM
ajlm-1644	42	28	to	to	ADP
ajlm-1644	42	29	31	31	NUM
ajlm-1644	42	30	december	december	PROPN
ajlm-1644	42	31	2020	2020	NUM
ajlm-1644	42	32	.	.	PUNCT
ajlm-1644	43	1	complete	complete	ADJ
ajlm-1644	43	2	blood	blood	NOUN
ajlm-1644	43	3	count	count	NOUN
ajlm-1644	43	4	reports	report	NOUN
ajlm-1644	43	5	were	be	AUX
ajlm-1644	43	6	performed	perform	VERB
ajlm-1644	43	7	using	use	VERB
ajlm-1644	43	8	various	various	ADJ
ajlm-1644	43	9	sysmex	sysmex	NOUN
ajlm-1644	43	10	analysers	analyser	NOUN
ajlm-1644	43	11	(	(	PUNCT
ajlm-1644	43	12	kx-21n	kx-21n	PROPN
ajlm-1644	43	13	,	,	PUNCT
ajlm-1644	43	14	xp	xp	ADV
ajlm-1644	43	15	300	300	NUM
ajlm-1644	43	16	,	,	PUNCT
ajlm-1644	43	17	sysmex	sysmex	NOUN
ajlm-1644	43	18	xnl	xnl	NOUN
ajlm-1644	43	19	330	330	NUM
ajlm-1644	43	20	,	,	PUNCT
ajlm-1644	43	21	symex	symex	VERB
ajlm-1644	43	22	xs	xs	PROPN
ajlm-1644	43	23	500i	500i	PROPN
ajlm-1644	43	24	and	and	CCONJ
ajlm-1644	43	25	sysmex	sysmex	NOUN
ajlm-1644	43	26	xs1000i	xs1000i	PROPN
ajlm-1644	43	27	;	;	PUNCT
ajlm-1644	43	28	sysmex	sysmex	NOUN
ajlm-1644	43	29	corporations	corporation	NOUN
ajlm-1644	43	30	,	,	PUNCT
ajlm-1644	43	31	kobe	kobe	PROPN
ajlm-1644	43	32	,	,	PUNCT
ajlm-1644	43	33	japan	japan	PROPN
ajlm-1644	43	34	)	)	PUNCT
ajlm-1644	43	35	.	.	PUNCT
ajlm-1644	44	1	the	the	DET
ajlm-1644	44	2	cases	case	NOUN
ajlm-1644	44	3	were	be	AUX
ajlm-1644	44	4	individuals	individual	NOUN
ajlm-1644	44	5	who	who	PRON
ajlm-1644	44	6	were	be	AUX
ajlm-1644	44	7	confirmed	confirm	VERB
ajlm-1644	44	8	for	for	ADP
ajlm-1644	44	9	various	various	ADJ
ajlm-1644	44	10	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	44	11	using	use	VERB
ajlm-1644	44	12	a	a	DET
ajlm-1644	44	13	high	high	ADJ
ajlm-1644	44	14	performance	performance	NOUN
ajlm-1644	44	15	liquid	liquid	NOUN
ajlm-1644	44	16	chromatography	chromatography	NOUN
ajlm-1644	44	17	(	(	PUNCT
ajlm-1644	44	18	bio	bio	NOUN
ajlm-1644	44	19	-	-	PROPN
ajlm-1644	44	20	rad	rad	PROPN
ajlm-1644	44	21	d10	d10	PROPN
ajlm-1644	44	22	)	)	PUNCT
ajlm-1644	44	23	machine	machine	NOUN
ajlm-1644	44	24	(	(	PUNCT
ajlm-1644	44	25	bio	bio	NOUN
ajlm-1644	44	26	-	-	ADJ
ajlm-1644	44	27	rad	rad	PROPN
ajlm-1644	44	28	laboratories	laboratory	NOUN
ajlm-1644	44	29	,	,	PUNCT
ajlm-1644	44	30	hercules	hercules	PROPN
ajlm-1644	44	31	,	,	PUNCT
ajlm-1644	44	32	california	california	PROPN
ajlm-1644	44	33	,	,	PUNCT
ajlm-1644	44	34	united	united	PROPN
ajlm-1644	44	35	states	states	PROPN
ajlm-1644	44	36	)	)	PUNCT
ajlm-1644	44	37	.	.	PUNCT
ajlm-1644	45	1	excluded	exclude	VERB
ajlm-1644	45	2	cases	case	NOUN
ajlm-1644	45	3	included	include	VERB
ajlm-1644	45	4	those	those	PRON
ajlm-1644	45	5	without	without	ADP
ajlm-1644	45	6	their	their	PRON
ajlm-1644	45	7	respective	respective	ADJ
ajlm-1644	45	8	complete	complete	ADJ
ajlm-1644	45	9	blood	blood	NOUN
ajlm-1644	45	10	counts	count	VERB
ajlm-1644	45	11	reports	report	NOUN
ajlm-1644	45	12	,	,	PUNCT
ajlm-1644	45	13	those	those	PRON
ajlm-1644	45	14	with	with	ADP
ajlm-1644	45	15	confirmed	confirm	VERB
ajlm-1644	45	16	leukaemia	leukaemia	NOUN
ajlm-1644	45	17	,	,	PUNCT
ajlm-1644	45	18	and	and	CCONJ
ajlm-1644	45	19	those	those	DET
ajlm-1644	45	20	cases	case	NOUN
ajlm-1644	45	21	that	that	PRON
ajlm-1644	45	22	had	have	AUX
ajlm-1644	45	23	received	receive	VERB
ajlm-1644	45	24	transfusion	transfusion	NOUN
ajlm-1644	45	25	in	in	ADP
ajlm-1644	45	26	the	the	DET
ajlm-1644	45	27	past	past	ADJ
ajlm-1644	45	28	three	three	NUM
ajlm-1644	45	29	months	month	NOUN
ajlm-1644	45	30	.	.	PUNCT
ajlm-1644	46	1	the	the	DET
ajlm-1644	46	2	control	control	PROPN
ajlm-1644	46	3	group	group	NOUN
ajlm-1644	46	4	consisted	consist	VERB
ajlm-1644	46	5	of	of	ADP
ajlm-1644	46	6	individuals	individual	NOUN
ajlm-1644	46	7	presumed	presume	VERB
ajlm-1644	46	8	free	free	ADJ
ajlm-1644	46	9	from	from	ADP
ajlm-1644	46	10	disorders	disorder	NOUN
ajlm-1644	46	11	normally	normally	ADV
ajlm-1644	46	12	associated	associate	VERB
ajlm-1644	46	13	with	with	ADP
ajlm-1644	46	14	abnormality	abnormality	NOUN
ajlm-1644	46	15	of	of	ADP
ajlm-1644	46	16	red	red	ADJ
ajlm-1644	46	17	erythrocyte	erythrocyte	NOUN
ajlm-1644	46	18	shape	shape	NOUN
ajlm-1644	46	19	and	and	CCONJ
ajlm-1644	46	20	size	size	NOUN
ajlm-1644	46	21	(	(	PUNCT
ajlm-1644	46	22	including	include	VERB
ajlm-1644	46	23	haemolytic	haemolytic	ADJ
ajlm-1644	46	24	,	,	PUNCT
ajlm-1644	46	25	macrocytic	macrocytic	ADJ
ajlm-1644	46	26	or	or	CCONJ
ajlm-1644	46	27	iron	iron	NOUN
ajlm-1644	46	28	deficiency	deficiency	NOUN
ajlm-1644	46	29	anaemia	anaemia	NOUN
ajlm-1644	46	30	)	)	PUNCT
ajlm-1644	46	31	and	and	CCONJ
ajlm-1644	46	32	haemoglobinopathy	haemoglobinopathy	ADV
ajlm-1644	46	33	-	-	PUNCT
ajlm-1644	46	34	free	free	ADJ
ajlm-1644	46	35	.	.	PUNCT
ajlm-1644	47	1	these	these	PRON
ajlm-1644	47	2	were	be	AUX
ajlm-1644	47	3	age	age	NOUN
ajlm-1644	47	4	-	-	PUNCT
ajlm-1644	47	5	mixed	mix	VERB
ajlm-1644	47	6	people	people	NOUN
ajlm-1644	47	7	electrophoretically	electrophoretically	ADV
ajlm-1644	47	8	confirmed	confirm	VERB
ajlm-1644	47	9	to	to	PART
ajlm-1644	47	10	have	have	VERB
ajlm-1644	47	11	normal	normal	ADJ
ajlm-1644	47	12	haemoglobin	haemoglobin	NOUN
ajlm-1644	47	13	(	(	PUNCT
ajlm-1644	47	14	haemoglobin	haemoglobin	PROPN
ajlm-1644	47	15	aa	aa	PROPN
ajlm-1644	47	16	genotype	genotype	PROPN
ajlm-1644	47	17	)	)	PUNCT
ajlm-1644	47	18	and	and	CCONJ
ajlm-1644	47	19	had	have	VERB
ajlm-1644	47	20	haemoglobin	haemoglobin	PROPN
ajlm-1644	47	21	concentrations	concentration	NOUN
ajlm-1644	47	22	of	of	ADP
ajlm-1644	47	23	≥	≥	NOUN
ajlm-1644	47	24	9.5	9.5	NUM
ajlm-1644	47	25	g	g	NOUN
ajlm-1644	47	26	/	/	SYM
ajlm-1644	47	27	dl	dl	PROPN
ajlm-1644	47	28	for	for	ADP
ajlm-1644	47	29	≤	≤	ADJ
ajlm-1644	47	30	5	5	NUM
ajlm-1644	47	31	-	-	PUNCT
ajlm-1644	47	32	year	year	NOUN
ajlm-1644	47	33	-	-	PUNCT
ajlm-1644	47	34	olds	old	NOUN
ajlm-1644	47	35	,	,	PUNCT
ajlm-1644	47	36	≥	≥	X
ajlm-1644	47	37	10.5	10.5	NUM
ajlm-1644	47	38	g	g	NOUN
ajlm-1644	47	39	/	/	SYM
ajlm-1644	47	40	dl	dl	PROPN
ajlm-1644	47	41	for	for	ADP
ajlm-1644	47	42	≤	≤	ADJ
ajlm-1644	47	43	12	12	NUM
ajlm-1644	47	44	-	-	PUNCT
ajlm-1644	47	45	year	year	NOUN
ajlm-1644	47	46	-	-	PUNCT
ajlm-1644	47	47	olds	old	NOUN
ajlm-1644	47	48	and	and	CCONJ
ajlm-1644	47	49	≥	≥	NUM
ajlm-1644	47	50	11	11	NUM
ajlm-1644	47	51	g	g	NOUN
ajlm-1644	47	52	/	/	SYM
ajlm-1644	47	53	dl	dl	PROPN
ajlm-1644	47	54	for	for	ADP
ajlm-1644	47	55	≥	≥	NUM
ajlm-1644	47	56	13	13	NUM
ajlm-1644	47	57	-	-	PUNCT
ajlm-1644	47	58	year	year	NOUN
ajlm-1644	47	59	-	-	PUNCT
ajlm-1644	47	60	olds.29	olds.29	NOUN
ajlm-1644	47	61	all	all	DET
ajlm-1644	47	62	participants	participant	NOUN
ajlm-1644	47	63	had	have	VERB
ajlm-1644	47	64	rdw	rdw	ADJ
ajlm-1644	47	65	results	result	NOUN
ajlm-1644	47	66	as	as	ADP
ajlm-1644	47	67	part	part	NOUN
ajlm-1644	47	68	of	of	ADP
ajlm-1644	47	69	the	the	DET
ajlm-1644	47	70	complete	complete	ADJ
ajlm-1644	47	71	blood	blood	NOUN
ajlm-1644	47	72	counts	count	NOUN
ajlm-1644	47	73	from	from	ADP
ajlm-1644	47	74	automated	automate	VERB
ajlm-1644	47	75	haematology	haematology	NOUN
ajlm-1644	47	76	analysers	analyser	NOUN
ajlm-1644	47	77	,	,	PUNCT
ajlm-1644	47	78	but	but	CCONJ
ajlm-1644	47	79	cases	case	NOUN
ajlm-1644	47	80	had	have	VERB
ajlm-1644	47	81	additional	additional	ADJ
ajlm-1644	47	82	haemoglobin	haemoglobin	NOUN
ajlm-1644	47	83	profiles	profile	NOUN
ajlm-1644	47	84	.	.	PUNCT
ajlm-1644	48	1	data	datum	NOUN
ajlm-1644	48	2	analysis	analysis	NOUN
ajlm-1644	48	3	statistical	statistical	ADJ
ajlm-1644	48	4	package	package	NOUN
ajlm-1644	48	5	for	for	ADP
ajlm-1644	48	6	social	social	ADJ
ajlm-1644	48	7	sciences	science	NOUN
ajlm-1644	48	8	version	version	NOUN
ajlm-1644	48	9	20	20	NUM
ajlm-1644	48	10	(	(	PUNCT
ajlm-1644	48	11	spss	spss	PROPN
ajlm-1644	48	12	inc	inc	PROPN
ajlm-1644	48	13	.	.	PROPN
ajlm-1644	48	14	,	,	PUNCT
ajlm-1644	48	15	chicago	chicago	PROPN
ajlm-1644	48	16	,	,	PUNCT
ajlm-1644	48	17	illinois	illinois	PROPN
ajlm-1644	48	18	,	,	PUNCT
ajlm-1644	48	19	united	united	PROPN
ajlm-1644	48	20	states	states	PROPN
ajlm-1644	48	21	)	)	PUNCT
ajlm-1644	48	22	was	be	AUX
ajlm-1644	48	23	used	use	VERB
ajlm-1644	48	24	to	to	PART
ajlm-1644	48	25	analyse	analyse	VERB
ajlm-1644	48	26	data	datum	NOUN
ajlm-1644	48	27	with	with	ADP
ajlm-1644	48	28	kolmogorov	kolmogorov	PROPN
ajlm-1644	48	29	-	-	PUNCT
ajlm-1644	48	30	smirnov	smirnov	PROPN
ajlm-1644	48	31	and	and	CCONJ
ajlm-1644	48	32	shapiro	shapiro	NOUN
ajlm-1644	48	33	-	-	PUNCT
ajlm-1644	48	34	wilks	wilk	NOUN
ajlm-1644	48	35	tests	test	NOUN
ajlm-1644	48	36	.	.	PUNCT
ajlm-1644	49	1	these	these	DET
ajlm-1644	49	2	tests	test	NOUN
ajlm-1644	49	3	revealed	reveal	VERB
ajlm-1644	49	4	that	that	SCONJ
ajlm-1644	49	5	the	the	DET
ajlm-1644	49	6	control	control	NOUN
ajlm-1644	49	7	group	group	NOUN
ajlm-1644	49	8	was	be	AUX
ajlm-1644	49	9	a	a	DET
ajlm-1644	49	10	skewed	skewed	ADJ
ajlm-1644	49	11	(	(	PUNCT
ajlm-1644	49	12	non	non	ADJ
ajlm-1644	49	13	-	-	ADJ
ajlm-1644	49	14	normal	normal	ADJ
ajlm-1644	49	15	)	)	PUNCT
ajlm-1644	49	16	distribution	distribution	NOUN
ajlm-1644	49	17	(	(	PUNCT
ajlm-1644	49	18	p	p	X
ajlm-1644	49	19	<	<	X
ajlm-1644	49	20	0.05	0.05	NUM
ajlm-1644	49	21	)	)	PUNCT
ajlm-1644	49	22	;	;	PUNCT
ajlm-1644	49	23	thus	thus	ADV
ajlm-1644	49	24	,	,	PUNCT
ajlm-1644	49	25	a	a	DET
ajlm-1644	49	26	non	non	ADJ
ajlm-1644	49	27	-	-	ADJ
ajlm-1644	49	28	parametric	parametric	ADJ
ajlm-1644	49	29	statistics	statistic	NOUN
ajlm-1644	49	30	test	test	NOUN
ajlm-1644	49	31	,	,	PUNCT
ajlm-1644	49	32	the	the	DET
ajlm-1644	49	33	kruskal	kruskal	PROPN
ajlm-1644	49	34	-	-	PUNCT
ajlm-1644	49	35	wallis	wallis	PROPN
ajlm-1644	49	36	h	h	NOUN
ajlm-1644	49	37	-	-	PUNCT
ajlm-1644	49	38	test	test	NOUN
ajlm-1644	49	39	,	,	PUNCT
ajlm-1644	49	40	was	be	AUX
ajlm-1644	49	41	used	use	VERB
ajlm-1644	49	42	to	to	PART
ajlm-1644	49	43	assess	assess	VERB
ajlm-1644	49	44	the	the	DET
ajlm-1644	49	45	rdw	rdw	ADJ
ajlm-1644	49	46	variation	variation	NOUN
ajlm-1644	49	47	within	within	ADP
ajlm-1644	49	48	haemoglobinopathy	haemoglobinopathy	ADJ
ajlm-1644	49	49	variants	variant	NOUN
ajlm-1644	49	50	while	while	SCONJ
ajlm-1644	49	51	the	the	DET
ajlm-1644	49	52	mann	mann	PROPN
ajlm-1644	49	53	whitney	whitney	PROPN
ajlm-1644	49	54	u	u	PROPN
ajlm-1644	49	55	-	-	NOUN
ajlm-1644	49	56	test	test	NOUN
ajlm-1644	49	57	was	be	AUX
ajlm-1644	49	58	used	use	VERB
ajlm-1644	49	59	to	to	PART
ajlm-1644	49	60	compare	compare	VERB
ajlm-1644	49	61	the	the	DET
ajlm-1644	49	62	rdw	rdw	ADJ
ajlm-1644	49	63	variations	variation	NOUN
ajlm-1644	49	64	between	between	ADP
ajlm-1644	49	65	groups	group	NOUN
ajlm-1644	49	66	as	as	SCONJ
ajlm-1644	49	67	recommended	recommend	VERB
ajlm-1644	49	68	by	by	ADP
ajlm-1644	49	69	nahm	nahm	PROPN
ajlm-1644	49	70	,	,	PUNCT
ajlm-1644	49	71	2016.30	2016.30	NUM
ajlm-1644	49	72	accordingly	accordingly	ADV
ajlm-1644	49	73	,	,	PUNCT
ajlm-1644	49	74	the	the	DET
ajlm-1644	49	75	normal	normal	ADJ
ajlm-1644	49	76	rdw	rdw	ADJ
ajlm-1644	49	77	reference	reference	NOUN
ajlm-1644	49	78	values	value	NOUN
ajlm-1644	49	79	were	be	AUX
ajlm-1644	49	80	derived	derive	VERB
ajlm-1644	49	81	from	from	ADP
ajlm-1644	49	82	the	the	DET
ajlm-1644	49	83	control	control	NOUN
ajlm-1644	49	84	group	group	NOUN
ajlm-1644	49	85	as	as	ADP
ajlm-1644	49	86	the	the	DET
ajlm-1644	49	87	upper	upper	ADJ
ajlm-1644	49	88	limit	limit	NOUN
ajlm-1644	49	89	of	of	ADP
ajlm-1644	49	90	95	95	NUM
ajlm-1644	49	91	%	%	NOUN
ajlm-1644	49	92	confidence	confidence	NOUN
ajlm-1644	49	93	interval	interval	NOUN
ajlm-1644	49	94	(	(	PUNCT
ajlm-1644	49	95	ci	ci	NOUN
ajlm-1644	49	96	)	)	PUNCT
ajlm-1644	49	97	of	of	ADP
ajlm-1644	49	98	the	the	DET
ajlm-1644	49	99	median	median	PROPN
ajlm-1644	49	100	.	.	PUNCT
ajlm-1644	50	1	data	datum	NOUN
ajlm-1644	50	2	were	be	AUX
ajlm-1644	50	3	summarised	summarise	VERB
ajlm-1644	50	4	as	as	ADP
ajlm-1644	50	5	a	a	DET
ajlm-1644	50	6	median	median	ADJ
ajlm-1644	50	7	and	and	CCONJ
ajlm-1644	50	8	interquartile	interquartile	ADJ
ajlm-1644	50	9	range	range	NOUN
ajlm-1644	50	10	for	for	ADP
ajlm-1644	50	11	the	the	DET
ajlm-1644	50	12	rdw	rdw	NOUN
ajlm-1644	50	13	and	and	CCONJ
ajlm-1644	50	14	percentage	percentage	NOUN
ajlm-1644	50	15	for	for	ADP
ajlm-1644	50	16	haemoglobinopathy	haemoglobinopathy	ADJ
ajlm-1644	50	17	presence	presence	NOUN
ajlm-1644	50	18	.	.	PUNCT
ajlm-1644	51	1	the	the	DET
ajlm-1644	51	2	clinical	clinical	ADJ
ajlm-1644	51	3	utility	utility	NOUN
ajlm-1644	51	4	of	of	ADP
ajlm-1644	51	5	the	the	DET
ajlm-1644	51	6	rdw	rdw	NOUN
ajlm-1644	51	7	was	be	AUX
ajlm-1644	51	8	studied	study	VERB
ajlm-1644	51	9	through	through	ADP
ajlm-1644	51	10	receiver	receiver	NOUN
ajlm-1644	51	11	operating	operate	VERB
ajlm-1644	51	12	characteristic	characteristic	NOUN
ajlm-1644	51	13	(	(	PUNCT
ajlm-1644	51	14	roc	roc	NOUN
ajlm-1644	51	15	)	)	PUNCT
ajlm-1644	51	16	curves	curve	VERB
ajlm-1644	51	17	analysis	analysis	NOUN
ajlm-1644	51	18	to	to	PART
ajlm-1644	51	19	assess	assess	VERB
ajlm-1644	51	20	its	its	PRON
ajlm-1644	51	21	diagnostic	diagnostic	ADJ
ajlm-1644	51	22	efficacy	efficacy	NOUN
ajlm-1644	51	23	in	in	ADP
ajlm-1644	51	24	differentiating	differentiate	VERB
ajlm-1644	51	25	diseased	diseased	ADJ
ajlm-1644	51	26	(	(	PUNCT
ajlm-1644	51	27	haemoglobinopathy	haemoglobinopathy	ADJ
ajlm-1644	51	28	)	)	PUNCT
ajlm-1644	51	29	from	from	ADP
ajlm-1644	51	30	non	non	ADJ
ajlm-1644	51	31	-	-	ADJ
ajlm-1644	51	32	diseased	diseased	ADJ
ajlm-1644	51	33	(	(	PUNCT
ajlm-1644	51	34	haemoglobinopathy	haemoglobinopathy	ADV
ajlm-1644	51	35	-	-	PUNCT
ajlm-1644	51	36	free	free	ADJ
ajlm-1644	51	37	)	)	PUNCT
ajlm-1644	51	38	population	population	NOUN
ajlm-1644	51	39	.	.	PUNCT
ajlm-1644	52	1	the	the	DET
ajlm-1644	52	2	sensitivity	sensitivity	NOUN
ajlm-1644	52	3	and	and	CCONJ
ajlm-1644	52	4	specificity	specificity	NOUN
ajlm-1644	52	5	at	at	ADP
ajlm-1644	52	6	optimal	optimal	ADJ
ajlm-1644	52	7	points	point	NOUN
ajlm-1644	52	8	by	by	ADP
ajlm-1644	52	9	use	use	NOUN
ajlm-1644	52	10	of	of	ADP
ajlm-1644	52	11	youden	youden	PROPN
ajlm-1644	52	12	index	index	NOUN
ajlm-1644	52	13	,	,	PUNCT
ajlm-1644	52	14	plus	plus	CCONJ
ajlm-1644	52	15	predictive	predictive	ADJ
ajlm-1644	52	16	values	value	NOUN
ajlm-1644	52	17	,	,	PUNCT
ajlm-1644	52	18	likelihood	likelihood	NOUN
ajlm-1644	52	19	ratio	ratio	NOUN
ajlm-1644	52	20	(	(	PUNCT
ajlm-1644	52	21	lr	lr	NOUN
ajlm-1644	52	22	)	)	PUNCT
ajlm-1644	52	23	,	,	PUNCT
ajlm-1644	52	24	and	and	CCONJ
ajlm-1644	52	25	odds	odd	NOUN
ajlm-1644	52	26	ratio	ratio	NOUN
ajlm-1644	52	27	(	(	PUNCT
ajlm-1644	52	28	or	or	CCONJ
ajlm-1644	52	29	)	)	PUNCT
ajlm-1644	52	30	at	at	ADP
ajlm-1644	52	31	the	the	DET
ajlm-1644	52	32	5	5	NUM
ajlm-1644	52	33	%	%	NOUN
ajlm-1644	52	34	significance	significance	NOUN
ajlm-1644	52	35	level	level	NOUN
ajlm-1644	52	36	(	(	PUNCT
ajlm-1644	52	37	p	p	NOUN
ajlm-1644	52	38	=	=	NOUN
ajlm-1644	52	39	0.05	0.05	NUM
ajlm-1644	52	40	)	)	PUNCT
ajlm-1644	52	41	were	be	AUX
ajlm-1644	52	42	determined.31	determined.31	PROPN
ajlm-1644	52	43	results	result	VERB
ajlm-1644	52	44	demographic	demographic	ADJ
ajlm-1644	52	45	characteristics	characteristic	NOUN
ajlm-1644	52	46	of	of	ADP
ajlm-1644	52	47	study	study	NOUN
ajlm-1644	52	48	participants	participant	NOUN
ajlm-1644	52	49	the	the	DET
ajlm-1644	52	50	proportions	proportion	NOUN
ajlm-1644	52	51	of	of	ADP
ajlm-1644	52	52	the	the	DET
ajlm-1644	52	53	control	control	NOUN
ajlm-1644	52	54	group	group	NOUN
ajlm-1644	52	55	(	(	PUNCT
ajlm-1644	52	56	49.4	49.4	NUM
ajlm-1644	52	57	%	%	NOUN
ajlm-1644	52	58	,	,	PUNCT
ajlm-1644	52	59	n	n	PROPN
ajlm-1644	52	60	=	=	SYM
ajlm-1644	52	61	241	241	NUM
ajlm-1644	52	62	)	)	PUNCT
ajlm-1644	52	63	and	and	CCONJ
ajlm-1644	52	64	the	the	DET
ajlm-1644	52	65	case	case	NOUN
ajlm-1644	52	66	group	group	NOUN
ajlm-1644	52	67	(	(	PUNCT
ajlm-1644	52	68	50.6	50.6	NUM
ajlm-1644	52	69	%	%	NOUN
ajlm-1644	52	70	,	,	PUNCT
ajlm-1644	52	71	n	n	NOUN
ajlm-1644	52	72	=	=	SYM
ajlm-1644	52	73	247	247	NUM
ajlm-1644	52	74	)	)	PUNCT
ajlm-1644	52	75	did	do	AUX
ajlm-1644	52	76	not	not	PART
ajlm-1644	52	77	differ	differ	VERB
ajlm-1644	52	78	significantly	significantly	ADV
ajlm-1644	52	79	(	(	PUNCT
ajlm-1644	52	80	p	p	X
ajlm-1644	52	81	=	=	NOUN
ajlm-1644	52	82	0.740	0.740	NUM
ajlm-1644	52	83	)	)	PUNCT
ajlm-1644	52	84	in	in	ADP
ajlm-1644	52	85	a	a	DET
ajlm-1644	52	86	total	total	NOUN
ajlm-1644	52	87	of	of	ADP
ajlm-1644	52	88	488	488	NUM
ajlm-1644	52	89	individuals	individual	NOUN
ajlm-1644	52	90	(	(	PUNCT
ajlm-1644	52	91	table	table	NOUN
ajlm-1644	52	92	1	1	NUM
ajlm-1644	52	93	)	)	PUNCT
ajlm-1644	52	94	.	.	PUNCT
ajlm-1644	53	1	there	there	PRON
ajlm-1644	53	2	was	be	VERB
ajlm-1644	53	3	no	no	DET
ajlm-1644	53	4	significant	significant	ADJ
ajlm-1644	53	5	difference	difference	NOUN
ajlm-1644	53	6	(	(	PUNCT
ajlm-1644	53	7	p	p	NOUN
ajlm-1644	53	8	=	=	NOUN
ajlm-1644	53	9	0.502	0.502	NUM
ajlm-1644	53	10	)	)	PUNCT
ajlm-1644	53	11	between	between	ADP
ajlm-1644	53	12	the	the	DET
ajlm-1644	53	13	number	number	NOUN
ajlm-1644	53	14	of	of	ADP
ajlm-1644	53	15	male	male	NOUN
ajlm-1644	53	16	(	(	PUNCT
ajlm-1644	53	17	43.9	43.9	NUM
ajlm-1644	53	18	%	%	NOUN
ajlm-1644	53	19	,	,	PUNCT
ajlm-1644	53	20	n	n	NOUN
ajlm-1644	53	21	=	=	SYM
ajlm-1644	53	22	214	214	NUM
ajlm-1644	53	23	)	)	PUNCT
ajlm-1644	53	24	and	and	CCONJ
ajlm-1644	53	25	female	female	ADJ
ajlm-1644	53	26	(	(	PUNCT
ajlm-1644	53	27	56.1	56.1	NUM
ajlm-1644	53	28	%	%	NOUN
ajlm-1644	53	29	,	,	PUNCT
ajlm-1644	53	30	n	n	NOUN
ajlm-1644	53	31	=	=	SYM
ajlm-1644	53	32	274	274	NUM
ajlm-1644	53	33	)	)	PUNCT
ajlm-1644	53	34	participants	participant	NOUN
ajlm-1644	53	35	.	.	PUNCT
ajlm-1644	54	1	the	the	DET
ajlm-1644	54	2	majority	majority	NOUN
ajlm-1644	54	3	of	of	ADP
ajlm-1644	54	4	the	the	DET
ajlm-1644	54	5	participants	participant	NOUN
ajlm-1644	54	6	were	be	AUX
ajlm-1644	54	7	from	from	ADP
ajlm-1644	54	8	the	the	DET
ajlm-1644	54	9	kisumu	kisumu	PROPN
ajlm-1644	54	10	station	station	NOUN
ajlm-1644	54	11	(	(	PUNCT
ajlm-1644	54	12	49.0	49.0	NUM
ajlm-1644	54	13	%	%	NOUN
ajlm-1644	54	14	,	,	PUNCT
ajlm-1644	54	15	n	n	PROPN
ajlm-1644	54	16	=	=	SYM
ajlm-1644	54	17	239	239	NUM
ajlm-1644	54	18	)	)	PUNCT
ajlm-1644	54	19	,	,	PUNCT
ajlm-1644	54	20	followed	follow	VERB
ajlm-1644	54	21	by	by	ADP
ajlm-1644	54	22	busia	busia	NOUN
ajlm-1644	54	23	(	(	PUNCT
ajlm-1644	54	24	15.4	15.4	NUM
ajlm-1644	54	25	%	%	NOUN
ajlm-1644	54	26	,	,	PUNCT
ajlm-1644	54	27	n	n	NOUN
ajlm-1644	54	28	=	=	SYM
ajlm-1644	54	29	75	75	NUM
ajlm-1644	54	30	)	)	PUNCT
ajlm-1644	54	31	and	and	CCONJ
ajlm-1644	54	32	homabay	homabay	X
ajlm-1644	54	33	(	(	PUNCT
ajlm-1644	54	34	12.3	12.3	NUM
ajlm-1644	54	35	%	%	NOUN
ajlm-1644	54	36	,	,	PUNCT
ajlm-1644	54	37	n	n	NOUN
ajlm-1644	54	38	=	=	SYM
ajlm-1644	54	39	60	60	NUM
ajlm-1644	54	40	;	;	PUNCT
ajlm-1644	54	41	p	p	X
ajlm-1644	54	42	<	<	X
ajlm-1644	54	43	0.001	0.001	NUM
ajlm-1644	54	44	)	)	PUNCT
ajlm-1644	54	45	.	.	PUNCT
ajlm-1644	55	1	the	the	DET
ajlm-1644	55	2	rest	rest	NOUN
ajlm-1644	55	3	of	of	ADP
ajlm-1644	55	4	the	the	DET
ajlm-1644	55	5	participants	participant	NOUN
ajlm-1644	55	6	were	be	AUX
ajlm-1644	55	7	distributed	distribute	VERB
ajlm-1644	55	8	among	among	ADP
ajlm-1644	55	9	the	the	DET
ajlm-1644	55	10	rest	rest	NOUN
ajlm-1644	55	11	of	of	ADP
ajlm-1644	55	12	the	the	DET
ajlm-1644	55	13	locations	location	NOUN
ajlm-1644	55	14	.	.	PUNCT
ajlm-1644	56	1	there	there	PRON
ajlm-1644	56	2	was	be	VERB
ajlm-1644	56	3	a	a	DET
ajlm-1644	56	4	statistically	statistically	ADV
ajlm-1644	56	5	significant	significant	ADJ
ajlm-1644	56	6	variation	variation	NOUN
ajlm-1644	56	7	in	in	ADP
ajlm-1644	56	8	scd	scd	NOUN
ajlm-1644	56	9	frequencies	frequency	NOUN
ajlm-1644	56	10	across	across	ADP
ajlm-1644	56	11	the	the	DET
ajlm-1644	56	12	three	three	NUM
ajlm-1644	56	13	age	age	NOUN
ajlm-1644	56	14	groups	group	NOUN
ajlm-1644	56	15	:	:	PUNCT
ajlm-1644	56	16	≤	≤	NUM
ajlm-1644	56	17	5	5	NUM
ajlm-1644	56	18	-	-	PUNCT
ajlm-1644	56	19	year	year	NOUN
ajlm-1644	56	20	-	-	PUNCT
ajlm-1644	56	21	olds	old	NOUN
ajlm-1644	56	22	(	(	PUNCT
ajlm-1644	56	23	42.4	42.4	NUM
ajlm-1644	56	24	%	%	NOUN
ajlm-1644	56	25	,	,	PUNCT
ajlm-1644	56	26	n	n	NOUN
ajlm-1644	56	27	=	=	SYM
ajlm-1644	56	28	207	207	NUM
ajlm-1644	56	29	)	)	PUNCT
ajlm-1644	56	30	,	,	PUNCT
ajlm-1644	56	31	≤	≤	ADV
ajlm-1644	56	32	12	12	NUM
ajlm-1644	56	33	-	-	PUNCT
ajlm-1644	56	34	year	year	NOUN
ajlm-1644	56	35	-	-	PUNCT
ajlm-1644	56	36	olds	old	NOUN
ajlm-1644	56	37	(	(	PUNCT
ajlm-1644	56	38	19.9	19.9	NUM
ajlm-1644	56	39	%	%	NOUN
ajlm-1644	56	40	,	,	PUNCT
ajlm-1644	56	41	n	n	NOUN
ajlm-1644	56	42	=	=	NUM
ajlm-1644	56	43	97	97	NUM
ajlm-1644	56	44	)	)	PUNCT
ajlm-1644	56	45	,	,	PUNCT
ajlm-1644	56	46	and	and	CCONJ
ajlm-1644	56	47	≥	≥	NUM
ajlm-1644	56	48	13	13	NUM
ajlm-1644	56	49	-	-	PUNCT
ajlm-1644	56	50	year	year	NOUN
ajlm-1644	56	51	-	-	PUNCT
ajlm-1644	56	52	olds	old	NOUN
ajlm-1644	56	53	(	(	PUNCT
ajlm-1644	56	54	37.7	37.7	NUM
ajlm-1644	56	55	%	%	NOUN
ajlm-1644	56	56	,	,	PUNCT
ajlm-1644	56	57	n	n	NOUN
ajlm-1644	56	58	=	=	SYM
ajlm-1644	56	59	184	184	NUM
ajlm-1644	56	60	;	;	PUNCT
ajlm-1644	56	61	p	p	X
ajlm-1644	56	62	<	<	X
ajlm-1644	56	63	0.001	0.001	NUM
ajlm-1644	56	64	)	)	PUNCT
ajlm-1644	56	65	.	.	PUNCT
ajlm-1644	57	1	table	table	NOUN
ajlm-1644	57	2	1	1	NUM
ajlm-1644	57	3	:	:	PUNCT
ajlm-1644	57	4	 	 	SPACE
ajlm-1644	57	5	demographic	demographic	ADJ
ajlm-1644	57	6	characteristics	characteristic	NOUN
ajlm-1644	57	7	of	of	ADP
ajlm-1644	57	8	study	study	NOUN
ajlm-1644	57	9	participants	participant	NOUN
ajlm-1644	57	10	and	and	CCONJ
ajlm-1644	57	11	rdw	rdw	X
ajlm-1644	57	12	in	in	ADP
ajlm-1644	57	13	control	control	NOUN
ajlm-1644	57	14	and	and	CCONJ
ajlm-1644	57	15	case	case	NOUN
ajlm-1644	57	16	(	(	PUNCT
ajlm-1644	57	17	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	57	18	)	)	PUNCT
ajlm-1644	57	19	groups	group	NOUN
ajlm-1644	57	20	in	in	ADP
ajlm-1644	57	21	western	western	ADJ
ajlm-1644	57	22	kenya	kenya	PROPN
ajlm-1644	57	23	,	,	PUNCT
ajlm-1644	57	24	01	01	NUM
ajlm-1644	57	25	january	january	PROPN
ajlm-1644	57	26	2015	2015	NUM
ajlm-1644	57	27	–	–	PUNCT
ajlm-1644	57	28	31	31	NUM
ajlm-1644	57	29	december	december	PROPN
ajlm-1644	57	30	2020	2020	NUM
ajlm-1644	57	31	.	.	PUNCT
ajlm-1644	58	1	rdw	rdw	AUX
ajlm-1644	58	2	in	in	ADP
ajlm-1644	58	3	haemoglobinopathy	haemoglobinopathy	ADJ
ajlm-1644	58	4	phenotyping	phenotype	VERB
ajlm-1644	58	5	the	the	DET
ajlm-1644	58	6	median	median	ADJ
ajlm-1644	58	7	rdw	rdw	ADJ
ajlm-1644	58	8	difference	difference	NOUN
ajlm-1644	58	9	was	be	AUX
ajlm-1644	58	10	6.2	6.2	NUM
ajlm-1644	58	11	between	between	ADP
ajlm-1644	58	12	the	the	DET
ajlm-1644	58	13	case	case	NOUN
ajlm-1644	58	14	(	(	PUNCT
ajlm-1644	58	15	20.7	20.7	NUM
ajlm-1644	58	16	,	,	PUNCT
ajlm-1644	59	1	interquartile	interquartile	ADJ
ajlm-1644	59	2	range	range	NOUN
ajlm-1644	59	3	[	[	X
ajlm-1644	59	4	iqr	iqr	X
ajlm-1644	59	5	]	]	X
ajlm-1644	59	6	=	=	SYM
ajlm-1644	59	7	8.3	8.3	NUM
ajlm-1644	59	8	)	)	PUNCT
ajlm-1644	59	9	and	and	CCONJ
ajlm-1644	59	10	the	the	DET
ajlm-1644	59	11	control	control	NOUN
ajlm-1644	59	12	groups	group	NOUN
ajlm-1644	59	13	(	(	PUNCT
ajlm-1644	59	14	14.5	14.5	NUM
ajlm-1644	59	15	,	,	PUNCT
ajlm-1644	59	16	iqr	iqr	X
ajlm-1644	59	17	=	=	NOUN
ajlm-1644	59	18	2.7	2.7	NUM
ajlm-1644	59	19	;	;	PUNCT
ajlm-1644	59	20	95	95	NUM
ajlm-1644	59	21	%	%	NOUN
ajlm-1644	59	22	,	,	PUNCT
ajlm-1644	59	23	ci	ci	PROPN
ajlm-1644	59	24	=	=	SYM
ajlm-1644	59	25	9.1–19.9	9.1–19.9	PROPN
ajlm-1644	59	26	;	;	PUNCT
ajlm-1644	59	27	p	p	X
ajlm-1644	59	28	<	<	X
ajlm-1644	59	29	0.001	0.001	NUM
ajlm-1644	59	30	)	)	PUNCT
ajlm-1644	59	31	.	.	PUNCT
ajlm-1644	60	1	the	the	DET
ajlm-1644	60	2	rdw	rdw	ADJ
ajlm-1644	60	3	median	median	NOUN
ajlm-1644	60	4	for	for	ADP
ajlm-1644	60	5	scd	scd	PROPN
ajlm-1644	60	6	phenotypes	phenotype	NOUN
ajlm-1644	60	7	were	be	AUX
ajlm-1644	60	8	:	:	PUNCT
ajlm-1644	60	9	haemoglobin	haemoglobin	PROPN
ajlm-1644	60	10	ss	ss	PROPN
ajlm-1644	60	11	genotype	genotype	PROPN
ajlm-1644	60	12	,	,	PUNCT
ajlm-1644	60	13	25.4	25.4	NUM
ajlm-1644	60	14	(	(	PUNCT
ajlm-1644	60	15	iqr	iqr	PROPN
ajlm-1644	60	16	=	=	NOUN
ajlm-1644	60	17	5.5	5.5	NUM
ajlm-1644	60	18	)	)	PUNCT
ajlm-1644	60	19	;	;	PUNCT
ajlm-1644	60	20	haemoglobin	haemoglobin	NOUN
ajlm-1644	60	21	ss	ss	PROPN
ajlm-1644	60	22	genotype	genotype	NOUN
ajlm-1644	60	23	+	+	CCONJ
ajlm-1644	60	24	β	β	NOUN
ajlm-1644	60	25	-	-	NOUN
ajlm-1644	60	26	thalassemia	thalassemia	NOUN
ajlm-1644	60	27	,	,	PUNCT
ajlm-1644	60	28	23.3	23.3	NUM
ajlm-1644	60	29	(	(	PUNCT
ajlm-1644	60	30	iqr	iqr	PROPN
ajlm-1644	60	31	=	=	NOUN
ajlm-1644	60	32	7.9	7.9	NUM
ajlm-1644	60	33	)	)	PUNCT
ajlm-1644	60	34	;	;	PUNCT
ajlm-1644	60	35	and	and	CCONJ
ajlm-1644	60	36	haemoglobin	haemoglobin	NOUN
ajlm-1644	60	37	ss	ss	PROPN
ajlm-1644	60	38	genotype	genotype	NOUN
ajlm-1644	61	1	+	+	CCONJ
ajlm-1644	61	2	haemoglobin	haemoglobin	PROPN
ajlm-1644	61	3	f	f	PROPN
ajlm-1644	61	4	,	,	PUNCT
ajlm-1644	61	5	20.9	20.9	NUM
ajlm-1644	61	6	(	(	PUNCT
ajlm-1644	61	7	iqr	iqr	PROPN
ajlm-1644	61	8	=	=	NOUN
ajlm-1644	61	9	5.5	5.5	NUM
ajlm-1644	61	10	)	)	PUNCT
ajlm-1644	61	11	which	which	PRON
ajlm-1644	61	12	were	be	AUX
ajlm-1644	61	13	significantly	significantly	ADV
ajlm-1644	61	14	higher	high	ADJ
ajlm-1644	61	15	compared	compare	VERB
ajlm-1644	61	16	to	to	ADP
ajlm-1644	61	17	the	the	DET
ajlm-1644	61	18	control	control	NOUN
ajlm-1644	61	19	group	group	NOUN
ajlm-1644	61	20	(	(	PUNCT
ajlm-1644	61	21	14.5	14.5	NUM
ajlm-1644	61	22	,	,	PUNCT
ajlm-1644	61	23	iqr	iqr	X
ajlm-1644	61	24	=	=	NOUN
ajlm-1644	62	1	2.7	2.7	NUM
ajlm-1644	62	2	;	;	PUNCT
ajlm-1644	62	3	95	95	NUM
ajlm-1644	62	4	%	%	NOUN
ajlm-1644	62	5	ci	ci	NOUN
ajlm-1644	62	6	=	=	SYM
ajlm-1644	62	7	9.1–19.9	9.1–19.9	NUM
ajlm-1644	62	8	;	;	PUNCT
ajlm-1644	62	9	p	p	X
ajlm-1644	62	10	<	<	X
ajlm-1644	62	11	0.001	0.001	NUM
ajlm-1644	62	12	)	)	PUNCT
ajlm-1644	62	13	.	.	PUNCT
ajlm-1644	63	1	individuals	individual	NOUN
ajlm-1644	63	2	with	with	ADP
ajlm-1644	63	3	pure	pure	ADJ
ajlm-1644	63	4	haemoglobin	haemoglobin	NOUN
ajlm-1644	63	5	as	as	ADP
ajlm-1644	63	6	genotype	genotype	NOUN
ajlm-1644	63	7	had	have	VERB
ajlm-1644	63	8	a	a	DET
ajlm-1644	63	9	significantly	significantly	ADV
ajlm-1644	63	10	higher	high	ADJ
ajlm-1644	63	11	(	(	PUNCT
ajlm-1644	63	12	p	p	X
ajlm-1644	63	13	<	<	X
ajlm-1644	63	14	0.001	0.001	NUM
ajlm-1644	63	15	)	)	PUNCT
ajlm-1644	63	16	rdw	rdw	ADJ
ajlm-1644	63	17	median	median	NOUN
ajlm-1644	63	18	of	of	ADP
ajlm-1644	63	19	16.4	16.4	NUM
ajlm-1644	63	20	(	(	PUNCT
ajlm-1644	63	21	iqr	iqr	PROPN
ajlm-1644	63	22	=	=	NOUN
ajlm-1644	63	23	6.5	6.5	NUM
ajlm-1644	63	24	)	)	PUNCT
ajlm-1644	63	25	compared	compare	VERB
ajlm-1644	63	26	to	to	ADP
ajlm-1644	63	27	the	the	DET
ajlm-1644	63	28	control	control	NOUN
ajlm-1644	63	29	group	group	NOUN
ajlm-1644	63	30	(	(	PUNCT
ajlm-1644	63	31	14.5	14.5	NUM
ajlm-1644	63	32	,	,	PUNCT
ajlm-1644	63	33	iqr	iqr	X
ajlm-1644	63	34	=	=	NOUN
ajlm-1644	63	35	2.7	2.7	NUM
ajlm-1644	63	36	;	;	PUNCT
ajlm-1644	63	37	95	95	NUM
ajlm-1644	63	38	%	%	NOUN
ajlm-1644	63	39	ci	ci	NOUN
ajlm-1644	63	40	=	=	SYM
ajlm-1644	63	41	9.1–19.9	9.1–19.9	NUM
ajlm-1644	63	42	)	)	PUNCT
ajlm-1644	63	43	.	.	PUNCT
ajlm-1644	64	1	the	the	DET
ajlm-1644	64	2	rdw	rdw	PROPN
ajlm-1644	64	3	was	be	AUX
ajlm-1644	64	4	high	high	ADJ
ajlm-1644	64	5	in	in	ADP
ajlm-1644	64	6	haemoglobin	haemoglobin	PROPN
ajlm-1644	64	7	as	as	ADP
ajlm-1644	64	8	genotype	genotype	NOUN
ajlm-1644	64	9	+	+	CCONJ
ajlm-1644	64	10	haemoglobin	haemoglobin	PROPN
ajlm-1644	64	11	f	f	PROPN
ajlm-1644	64	12	(	(	PUNCT
ajlm-1644	64	13	24.2	24.2	NUM
ajlm-1644	64	14	,	,	PUNCT
ajlm-1644	64	15	p	p	X
ajlm-1644	64	16	=	=	NOUN
ajlm-1644	64	17	0.449	0.449	NUM
ajlm-1644	64	18	)	)	PUNCT
ajlm-1644	64	19	,	,	PUNCT
ajlm-1644	64	20	haemoglobin	haemoglobin	NOUN
ajlm-1644	64	21	as	as	ADP
ajlm-1644	64	22	genotype	genotype	NOUN
ajlm-1644	64	23	+	+	CCONJ
ajlm-1644	64	24	β	β	NOUN
ajlm-1644	64	25	-	-	NOUN
ajlm-1644	64	26	thalassemia	thalassemia	NOUN
ajlm-1644	64	27	(	(	PUNCT
ajlm-1644	64	28	20.9	20.9	NUM
ajlm-1644	64	29	,	,	PUNCT
ajlm-1644	64	30	iqr	iqr	X
ajlm-1644	64	31	=	=	NOUN
ajlm-1644	65	1	10.5	10.5	NUM
ajlm-1644	65	2	;	;	PUNCT
ajlm-1644	65	3	p	p	PROPN
ajlm-1644	65	4	=	=	NOUN
ajlm-1644	65	5	0.791	0.791	NUM
ajlm-1644	65	6	)	)	PUNCT
ajlm-1644	65	7	and	and	CCONJ
ajlm-1644	65	8	β	β	NOUN
ajlm-1644	65	9	-	-	NOUN
ajlm-1644	65	10	thalassaemia	thalassaemia	NOUN
ajlm-1644	65	11	(	(	PUNCT
ajlm-1644	65	12	19.9	19.9	NUM
ajlm-1644	65	13	,	,	PUNCT
ajlm-1644	65	14	iqr	iqr	X
ajlm-1644	65	15	=	=	NOUN
ajlm-1644	65	16	8.6	8.6	NUM
ajlm-1644	65	17	;	;	PUNCT
ajlm-1644	65	18	p	p	X
ajlm-1644	65	19	=	=	NOUN
ajlm-1644	65	20	1.00	1.00	NUM
ajlm-1644	65	21	)	)	PUNCT
ajlm-1644	65	22	patients	patient	NOUN
ajlm-1644	65	23	but	but	CCONJ
ajlm-1644	65	24	the	the	DET
ajlm-1644	65	25	difference	difference	NOUN
ajlm-1644	65	26	was	be	AUX
ajlm-1644	65	27	not	not	PART
ajlm-1644	65	28	statistically	statistically	ADV
ajlm-1644	65	29	significant	significant	ADJ
ajlm-1644	65	30	when	when	SCONJ
ajlm-1644	65	31	compared	compare	VERB
ajlm-1644	65	32	to	to	ADP
ajlm-1644	65	33	the	the	DET
ajlm-1644	65	34	control	control	NOUN
ajlm-1644	65	35	group	group	NOUN
ajlm-1644	65	36	(	(	PUNCT
ajlm-1644	65	37	14.5	14.5	NUM
ajlm-1644	65	38	,	,	PUNCT
ajlm-1644	65	39	iqr	iqr	X
ajlm-1644	65	40	=	=	NOUN
ajlm-1644	65	41	2.7	2.7	NUM
ajlm-1644	65	42	;	;	PUNCT
ajlm-1644	65	43	95	95	NUM
ajlm-1644	65	44	%	%	NOUN
ajlm-1644	65	45	ci	ci	NOUN
ajlm-1644	65	46	=	=	SYM
ajlm-1644	65	47	9.1–19.9	9.1–19.9	PROPN
ajlm-1644	65	48	)	)	PUNCT
ajlm-1644	65	49	.	.	PUNCT
ajlm-1644	66	1	diagnostic	diagnostic	ADJ
ajlm-1644	66	2	efficacy	efficacy	NOUN
ajlm-1644	66	3	of	of	ADP
ajlm-1644	66	4	the	the	DET
ajlm-1644	66	5	rdw	rdw	NOUN
ajlm-1644	66	6	in	in	ADP
ajlm-1644	66	7	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	66	8	at	at	ADP
ajlm-1644	66	9	given	give	VERB
ajlm-1644	66	10	optimal	optimal	ADJ
ajlm-1644	66	11	points	point	NOUN
ajlm-1644	66	12	,	,	PUNCT
ajlm-1644	66	13	the	the	DET
ajlm-1644	66	14	rdw	rdw	NOUN
ajlm-1644	66	15	demonstrated	demonstrate	VERB
ajlm-1644	66	16	its	its	PRON
ajlm-1644	66	17	diagnostic	diagnostic	ADJ
ajlm-1644	66	18	efficacy	efficacy	NOUN
ajlm-1644	66	19	by	by	ADP
ajlm-1644	66	20	marking	mark	VERB
ajlm-1644	66	21	some	some	DET
ajlm-1644	66	22	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	66	23	with	with	ADP
ajlm-1644	66	24	a	a	DET
ajlm-1644	66	25	high	high	ADJ
ajlm-1644	66	26	sensitivity	sensitivity	NOUN
ajlm-1644	66	27	,	,	PUNCT
ajlm-1644	66	28	specifity	specifity	NOUN
ajlm-1644	66	29	,	,	PUNCT
ajlm-1644	66	30	youden	youden	NOUN
ajlm-1644	66	31	index	index	NOUN
ajlm-1644	66	32	and	and	CCONJ
ajlm-1644	66	33	asymptotic	asymptotic	ADJ
ajlm-1644	66	34	significance	significance	NOUN
ajlm-1644	66	35	(	(	PUNCT
ajlm-1644	66	36	p	p	X
ajlm-1644	66	37	<	<	X
ajlm-1644	66	38	0.001	0.001	NUM
ajlm-1644	66	39	)	)	PUNCT
ajlm-1644	66	40	with	with	ADP
ajlm-1644	66	41	their	their	PRON
ajlm-1644	66	42	roc	roc	PROPN
ajlm-1644	66	43	curves	curve	NOUN
ajlm-1644	66	44	flowing	flow	VERB
ajlm-1644	66	45	upwards	upwards	ADV
ajlm-1644	66	46	on	on	ADP
ajlm-1644	66	47	the	the	DET
ajlm-1644	66	48	left	left	ADJ
ajlm-1644	66	49	side	side	NOUN
ajlm-1644	66	50	of	of	ADP
ajlm-1644	66	51	the	the	DET
ajlm-1644	66	52	curve	curve	NOUN
ajlm-1644	66	53	(	(	PUNCT
ajlm-1644	66	54	table	table	NOUN
ajlm-1644	66	55	2	2	NUM
ajlm-1644	66	56	;	;	PUNCT
ajlm-1644	66	57	figure	figure	NOUN
ajlm-1644	66	58	1	1	NUM
ajlm-1644	66	59	)	)	PUNCT
ajlm-1644	66	60	.	.	PUNCT
ajlm-1644	67	1	on	on	ADP
ajlm-1644	67	2	the	the	DET
ajlm-1644	67	3	other	other	ADJ
ajlm-1644	67	4	hand	hand	NOUN
ajlm-1644	67	5	,	,	PUNCT
ajlm-1644	67	6	the	the	DET
ajlm-1644	67	7	diagnostic	diagnostic	ADJ
ajlm-1644	67	8	utility	utility	NOUN
ajlm-1644	67	9	of	of	ADP
ajlm-1644	67	10	rdw	rdw	NOUN
ajlm-1644	67	11	for	for	ADP
ajlm-1644	67	12	some	some	DET
ajlm-1644	67	13	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	67	14	was	be	AUX
ajlm-1644	67	15	marked	mark	VERB
ajlm-1644	67	16	by	by	ADP
ajlm-1644	67	17	low	low	ADJ
ajlm-1644	67	18	sensitivity	sensitivity	NOUN
ajlm-1644	67	19	,	,	PUNCT
ajlm-1644	67	20	specifity	specifity	NOUN
ajlm-1644	67	21	and	and	CCONJ
ajlm-1644	67	22	youden	youden	NOUN
ajlm-1644	67	23	index	index	NOUN
ajlm-1644	67	24	and	and	CCONJ
ajlm-1644	67	25	did	do	AUX
ajlm-1644	67	26	not	not	PART
ajlm-1644	67	27	have	have	VERB
ajlm-1644	67	28	asymptotic	asymptotic	ADJ
ajlm-1644	67	29	significance	significance	NOUN
ajlm-1644	67	30	with	with	ADP
ajlm-1644	67	31	their	their	PRON
ajlm-1644	67	32	roc	roc	PROPN
ajlm-1644	67	33	curve	curve	NOUN
ajlm-1644	67	34	flowing	flow	VERB
ajlm-1644	67	35	along	along	ADP
ajlm-1644	67	36	the	the	DET
ajlm-1644	67	37	diagonal	diagonal	ADJ
ajlm-1644	67	38	line	line	NOUN
ajlm-1644	67	39	(	(	PUNCT
ajlm-1644	67	40	figure	figure	NOUN
ajlm-1644	67	41	2	2	NUM
ajlm-1644	67	42	and	and	CCONJ
ajlm-1644	67	43	figure	figure	VERB
ajlm-1644	67	44	3	3	NUM
ajlm-1644	67	45	)	)	PUNCT
ajlm-1644	67	46	.	.	PUNCT
ajlm-1644	68	1	table	table	NOUN
ajlm-1644	68	2	2	2	NUM
ajlm-1644	68	3	:	:	PUNCT
ajlm-1644	68	4	 	 	SPACE
ajlm-1644	68	5	summary	summary	NOUN
ajlm-1644	68	6	of	of	ADP
ajlm-1644	68	7	rdw	rdw	ADJ
ajlm-1644	68	8	predictive	predictive	ADJ
ajlm-1644	68	9	ability	ability	NOUN
ajlm-1644	68	10	in	in	ADP
ajlm-1644	68	11	haemoglobin	haemoglobin	PROPN
ajlm-1644	68	12	disorders	disorder	NOUN
ajlm-1644	68	13	in	in	ADP
ajlm-1644	68	14	western	western	ADJ
ajlm-1644	68	15	kenya	kenya	NOUN
ajlm-1644	68	16	,	,	PUNCT
ajlm-1644	68	17	01	01	NUM
ajlm-1644	68	18	january	january	PROPN
ajlm-1644	68	19	2015	2015	NUM
ajlm-1644	68	20	–	–	PUNCT
ajlm-1644	68	21	31	31	NUM
ajlm-1644	68	22	december	december	PROPN
ajlm-1644	68	23	2020	2020	NUM
ajlm-1644	68	24	.	.	PUNCT
ajlm-1644	69	1	figure	figure	NOUN
ajlm-1644	69	2	1	1	NUM
ajlm-1644	69	3	:	:	PUNCT
ajlm-1644	69	4	red	red	ADJ
ajlm-1644	69	5	cell	cell	NOUN
ajlm-1644	69	6	distribution	distribution	NOUN
ajlm-1644	69	7	width	width	NOUN
ajlm-1644	69	8	,	,	PUNCT
ajlm-1644	69	9	roc	roc	PROPN
ajlm-1644	69	10	curve	curve	NOUN
ajlm-1644	69	11	in	in	ADP
ajlm-1644	69	12	scd	scd	PROPN
ajlm-1644	69	13	phenotypes	phenotype	NOUN
ajlm-1644	69	14	(	(	PUNCT
ajlm-1644	69	15	haemoglobin	haemoglobin	NOUN
ajlm-1644	69	16	ss	ss	PROPN
ajlm-1644	69	17	genotype	genotype	PROPN
ajlm-1644	69	18	,	,	PUNCT
ajlm-1644	69	19	haemoglobin	haemoglobin	NOUN
ajlm-1644	69	20	ss	ss	PROPN
ajlm-1644	69	21	genotype	genotype	NOUN
ajlm-1644	70	1	+	+	CCONJ
ajlm-1644	70	2	haemoglobin	haemoglobin	NOUN
ajlm-1644	70	3	f	f	PROPN
ajlm-1644	70	4	,	,	PUNCT
ajlm-1644	70	5	haemoglobin	haemoglobin	NOUN
ajlm-1644	70	6	ss	ss	NOUN
ajlm-1644	70	7	genotype	genotype	NOUN
ajlm-1644	70	8	+	+	CCONJ
ajlm-1644	70	9	β	β	NOUN
ajlm-1644	70	10	-	-	NOUN
ajlm-1644	70	11	thalassaemia	thalassaemia	NOUN
ajlm-1644	70	12	)	)	PUNCT
ajlm-1644	70	13	in	in	ADP
ajlm-1644	70	14	western	western	ADJ
ajlm-1644	70	15	kenya	kenya	PROPN
ajlm-1644	70	16	,	,	PUNCT
ajlm-1644	70	17	01	01	NUM
ajlm-1644	70	18	january	january	PROPN
ajlm-1644	70	19	2015	2015	NUM
ajlm-1644	70	20	–	–	PUNCT
ajlm-1644	70	21	31	31	NUM
ajlm-1644	70	22	december	december	PROPN
ajlm-1644	70	23	2020	2020	NUM
ajlm-1644	70	24	.	.	PUNCT
ajlm-1644	71	1	(	(	PUNCT
ajlm-1644	71	2	a	a	X
ajlm-1644	71	3	)	)	PUNCT
ajlm-1644	71	4	red	red	ADJ
ajlm-1644	71	5	cell	cell	NOUN
ajlm-1644	71	6	distribution	distribution	NOUN
ajlm-1644	71	7	width	width	NOUN
ajlm-1644	71	8	roc	roc	PROPN
ajlm-1644	71	9	curve	curve	NOUN
ajlm-1644	71	10	in	in	ADP
ajlm-1644	71	11	diagnosis	diagnosis	NOUN
ajlm-1644	71	12	of	of	ADP
ajlm-1644	71	13	homozygous	homozygous	ADJ
ajlm-1644	71	14	scd	scd	NOUN
ajlm-1644	71	15	.	.	PUNCT
ajlm-1644	72	1	(	(	PUNCT
ajlm-1644	72	2	b	b	X
ajlm-1644	72	3	)	)	PUNCT
ajlm-1644	72	4	red	red	ADJ
ajlm-1644	72	5	cell	cell	NOUN
ajlm-1644	72	6	distribution	distribution	NOUN
ajlm-1644	72	7	width	width	NOUN
ajlm-1644	72	8	roc	roc	PROPN
ajlm-1644	72	9	curve	curve	NOUN
ajlm-1644	72	10	in	in	ADP
ajlm-1644	72	11	diagnosis	diagnosis	NOUN
ajlm-1644	72	12	of	of	ADP
ajlm-1644	72	13	sickle	sickle	NOUN
ajlm-1644	72	14	cell	cell	NOUN
ajlm-1644	72	15	disease	disease	NOUN
ajlm-1644	72	16	with	with	ADP
ajlm-1644	72	17	haemoglobin	haemoglobin	PROPN
ajlm-1644	72	18	f.	f.	PROPN
ajlm-1644	72	19	(	(	PUNCT
ajlm-1644	72	20	c	c	X
ajlm-1644	72	21	)	)	PUNCT
ajlm-1644	72	22	red	red	ADJ
ajlm-1644	72	23	cell	cell	NOUN
ajlm-1644	72	24	distribution	distribution	NOUN
ajlm-1644	72	25	width	width	NOUN
ajlm-1644	72	26	roc	roc	PROPN
ajlm-1644	72	27	curve	curve	NOUN
ajlm-1644	72	28	in	in	ADP
ajlm-1644	72	29	diagnosis	diagnosis	NOUN
ajlm-1644	72	30	of	of	ADP
ajlm-1644	72	31	scd	scd	NOUN
ajlm-1644	72	32	with	with	ADP
ajlm-1644	72	33	β	β	NOUN
ajlm-1644	72	34	-	-	NOUN
ajlm-1644	72	35	thalassaemia	thalassaemia	NOUN
ajlm-1644	72	36	.	.	PUNCT
ajlm-1644	73	1	figure	figure	NOUN
ajlm-1644	73	2	2	2	NUM
ajlm-1644	73	3	:	:	PUNCT
ajlm-1644	73	4	red	red	ADJ
ajlm-1644	73	5	cell	cell	NOUN
ajlm-1644	73	6	distribution	distribution	NOUN
ajlm-1644	73	7	width	width	NOUN
ajlm-1644	73	8	roc	roc	PROPN
ajlm-1644	73	9	curve	curve	NOUN
ajlm-1644	73	10	in	in	ADP
ajlm-1644	73	11	sickle	sickle	NOUN
ajlm-1644	73	12	cell	cell	NOUN
ajlm-1644	73	13	triat	triat	NOUN
ajlm-1644	73	14	phenotypes	phenotype	NOUN
ajlm-1644	73	15	(	(	PUNCT
ajlm-1644	73	16	haemoglobin	haemoglobin	NOUN
ajlm-1644	73	17	as	as	ADP
ajlm-1644	73	18	genotype	genotype	NOUN
ajlm-1644	73	19	and	and	CCONJ
ajlm-1644	73	20	β	β	NOUN
ajlm-1644	73	21	-	-	NOUN
ajlm-1644	73	22	thalassaemia	thalassaemia	NOUN
ajlm-1644	73	23	)	)	PUNCT
ajlm-1644	73	24	in	in	ADP
ajlm-1644	73	25	western	western	ADJ
ajlm-1644	73	26	kenya	kenya	PROPN
ajlm-1644	73	27	,	,	PUNCT
ajlm-1644	73	28	01	01	NUM
ajlm-1644	73	29	january	january	PROPN
ajlm-1644	73	30	2015	2015	NUM
ajlm-1644	73	31	–	–	PUNCT
ajlm-1644	73	32	31	31	NUM
ajlm-1644	73	33	december	december	PROPN
ajlm-1644	73	34	2020	2020	NUM
ajlm-1644	73	35	.	.	PUNCT
ajlm-1644	74	1	(	(	PUNCT
ajlm-1644	74	2	a	a	X
ajlm-1644	74	3	)	)	PUNCT
ajlm-1644	74	4	red	red	ADJ
ajlm-1644	74	5	cell	cell	NOUN
ajlm-1644	74	6	distribution	distribution	NOUN
ajlm-1644	74	7	width	width	NOUN
ajlm-1644	74	8	,	,	PUNCT
ajlm-1644	74	9	receiver	receiver	ADV
ajlm-1644	74	10	operating	operate	VERB
ajlm-1644	74	11	characteristic	characteristic	ADJ
ajlm-1644	74	12	curve	curve	NOUN
ajlm-1644	74	13	for	for	ADP
ajlm-1644	74	14	sickle	sickle	NOUN
ajlm-1644	74	15	cell	cell	NOUN
ajlm-1644	74	16	trait	trait	NOUN
ajlm-1644	74	17	flowing	flow	VERB
ajlm-1644	74	18	along	along	ADP
ajlm-1644	74	19	diagonal	diagonal	ADJ
ajlm-1644	74	20	line	line	NOUN
ajlm-1644	74	21	of	of	ADP
ajlm-1644	74	22	the	the	DET
ajlm-1644	74	23	roc	roc	PROPN
ajlm-1644	74	24	curve	curve	NOUN
ajlm-1644	74	25	.	.	PUNCT
ajlm-1644	75	1	(	(	PUNCT
ajlm-1644	75	2	b	b	X
ajlm-1644	75	3	)	)	PUNCT
ajlm-1644	75	4	red	red	ADJ
ajlm-1644	75	5	cell	cell	NOUN
ajlm-1644	75	6	distribution	distribution	NOUN
ajlm-1644	75	7	width	width	NOUN
ajlm-1644	75	8	,	,	PUNCT
ajlm-1644	75	9	receiver	receiver	ADV
ajlm-1644	75	10	operating	operate	VERB
ajlm-1644	75	11	characteristic	characteristic	ADJ
ajlm-1644	75	12	curve	curve	NOUN
ajlm-1644	75	13	for	for	ADP
ajlm-1644	75	14	sickle	sickle	NOUN
ajlm-1644	75	15	cell	cell	PROPN
ajlm-1644	75	16	trait+β	trait+β	NOUN
ajlm-1644	75	17	-	-	PUNCT
ajlm-1644	75	18	thalassaemia	thalassaemia	NOUN
ajlm-1644	75	19	also	also	ADV
ajlm-1644	75	20	flowing	flow	VERB
ajlm-1644	75	21	along	along	ADP
ajlm-1644	75	22	the	the	DET
ajlm-1644	75	23	diagonal	diagonal	ADJ
ajlm-1644	75	24	line	line	NOUN
ajlm-1644	75	25	of	of	ADP
ajlm-1644	75	26	the	the	DET
ajlm-1644	75	27	roc	roc	PROPN
ajlm-1644	75	28	curve	curve	NOUN
ajlm-1644	75	29	.	.	PUNCT
ajlm-1644	76	1	figure	figure	VERB
ajlm-1644	76	2	3	3	NUM
ajlm-1644	76	3	:	:	PUNCT
ajlm-1644	76	4	red	red	ADJ
ajlm-1644	76	5	cell	cell	NOUN
ajlm-1644	76	6	distribution	distribution	NOUN
ajlm-1644	76	7	width	width	NOUN
ajlm-1644	76	8	roc	roc	PROPN
ajlm-1644	76	9	curve	curve	NOUN
ajlm-1644	76	10	in	in	ADP
ajlm-1644	76	11	β	β	NOUN
ajlm-1644	76	12	-	-	NOUN
ajlm-1644	76	13	thalassaemia	thalassaemia	NOUN
ajlm-1644	76	14	in	in	ADP
ajlm-1644	76	15	western	western	ADJ
ajlm-1644	76	16	kenya	kenya	PROPN
ajlm-1644	76	17	from	from	ADP
ajlm-1644	76	18	01	01	NUM
ajlm-1644	76	19	january	january	PROPN
ajlm-1644	76	20	2015	2015	NUM
ajlm-1644	76	21	–	–	PUNCT
ajlm-1644	76	22	31	31	NUM
ajlm-1644	76	23	december	december	PROPN
ajlm-1644	76	24	2020	2020	NUM
ajlm-1644	76	25	.	.	PUNCT
ajlm-1644	77	1	red	red	ADJ
ajlm-1644	77	2	cell	cell	NOUN
ajlm-1644	77	3	distribution	distribution	NOUN
ajlm-1644	77	4	roc	roc	PROPN
ajlm-1644	77	5	curve	curve	NOUN
ajlm-1644	77	6	in	in	ADP
ajlm-1644	77	7	sct	sct	PROPN
ajlm-1644	77	8	phenotyping	phenotype	VERB
ajlm-1644	77	9	the	the	DET
ajlm-1644	77	10	rdw	rdw	ADJ
ajlm-1644	77	11	proportion	proportion	NOUN
ajlm-1644	77	12	for	for	ADP
ajlm-1644	77	13	pure	pure	ADJ
ajlm-1644	77	14	haemoglobin	haemoglobin	NOUN
ajlm-1644	77	15	as	as	ADP
ajlm-1644	77	16	genotype	genotype	NOUN
ajlm-1644	77	17	was	be	AUX
ajlm-1644	77	18	21.1	21.1	NUM
ajlm-1644	77	19	%	%	NOUN
ajlm-1644	77	20	(	(	PUNCT
ajlm-1644	77	21	n	n	NOUN
ajlm-1644	77	22	=	=	SYM
ajlm-1644	77	23	103	103	NUM
ajlm-1644	77	24	;	;	PUNCT
ajlm-1644	77	25	roc	roc	PROPN
ajlm-1644	77	26	curve	curve	NOUN
ajlm-1644	77	27	flowed	flow	VERB
ajlm-1644	77	28	along	along	ADP
ajlm-1644	77	29	the	the	DET
ajlm-1644	77	30	diagonal	diagonal	ADJ
ajlm-1644	77	31	line	line	NOUN
ajlm-1644	77	32	with	with	ADP
ajlm-1644	77	33	a	a	DET
ajlm-1644	77	34	youden	youden	NOUN
ajlm-1644	77	35	index	index	NOUN
ajlm-1644	77	36	=	=	NOUN
ajlm-1644	77	37	0.501	0.501	NUM
ajlm-1644	77	38	;	;	PUNCT
ajlm-1644	77	39	p	p	X
ajlm-1644	77	40	=	=	NOUN
ajlm-1644	77	41	0.976	0.976	NUM
ajlm-1644	77	42	)	)	PUNCT
ajlm-1644	77	43	for	for	ADP
ajlm-1644	77	44	diagnosis	diagnosis	NOUN
ajlm-1644	77	45	of	of	ADP
ajlm-1644	77	46	pure	pure	ADJ
ajlm-1644	77	47	sickle	sickle	NOUN
ajlm-1644	77	48	cell	cell	NOUN
ajlm-1644	77	49	trait	trait	NOUN
ajlm-1644	77	50	(	(	PUNCT
ajlm-1644	77	51	sct	sct	PROPN
ajlm-1644	77	52	)	)	PUNCT
ajlm-1644	77	53	phenotype	phenotype	NOUN
ajlm-1644	77	54	(	(	PUNCT
ajlm-1644	77	55	table	table	NOUN
ajlm-1644	77	56	2	2	NUM
ajlm-1644	77	57	,	,	PUNCT
ajlm-1644	77	58	figure	figure	NOUN
ajlm-1644	77	59	2	2	NUM
ajlm-1644	77	60	)	)	PUNCT
ajlm-1644	77	61	.	.	PUNCT
ajlm-1644	78	1	similarly	similarly	ADV
ajlm-1644	78	2	,	,	PUNCT
ajlm-1644	78	3	the	the	DET
ajlm-1644	78	4	rdw	rdw	PROPN
ajlm-1644	78	5	roc	roc	PROPN
ajlm-1644	78	6	curve	curve	NOUN
ajlm-1644	78	7	coordinates	coordinate	NOUN
ajlm-1644	78	8	at	at	ADP
ajlm-1644	78	9	the	the	DET
ajlm-1644	78	10	optimal	optimal	ADJ
ajlm-1644	78	11	point	point	NOUN
ajlm-1644	78	12	of	of	ADP
ajlm-1644	78	13	19.8	19.8	NUM
ajlm-1644	78	14	did	do	AUX
ajlm-1644	78	15	not	not	PART
ajlm-1644	78	16	have	have	VERB
ajlm-1644	78	17	diagnostic	diagnostic	ADJ
ajlm-1644	78	18	significance	significance	NOUN
ajlm-1644	78	19	(	(	PUNCT
ajlm-1644	78	20	p	p	X
ajlm-1644	78	21	=	=	NOUN
ajlm-1644	78	22	0.399	0.399	NUM
ajlm-1644	78	23	,	,	PUNCT
ajlm-1644	78	24	sensitivity	sensitivity	NOUN
ajlm-1644	78	25	,	,	PUNCT
ajlm-1644	78	26	50	50	NUM
ajlm-1644	78	27	%	%	NOUN
ajlm-1644	78	28	,	,	PUNCT
ajlm-1644	78	29	specificity	specificity	NOUN
ajlm-1644	78	30	70	70	NUM
ajlm-1644	78	31	%	%	NOUN
ajlm-1644	78	32	;	;	PUNCT
ajlm-1644	78	33	curve	curve	NOUN
ajlm-1644	78	34	flowed	flow	VERB
ajlm-1644	78	35	along	along	ADP
ajlm-1644	78	36	the	the	DET
ajlm-1644	78	37	diagonal	diagonal	ADJ
ajlm-1644	78	38	line	line	NOUN
ajlm-1644	78	39	with	with	ADP
ajlm-1644	78	40	a	a	DET
ajlm-1644	78	41	low	low	ADJ
ajlm-1644	78	42	youden	youden	NOUN
ajlm-1644	78	43	index	index	NOUN
ajlm-1644	78	44	=	=	NOUN
ajlm-1644	78	45	0.600	0.600	NUM
ajlm-1644	78	46	)	)	PUNCT
ajlm-1644	78	47	for	for	ADP
ajlm-1644	78	48	the	the	DET
ajlm-1644	78	49	diagnosis	diagnosis	NOUN
ajlm-1644	78	50	of	of	ADP
ajlm-1644	78	51	haemoglobin	haemoglobin	NOUN
ajlm-1644	78	52	as	as	ADP
ajlm-1644	78	53	genotype	genotype	NOUN
ajlm-1644	78	54	+	+	CCONJ
ajlm-1644	78	55	β	β	NOUN
ajlm-1644	78	56	-	-	NOUN
ajlm-1644	78	57	thalassaemia	thalassaemia	NOUN
ajlm-1644	78	58	.	.	PUNCT
ajlm-1644	79	1	red	red	ADJ
ajlm-1644	79	2	cell	cell	NOUN
ajlm-1644	79	3	distribution	distribution	NOUN
ajlm-1644	79	4	roc	roc	PROPN
ajlm-1644	79	5	curve	curve	NOUN
ajlm-1644	79	6	in	in	ADP
ajlm-1644	79	7	scd	scd	PROPN
ajlm-1644	79	8	phenotyping	phenotype	VERB
ajlm-1644	79	9	the	the	DET
ajlm-1644	79	10	rdw	rdw	ADJ
ajlm-1644	79	11	proportion	proportion	NOUN
ajlm-1644	79	12	for	for	ADP
ajlm-1644	79	13	haemoglobin	haemoglobin	PROPN
ajlm-1644	79	14	ss	ss	PROPN
ajlm-1644	79	15	genotype	genotype	NOUN
ajlm-1644	79	16	was	be	AUX
ajlm-1644	79	17	9.2	9.2	NUM
ajlm-1644	79	18	%	%	NOUN
ajlm-1644	79	19	(	(	PUNCT
ajlm-1644	79	20	n	n	NOUN
ajlm-1644	79	21	=	=	SYM
ajlm-1644	79	22	45	45	NUM
ajlm-1644	79	23	;	;	PUNCT
ajlm-1644	79	24	optimal	optimal	ADJ
ajlm-1644	79	25	point	point	NOUN
ajlm-1644	79	26	=	=	PUNCT
ajlm-1644	79	27	21.1	21.1	NUM
ajlm-1644	79	28	;	;	PUNCT
ajlm-1644	79	29	p	p	X
ajlm-1644	79	30	<	<	X
ajlm-1644	79	31	0.001	0.001	NUM
ajlm-1644	79	32	;	;	PUNCT
ajlm-1644	79	33	accuracy	accuracy	NOUN
ajlm-1644	79	34	=	=	SYM
ajlm-1644	79	35	0.892	0.892	NUM
ajlm-1644	79	36	;	;	PUNCT
ajlm-1644	79	37	sensitivity	sensitivity	NOUN
ajlm-1644	79	38	=	=	NUM
ajlm-1644	79	39	86.7	86.7	NUM
ajlm-1644	79	40	%	%	NOUN
ajlm-1644	79	41	;	;	PUNCT
ajlm-1644	79	42	specificity	specificity	NOUN
ajlm-1644	79	43	=	=	SYM
ajlm-1644	79	44	80.0	80.0	NUM
ajlm-1644	79	45	%	%	NOUN
ajlm-1644	79	46	)	)	PUNCT
ajlm-1644	79	47	(	(	PUNCT
ajlm-1644	79	48	table	table	NOUN
ajlm-1644	79	49	2	2	NUM
ajlm-1644	79	50	,	,	PUNCT
ajlm-1644	79	51	figure	figure	NOUN
ajlm-1644	79	52	1	1	NUM
ajlm-1644	79	53	)	)	PUNCT
ajlm-1644	79	54	pushing	push	VERB
ajlm-1644	79	55	the	the	DET
ajlm-1644	79	56	curve	curve	NOUN
ajlm-1644	79	57	to	to	ADP
ajlm-1644	79	58	the	the	DET
ajlm-1644	79	59	left	left	ADJ
ajlm-1644	79	60	upper	upper	ADJ
ajlm-1644	79	61	side	side	NOUN
ajlm-1644	79	62	of	of	ADP
ajlm-1644	79	63	the	the	DET
ajlm-1644	79	64	roc	roc	PROPN
ajlm-1644	79	65	curve	curve	NOUN
ajlm-1644	79	66	.	.	PUNCT
ajlm-1644	80	1	the	the	DET
ajlm-1644	80	2	proportion	proportion	NOUN
ajlm-1644	80	3	for	for	ADP
ajlm-1644	80	4	haemoglobin	haemoglobin	PROPN
ajlm-1644	80	5	ss	ss	PROPN
ajlm-1644	80	6	genotype	genotype	NOUN
ajlm-1644	80	7	and	and	CCONJ
ajlm-1644	80	8	haemoglobin	haemoglobin	PROPN
ajlm-1644	80	9	f	f	PROPN
ajlm-1644	80	10	was	be	AUX
ajlm-1644	80	11	4.1	4.1	NUM
ajlm-1644	80	12	%	%	NOUN
ajlm-1644	80	13	(	(	PUNCT
ajlm-1644	80	14	n	n	NOUN
ajlm-1644	80	15	=	=	SYM
ajlm-1644	80	16	20	20	NUM
ajlm-1644	80	17	;	;	PUNCT
ajlm-1644	80	18	optimal	optimal	ADJ
ajlm-1644	80	19	point	point	NOUN
ajlm-1644	80	20	=	=	SYM
ajlm-1644	80	21	21.8	21.8	NUM
ajlm-1644	80	22	;	;	PUNCT
ajlm-1644	80	23	p	p	X
ajlm-1644	80	24	<	<	X
ajlm-1644	80	25	0.001	0.001	NUM
ajlm-1644	80	26	;	;	PUNCT
ajlm-1644	80	27	sensitivity	sensitivity	NOUN
ajlm-1644	80	28	=	=	SYM
ajlm-1644	80	29	70.0	70.0	NUM
ajlm-1644	80	30	%	%	NOUN
ajlm-1644	80	31	;	;	PUNCT
ajlm-1644	80	32	specificity	specificity	NOUN
ajlm-1644	80	33	=	=	SYM
ajlm-1644	80	34	67.6	67.6	NUM
ajlm-1644	80	35	%	%	NOUN
ajlm-1644	80	36	;	;	PUNCT
ajlm-1644	80	37	youden	youden	PROPN
ajlm-1644	80	38	index	index	NOUN
ajlm-1644	80	39	=	=	PROPN
ajlm-1644	80	40	0.766	0.766	NUM
ajlm-1644	80	41	)	)	PUNCT
ajlm-1644	80	42	,	,	PUNCT
ajlm-1644	80	43	with	with	ADP
ajlm-1644	80	44	the	the	DET
ajlm-1644	80	45	roc	roc	PROPN
ajlm-1644	80	46	curve	curve	NOUN
ajlm-1644	80	47	flowing	flow	VERB
ajlm-1644	80	48	above	above	ADP
ajlm-1644	80	49	the	the	DET
ajlm-1644	80	50	diagonal	diagonal	ADJ
ajlm-1644	80	51	line	line	NOUN
ajlm-1644	80	52	.	.	PUNCT
ajlm-1644	81	1	a	a	DET
ajlm-1644	81	2	haemoglobin	haemoglobin	NOUN
ajlm-1644	81	3	ss	ss	PROPN
ajlm-1644	81	4	genotype	genotype	NOUN
ajlm-1644	81	5	+	+	CCONJ
ajlm-1644	81	6	β	β	NOUN
ajlm-1644	81	7	-	-	ADJ
ajlm-1644	81	8	thalassaemia	thalassaemia	NOUN
ajlm-1644	81	9	prevalence	prevalence	NOUN
ajlm-1644	81	10	of	of	ADP
ajlm-1644	81	11	12.7	12.7	NUM
ajlm-1644	81	12	%	%	NOUN
ajlm-1644	81	13	(	(	PUNCT
ajlm-1644	81	14	n	n	NOUN
ajlm-1644	81	15	=	=	SYM
ajlm-1644	81	16	62	62	NUM
ajlm-1644	81	17	)	)	PUNCT
ajlm-1644	81	18	was	be	AUX
ajlm-1644	81	19	obtained	obtain	VERB
ajlm-1644	81	20	and	and	CCONJ
ajlm-1644	81	21	at	at	ADP
ajlm-1644	81	22	17.7	17.7	NUM
ajlm-1644	81	23	the	the	DET
ajlm-1644	81	24	rdw	rdw	ADJ
ajlm-1644	81	25	optimal	optimal	ADJ
ajlm-1644	81	26	point	point	NOUN
ajlm-1644	81	27	(	(	PUNCT
ajlm-1644	81	28	p	p	X
ajlm-1644	81	29	<	<	X
ajlm-1644	81	30	0.001	0.001	NUM
ajlm-1644	81	31	;	;	PUNCT
ajlm-1644	81	32	sensitivity	sensitivity	NOUN
ajlm-1644	81	33	=	=	SYM
ajlm-1644	81	34	78.0	78.0	NUM
ajlm-1644	81	35	%	%	NOUN
ajlm-1644	81	36	;	;	PUNCT
ajlm-1644	81	37	specifity	specifity	NOUN
ajlm-1644	81	38	=	=	SYM
ajlm-1644	81	39	64.5	64.5	NUM
ajlm-1644	81	40	%	%	NOUN
ajlm-1644	81	41	;	;	PUNCT
ajlm-1644	81	42	youden	youden	PROPN
ajlm-1644	81	43	index	index	NOUN
ajlm-1644	81	44	=	=	PROPN
ajlm-1644	81	45	0.805	0.805	NUM
ajlm-1644	81	46	)	)	PUNCT
ajlm-1644	81	47	.	.	PUNCT
ajlm-1644	82	1	roc	roc	PROPN
ajlm-1644	82	2	curve	curve	NOUN
ajlm-1644	82	3	in	in	ADP
ajlm-1644	82	4	β	β	NOUN
ajlm-1644	82	5	-	-	NOUN
ajlm-1644	82	6	thalassaemia	thalassaemia	VERB
ajlm-1644	82	7	the	the	DET
ajlm-1644	82	8	rdw	rdw	ADJ
ajlm-1644	82	9	optimal	optimal	ADJ
ajlm-1644	82	10	point	point	NOUN
ajlm-1644	82	11	of	of	ADP
ajlm-1644	82	12	16.8	16.8	NUM
ajlm-1644	82	13	for	for	ADP
ajlm-1644	82	14	β	β	NOUN
ajlm-1644	82	15	-	-	NOUN
ajlm-1644	82	16	thalassaemia	thalassaemia	NOUN
ajlm-1644	82	17	was	be	AUX
ajlm-1644	82	18	not	not	PART
ajlm-1644	82	19	significant	significant	ADJ
ajlm-1644	82	20	(	(	PUNCT
ajlm-1644	82	21	p	p	X
ajlm-1644	82	22	=	=	NOUN
ajlm-1644	82	23	0.706	0.706	NUM
ajlm-1644	82	24	)	)	PUNCT
ajlm-1644	82	25	.	.	PUNCT
ajlm-1644	83	1	the	the	DET
ajlm-1644	83	2	roc	roc	PROPN
ajlm-1644	83	3	curve	curve	NOUN
ajlm-1644	83	4	flowed	flow	VERB
ajlm-1644	83	5	along	along	ADP
ajlm-1644	83	6	the	the	DET
ajlm-1644	83	7	diagonal	diagonal	ADJ
ajlm-1644	83	8	line	line	NOUN
ajlm-1644	83	9	area	area	NOUN
ajlm-1644	83	10	under	under	ADP
ajlm-1644	83	11	curve	curve	NOUN
ajlm-1644	83	12	=	=	PUNCT
ajlm-1644	83	13	0.539	0.539	NUM
ajlm-1644	83	14	with	with	ADP
ajlm-1644	83	15	sensitivity	sensitivity	NOUN
ajlm-1644	83	16	=	=	SYM
ajlm-1644	83	17	63	63	NUM
ajlm-1644	83	18	%	%	NOUN
ajlm-1644	83	19	and	and	CCONJ
ajlm-1644	83	20	specificity	specificity	NOUN
ajlm-1644	83	21	=	=	SYM
ajlm-1644	83	22	60	60	NUM
ajlm-1644	83	23	%	%	NOUN
ajlm-1644	83	24	)	)	PUNCT
ajlm-1644	83	25	(	(	PUNCT
ajlm-1644	83	26	table	table	NOUN
ajlm-1644	83	27	2	2	NUM
ajlm-1644	83	28	;	;	PUNCT
ajlm-1644	83	29	figure	figure	NOUN
ajlm-1644	83	30	3	3	NUM
ajlm-1644	83	31	)	)	PUNCT
ajlm-1644	83	32	.	.	PUNCT
ajlm-1644	84	1	sensitivity	sensitivity	NOUN
ajlm-1644	84	2	and	and	CCONJ
ajlm-1644	84	3	specificity	specificity	NOUN
ajlm-1644	84	4	of	of	ADP
ajlm-1644	84	5	rdw	rdw	PROPN
ajlm-1644	84	6	in	in	ADP
ajlm-1644	84	7	scd	scd	PROPN
ajlm-1644	84	8	phenotype	phenotype	NOUN
ajlm-1644	84	9	diagnosis	diagnosis	NOUN
ajlm-1644	84	10	the	the	DET
ajlm-1644	84	11	roc	roc	PROPN
ajlm-1644	84	12	curves	curve	NOUN
ajlm-1644	84	13	grouped	group	VERB
ajlm-1644	84	14	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	84	15	into	into	ADP
ajlm-1644	84	16	two	two	NUM
ajlm-1644	84	17	groups	group	NOUN
ajlm-1644	84	18	serving	serve	VERB
ajlm-1644	84	19	as	as	ADP
ajlm-1644	84	20	an	an	DET
ajlm-1644	84	21	excellent	excellent	ADJ
ajlm-1644	84	22	significant	significant	ADJ
ajlm-1644	84	23	(	(	PUNCT
ajlm-1644	84	24	p	p	X
ajlm-1644	84	25	<	<	X
ajlm-1644	84	26	0.001	0.001	NUM
ajlm-1644	84	27	)	)	PUNCT
ajlm-1644	84	28	biomarker	biomarker	NOUN
ajlm-1644	84	29	in	in	ADP
ajlm-1644	84	30	scd	scd	NOUN
ajlm-1644	84	31	phenotypes	phenotype	NOUN
ajlm-1644	84	32	diagnosis	diagnosis	NOUN
ajlm-1644	84	33	;	;	PUNCT
ajlm-1644	84	34	but	but	CCONJ
ajlm-1644	84	35	it	it	PRON
ajlm-1644	84	36	was	be	AUX
ajlm-1644	84	37	poor	poor	ADJ
ajlm-1644	84	38	in	in	ADP
ajlm-1644	84	39	the	the	DET
ajlm-1644	84	40	diagnosis	diagnosis	NOUN
ajlm-1644	84	41	of	of	ADP
ajlm-1644	84	42	sct	sct	PROPN
ajlm-1644	84	43	phenotypes	phenotype	NOUN
ajlm-1644	84	44	and	and	CCONJ
ajlm-1644	84	45	β	β	NOUN
ajlm-1644	84	46	-	-	NOUN
ajlm-1644	84	47	thalassemia	thalassemia	NOUN
ajlm-1644	84	48	(	(	PUNCT
ajlm-1644	84	49	low	low	ADJ
ajlm-1644	84	50	youden	youden	PROPN
ajlm-1644	84	51	index	index	NOUN
ajlm-1644	84	52	,	,	PUNCT
ajlm-1644	84	53	sensitivity	sensitivity	NOUN
ajlm-1644	84	54	,	,	PUNCT
ajlm-1644	84	55	and	and	CCONJ
ajlm-1644	84	56	specificity	specificity	NOUN
ajlm-1644	84	57	)	)	PUNCT
ajlm-1644	84	58	(	(	PUNCT
ajlm-1644	84	59	table	table	NOUN
ajlm-1644	84	60	2	2	NUM
ajlm-1644	84	61	)	)	PUNCT
ajlm-1644	84	62	.	.	PUNCT
ajlm-1644	85	1	therefore	therefore	ADV
ajlm-1644	85	2	,	,	PUNCT
ajlm-1644	85	3	the	the	DET
ajlm-1644	85	4	efficacy	efficacy	NOUN
ajlm-1644	85	5	of	of	ADP
ajlm-1644	85	6	rdw	rdw	PROPN
ajlm-1644	85	7	as	as	ADP
ajlm-1644	85	8	a	a	DET
ajlm-1644	85	9	biomarker	biomarker	NOUN
ajlm-1644	85	10	for	for	ADP
ajlm-1644	85	11	use	use	NOUN
ajlm-1644	85	12	in	in	ADP
ajlm-1644	85	13	scd	scd	PROPN
ajlm-1644	85	14	phenotype	phenotype	NOUN
ajlm-1644	85	15	diagnosis	diagnosis	NOUN
ajlm-1644	85	16	was	be	AUX
ajlm-1644	85	17	evaluated	evaluate	VERB
ajlm-1644	85	18	in	in	ADP
ajlm-1644	85	19	a	a	DET
ajlm-1644	85	20	single	single	ADJ
ajlm-1644	85	21	roc	roc	PROPN
ajlm-1644	85	22	curve	curve	NOUN
ajlm-1644	85	23	(	(	PUNCT
ajlm-1644	85	24	figure	figure	NOUN
ajlm-1644	85	25	4	4	NUM
ajlm-1644	85	26	)	)	PUNCT
ajlm-1644	85	27	giving	give	VERB
ajlm-1644	85	28	a	a	DET
ajlm-1644	85	29	sensitivity	sensitivity	NOUN
ajlm-1644	85	30	of	of	ADP
ajlm-1644	85	31	67.7	67.7	NUM
ajlm-1644	85	32	%	%	NOUN
ajlm-1644	85	33	,	,	PUNCT
ajlm-1644	85	34	specificity	specificity	NOUN
ajlm-1644	85	35	of	of	ADP
ajlm-1644	85	36	90.0	90.0	NUM
ajlm-1644	85	37	%	%	NOUN
ajlm-1644	85	38	and	and	CCONJ
ajlm-1644	85	39	an	an	DET
ajlm-1644	85	40	accuracy	accuracy	NOUN
ajlm-1644	85	41	of	of	ADP
ajlm-1644	85	42	0.789	0.789	NUM
ajlm-1644	85	43	at	at	ADP
ajlm-1644	85	44	an	an	DET
ajlm-1644	85	45	optimal	optimal	ADJ
ajlm-1644	85	46	point	point	NOUN
ajlm-1644	85	47	of	of	ADP
ajlm-1644	85	48	21.1	21.1	NUM
ajlm-1644	85	49	(	(	PUNCT
ajlm-1644	85	50	table	table	NOUN
ajlm-1644	85	51	2	2	NUM
ajlm-1644	85	52	)	)	PUNCT
ajlm-1644	85	53	.	.	PUNCT
ajlm-1644	86	1	figure	figure	VERB
ajlm-1644	86	2	4	4	NUM
ajlm-1644	86	3	:	:	PUNCT
ajlm-1644	86	4	red	red	ADJ
ajlm-1644	86	5	cell	cell	NOUN
ajlm-1644	86	6	distribution	distribution	NOUN
ajlm-1644	86	7	width	width	NOUN
ajlm-1644	86	8	roc	roc	PROPN
ajlm-1644	86	9	curve	curve	NOUN
ajlm-1644	86	10	in	in	ADP
ajlm-1644	86	11	haemoglobin	haemoglobin	PROPN
ajlm-1644	86	12	ss	ss	PROPN
ajlm-1644	86	13	phenotypes	phenotype	NOUN
ajlm-1644	86	14	in	in	ADP
ajlm-1644	86	15	western	western	ADJ
ajlm-1644	86	16	kenya	kenya	NOUN
ajlm-1644	86	17	,	,	PUNCT
ajlm-1644	86	18	01	01	NUM
ajlm-1644	86	19	janauary	janauary	PROPN
ajlm-1644	86	20	2015	2015	NUM
ajlm-1644	86	21	–	–	PUNCT
ajlm-1644	86	22	31	31	NUM
ajlm-1644	86	23	december	december	PROPN
ajlm-1644	86	24	2020	2020	NUM
ajlm-1644	86	25	.	.	PUNCT
ajlm-1644	87	1	this	this	DET
ajlm-1644	87	2	roc	roc	PROPN
ajlm-1644	87	3	curve	curve	NOUN
ajlm-1644	87	4	demonstrates	demonstrate	VERB
ajlm-1644	87	5	the	the	DET
ajlm-1644	87	6	efficacy	efficacy	NOUN
ajlm-1644	87	7	of	of	ADP
ajlm-1644	87	8	rdw	rdw	PROPN
ajlm-1644	87	9	at	at	ADP
ajlm-1644	87	10	21.1	21.1	NUM
ajlm-1644	87	11	%	%	NOUN
ajlm-1644	87	12	optimal	optimal	ADJ
ajlm-1644	87	13	point	point	NOUN
ajlm-1644	87	14	in	in	ADP
ajlm-1644	87	15	scd	scd	PROPN
ajlm-1644	87	16	(	(	PUNCT
ajlm-1644	87	17	haemoglobin	haemoglobin	PROPN
ajlm-1644	87	18	ss	ss	PROPN
ajlm-1644	87	19	)	)	PUNCT
ajlm-1644	87	20	phenotypes	phenotype	NOUN
ajlm-1644	87	21	diagnosis	diagnosis	NOUN
ajlm-1644	87	22	.	.	PUNCT
ajlm-1644	88	1	predictive	predictive	ADJ
ajlm-1644	88	2	validity	validity	NOUN
ajlm-1644	88	3	,	,	PUNCT
ajlm-1644	88	4	likelihood	likelihood	NOUN
ajlm-1644	88	5	and	and	CCONJ
ajlm-1644	88	6	or	or	CCONJ
ajlm-1644	88	7	of	of	ADP
ajlm-1644	88	8	rdw	rdw	PROPN
ajlm-1644	88	9	in	in	ADP
ajlm-1644	88	10	scd	scd	PROPN
ajlm-1644	88	11	phenotyping	phenotype	VERB
ajlm-1644	88	12	the	the	DET
ajlm-1644	88	13	rdw	rdw	NOUN
ajlm-1644	88	14	at	at	ADP
ajlm-1644	88	15	21.1	21.1	NUM
ajlm-1644	88	16	optimal	optimal	ADJ
ajlm-1644	88	17	value	value	NOUN
ajlm-1644	88	18	,	,	PUNCT
ajlm-1644	88	19	recorded	record	VERB
ajlm-1644	88	20	70.5	70.5	NUM
ajlm-1644	88	21	%	%	NOUN
ajlm-1644	88	22	positive	positive	ADJ
ajlm-1644	88	23	predictive	predictive	ADJ
ajlm-1644	88	24	validity	validity	NOUN
ajlm-1644	88	25	and	and	CCONJ
ajlm-1644	88	26	88.8	88.8	NUM
ajlm-1644	88	27	%	%	NOUN
ajlm-1644	88	28	negative	negative	ADJ
ajlm-1644	88	29	predictive	predictive	ADJ
ajlm-1644	88	30	validity	validity	NOUN
ajlm-1644	88	31	in	in	ADP
ajlm-1644	88	32	scd	scd	PROPN
ajlm-1644	88	33	phenotypes	phenotypes	NOUN
ajlm-1644	88	34	diagnosis	diagnosis	NOUN
ajlm-1644	88	35	(	(	PUNCT
ajlm-1644	88	36	table	table	NOUN
ajlm-1644	88	37	2	2	NUM
ajlm-1644	88	38	)	)	PUNCT
ajlm-1644	88	39	.	.	PUNCT
ajlm-1644	89	1	similarly	similarly	ADV
ajlm-1644	89	2	,	,	PUNCT
ajlm-1644	89	3	the	the	DET
ajlm-1644	89	4	same	same	ADJ
ajlm-1644	89	5	optimal	optimal	ADJ
ajlm-1644	89	6	value	value	NOUN
ajlm-1644	89	7	had	have	VERB
ajlm-1644	89	8	a	a	DET
ajlm-1644	89	9	6.77	6.77	NUM
ajlm-1644	89	10	positive	positive	ADJ
ajlm-1644	89	11	likelihood	likelihood	NOUN
ajlm-1644	89	12	ratio	ratio	NOUN
ajlm-1644	89	13	(	(	PUNCT
ajlm-1644	89	14	lr+	lr+	PROPN
ajlm-1644	89	15	)	)	PUNCT
ajlm-1644	89	16	,	,	PUNCT
ajlm-1644	89	17	0.36	0.36	NUM
ajlm-1644	89	18	negative	negative	ADJ
ajlm-1644	89	19	likelihood	likelihood	NOUN
ajlm-1644	89	20	ratio	ratio	NOUN
ajlm-1644	89	21	(	(	PUNCT
ajlm-1644	89	22	lr-	lr-	NOUN
ajlm-1644	89	23	)	)	PUNCT
ajlm-1644	89	24	and	and	CCONJ
ajlm-1644	89	25	18.94	18.94	NUM
ajlm-1644	89	26	or	or	CCONJ
ajlm-1644	89	27	in	in	ADP
ajlm-1644	89	28	the	the	DET
ajlm-1644	89	29	diagnosis	diagnosis	NOUN
ajlm-1644	89	30	of	of	ADP
ajlm-1644	89	31	haemoglobin	haemoglobin	NOUN
ajlm-1644	89	32	ss	ss	PROPN
ajlm-1644	89	33	phenotypes	phenotype	NOUN
ajlm-1644	89	34	.	.	PUNCT
ajlm-1644	90	1	discussion	discussion	NOUN
ajlm-1644	90	2	the	the	DET
ajlm-1644	90	3	rdw	rdw	PROPN
ajlm-1644	90	4	was	be	AUX
ajlm-1644	90	5	able	able	ADJ
ajlm-1644	90	6	to	to	PART
ajlm-1644	90	7	diagnose	diagnose	VERB
ajlm-1644	90	8	scd	scd	NOUN
ajlm-1644	90	9	phenotypes	phenotype	NOUN
ajlm-1644	90	10	significantly	significantly	ADV
ajlm-1644	90	11	(	(	PUNCT
ajlm-1644	90	12	p	p	X
ajlm-1644	90	13	<	<	X
ajlm-1644	90	14	0.001	0.001	NUM
ajlm-1644	90	15	)	)	PUNCT
ajlm-1644	90	16	,	,	PUNCT
ajlm-1644	90	17	but	but	CCONJ
ajlm-1644	90	18	could	could	AUX
ajlm-1644	90	19	not	not	PART
ajlm-1644	90	20	diagnose	diagnose	VERB
ajlm-1644	90	21	sct	sct	PROPN
ajlm-1644	90	22	phenotypes	phenotype	NOUN
ajlm-1644	90	23	and	and	CCONJ
ajlm-1644	90	24	β	β	NOUN
ajlm-1644	90	25	-	-	NOUN
ajlm-1644	90	26	thalassaemia	thalassaemia	NOUN
ajlm-1644	90	27	(	(	PUNCT
ajlm-1644	90	28	p	p	X
ajlm-1644	90	29	>	>	X
ajlm-1644	90	30	0.05	0.05	NUM
ajlm-1644	90	31	;	;	PUNCT
ajlm-1644	90	32	low	low	ADJ
ajlm-1644	90	33	youden	youden	PROPN
ajlm-1644	90	34	index	index	NOUN
ajlm-1644	90	35	,	,	PUNCT
ajlm-1644	90	36	sensitivity	sensitivity	NOUN
ajlm-1644	90	37	,	,	PUNCT
ajlm-1644	90	38	and	and	CCONJ
ajlm-1644	90	39	specificity	specificity	NOUN
ajlm-1644	90	40	)	)	PUNCT
ajlm-1644	90	41	.	.	PUNCT
ajlm-1644	91	1	the	the	DET
ajlm-1644	91	2	overall	overall	ADJ
ajlm-1644	91	3	accuracy	accuracy	NOUN
ajlm-1644	91	4	of	of	ADP
ajlm-1644	91	5	the	the	DET
ajlm-1644	91	6	rdw	rdw	NOUN
ajlm-1644	91	7	proved	prove	VERB
ajlm-1644	91	8	to	to	PART
ajlm-1644	91	9	be	be	AUX
ajlm-1644	91	10	an	an	DET
ajlm-1644	91	11	excellent	excellent	ADJ
ajlm-1644	91	12	biomarker	biomarker	NOUN
ajlm-1644	91	13	for	for	ADP
ajlm-1644	91	14	scd	scd	NOUN
ajlm-1644	91	15	haemoglobinoathies	haemoglobinoathie	NOUN
ajlm-1644	91	16	;	;	PUNCT
ajlm-1644	91	17	thus	thus	ADV
ajlm-1644	91	18	,	,	PUNCT
ajlm-1644	91	19	unknown	unknown	ADJ
ajlm-1644	91	20	(	(	PUNCT
ajlm-1644	91	21	seemingly	seemingly	ADV
ajlm-1644	91	22	haemoglobinopathy	haemoglobinopathy	ADV
ajlm-1644	91	23	-	-	PUNCT
ajlm-1644	91	24	free	free	ADJ
ajlm-1644	91	25	)	)	PUNCT
ajlm-1644	91	26	cases	case	NOUN
ajlm-1644	91	27	with	with	ADP
ajlm-1644	91	28	rdw	rdw	PROPN
ajlm-1644	91	29	above	above	ADP
ajlm-1644	91	30	21.1	21.1	NUM
ajlm-1644	91	31	need	need	NOUN
ajlm-1644	91	32	to	to	PART
ajlm-1644	91	33	be	be	AUX
ajlm-1644	91	34	confirmed	confirm	VERB
ajlm-1644	91	35	using	use	VERB
ajlm-1644	91	36	advanced	advanced	ADJ
ajlm-1644	91	37	technology	technology	NOUN
ajlm-1644	91	38	.	.	PUNCT
ajlm-1644	92	1	therefore	therefore	ADV
ajlm-1644	92	2	,	,	PUNCT
ajlm-1644	92	3	countries	country	NOUN
ajlm-1644	92	4	with	with	ADP
ajlm-1644	92	5	limited	limited	ADJ
ajlm-1644	92	6	financial	financial	ADJ
ajlm-1644	92	7	resources	resource	NOUN
ajlm-1644	92	8	who	who	PRON
ajlm-1644	92	9	have	have	AUX
ajlm-1644	92	10	not	not	PART
ajlm-1644	92	11	implemented	implement	VERB
ajlm-1644	92	12	newborn	newborn	ADJ
ajlm-1644	92	13	and	and	CCONJ
ajlm-1644	92	14	population	population	NOUN
ajlm-1644	92	15	screening	screening	NOUN
ajlm-1644	92	16	can	can	AUX
ajlm-1644	92	17	use	use	VERB
ajlm-1644	92	18	this	this	DET
ajlm-1644	92	19	potential	potential	ADJ
ajlm-1644	92	20	biomarker	biomarker	NOUN
ajlm-1644	92	21	as	as	ADP
ajlm-1644	92	22	a	a	DET
ajlm-1644	92	23	cost	cost	NOUN
ajlm-1644	92	24	-	-	PUNCT
ajlm-1644	92	25	effective	effective	ADJ
ajlm-1644	92	26	approach	approach	NOUN
ajlm-1644	92	27	.	.	PUNCT
ajlm-1644	93	1	a	a	DET
ajlm-1644	93	2	worthless	worthless	ADJ
ajlm-1644	93	3	test	test	NOUN
ajlm-1644	93	4	has	have	VERB
ajlm-1644	93	5	a	a	DET
ajlm-1644	93	6	youden	youden	ADJ
ajlm-1644	93	7	index	index	NOUN
ajlm-1644	93	8	of	of	ADP
ajlm-1644	93	9	0.5	0.5	NUM
ajlm-1644	93	10	,	,	PUNCT
ajlm-1644	93	11	poor	poor	ADJ
ajlm-1644	93	12	sensitivity	sensitivity	NOUN
ajlm-1644	93	13	of	of	ADP
ajlm-1644	93	14	50	50	NUM
ajlm-1644	93	15	%	%	NOUN
ajlm-1644	93	16	,	,	PUNCT
ajlm-1644	93	17	a	a	DET
ajlm-1644	93	18	specificity	specificity	NOUN
ajlm-1644	93	19	of	of	ADP
ajlm-1644	93	20	about	about	ADV
ajlm-1644	93	21	50	50	NUM
ajlm-1644	93	22	%	%	NOUN
ajlm-1644	93	23	and	and	CCONJ
ajlm-1644	93	24	a	a	DET
ajlm-1644	93	25	roc	roc	PROPN
ajlm-1644	93	26	curve	curve	NOUN
ajlm-1644	93	27	that	that	PRON
ajlm-1644	93	28	flows	flow	VERB
ajlm-1644	93	29	along	along	ADP
ajlm-1644	93	30	the	the	DET
ajlm-1644	93	31	diagonal	diagonal	ADJ
ajlm-1644	93	32	line	line	NOUN
ajlm-1644	93	33	and	and	CCONJ
ajlm-1644	93	34	thus	thus	ADV
ajlm-1644	93	35	is	be	AUX
ajlm-1644	93	36	unable	unable	ADJ
ajlm-1644	93	37	to	to	PART
ajlm-1644	93	38	distinguish	distinguish	VERB
ajlm-1644	93	39	diseased	diseased	ADJ
ajlm-1644	93	40	from	from	ADP
ajlm-1644	93	41	non	non	ADJ
ajlm-1644	93	42	-	-	ADJ
ajlm-1644	93	43	diseased	diseased	ADJ
ajlm-1644	93	44	individuals.31	individuals.31	NOUN
ajlm-1644	93	45	the	the	DET
ajlm-1644	93	46	rdw	rdw	NOUN
ajlm-1644	93	47	could	could	AUX
ajlm-1644	93	48	not	not	PART
ajlm-1644	93	49	serve	serve	VERB
ajlm-1644	93	50	as	as	ADP
ajlm-1644	93	51	a	a	DET
ajlm-1644	93	52	biomarker	biomarker	NOUN
ajlm-1644	93	53	for	for	ADP
ajlm-1644	93	54	pure	pure	ADJ
ajlm-1644	93	55	sct	sct	PROPN
ajlm-1644	94	1	(	(	PUNCT
ajlm-1644	94	2	p	p	NOUN
ajlm-1644	94	3	=	=	NOUN
ajlm-1644	94	4	0.976	0.976	NUM
ajlm-1644	94	5	)	)	PUNCT
ajlm-1644	94	6	and	and	CCONJ
ajlm-1644	94	7	sct+β	sct+β	PROPN
ajlm-1644	94	8	-	-	PUNCT
ajlm-1644	94	9	thalassaemia	thalassaemia	NOUN
ajlm-1644	94	10	(	(	PUNCT
ajlm-1644	94	11	p	p	X
ajlm-1644	94	12	=	=	NOUN
ajlm-1644	94	13	0.399	0.399	NUM
ajlm-1644	94	14	)	)	PUNCT
ajlm-1644	94	15	diagnoses	diagnosis	NOUN
ajlm-1644	94	16	;	;	PUNCT
ajlm-1644	94	17	both	both	PRON
ajlm-1644	94	18	had	have	VERB
ajlm-1644	94	19	low	low	ADJ
ajlm-1644	94	20	youden	youden	PROPN
ajlm-1644	94	21	index	index	NOUN
ajlm-1644	94	22	,	,	PUNCT
ajlm-1644	94	23	sensitivity	sensitivity	NOUN
ajlm-1644	94	24	and	and	CCONJ
ajlm-1644	94	25	specifity	specifity	NOUN
ajlm-1644	94	26	.	.	PUNCT
ajlm-1644	95	1	in	in	ADP
ajlm-1644	95	2	homozygous	homozygous	ADJ
ajlm-1644	95	3	scd	scd	NOUN
ajlm-1644	95	4	,	,	PUNCT
ajlm-1644	95	5	the	the	DET
ajlm-1644	95	6	rdw	rdw	NOUN
ajlm-1644	95	7	had	have	VERB
ajlm-1644	95	8	a	a	DET
ajlm-1644	95	9	sensitivity	sensitivity	NOUN
ajlm-1644	95	10	of	of	ADP
ajlm-1644	95	11	86.7	86.7	NUM
ajlm-1644	95	12	%	%	NOUN
ajlm-1644	95	13	,	,	PUNCT
ajlm-1644	95	14	specificity	specificity	NOUN
ajlm-1644	95	15	of	of	ADP
ajlm-1644	95	16	80	80	NUM
ajlm-1644	95	17	%	%	NOUN
ajlm-1644	95	18	and	and	CCONJ
ajlm-1644	95	19	an	an	DET
ajlm-1644	95	20	accuracy	accuracy	NOUN
ajlm-1644	95	21	of	of	ADP
ajlm-1644	95	22	0.892	0.892	NUM
ajlm-1644	95	23	which	which	PRON
ajlm-1644	95	24	are	be	AUX
ajlm-1644	95	25	features	feature	NOUN
ajlm-1644	95	26	of	of	ADP
ajlm-1644	95	27	a	a	DET
ajlm-1644	95	28	significant	significant	ADJ
ajlm-1644	95	29	(	(	PUNCT
ajlm-1644	95	30	p	p	X
ajlm-1644	95	31	<	<	X
ajlm-1644	95	32	0.001	0.001	NUM
ajlm-1644	95	33	)	)	PUNCT
ajlm-1644	95	34	biomarker	biomarker	NOUN
ajlm-1644	95	35	at	at	ADP
ajlm-1644	95	36	21.1	21.1	NUM
ajlm-1644	95	37	roc	roc	PROPN
ajlm-1644	95	38	curve	curve	NOUN
ajlm-1644	95	39	coordinate.31	coordinate.31	PROPN
ajlm-1644	95	40	similar	similar	ADJ
ajlm-1644	95	41	findings	finding	NOUN
ajlm-1644	95	42	of	of	ADP
ajlm-1644	95	43	elevated	elevated	ADJ
ajlm-1644	95	44	rdw	rdw	NOUN
ajlm-1644	95	45	were	be	AUX
ajlm-1644	95	46	documented	document	VERB
ajlm-1644	95	47	by	by	ADP
ajlm-1644	95	48	webster	webster	PROPN
ajlm-1644	95	49	and	and	CCONJ
ajlm-1644	95	50	castro32	castro32	VERB
ajlm-1644	95	51	with	with	ADP
ajlm-1644	95	52	homozygous	homozygous	ADJ
ajlm-1644	95	53	scd	scd	NOUN
ajlm-1644	95	54	having	have	VERB
ajlm-1644	95	55	the	the	DET
ajlm-1644	95	56	highest	high	ADJ
ajlm-1644	95	57	rdw	rdw	ADJ
ajlm-1644	95	58	,	,	PUNCT
ajlm-1644	95	59	followed	follow	VERB
ajlm-1644	95	60	by	by	ADP
ajlm-1644	95	61	heterozygous	heterozygous	ADJ
ajlm-1644	95	62	scd+β	scd+β	NOUN
ajlm-1644	95	63	-	-	PUNCT
ajlm-1644	95	64	thalassaemia	thalassaemia	NOUN
ajlm-1644	95	65	and	and	CCONJ
ajlm-1644	95	66	then	then	ADV
ajlm-1644	95	67	scd	scd	PROPN
ajlm-1644	95	68	and	and	CCONJ
ajlm-1644	95	69	haemoglobin	haemoglobin	PROPN
ajlm-1644	95	70	f.	f.	PROPN
ajlm-1644	96	1	the	the	DET
ajlm-1644	96	2	rdw	rdw	PROPN
ajlm-1644	96	3	proved	prove	VERB
ajlm-1644	96	4	to	to	PART
ajlm-1644	96	5	be	be	AUX
ajlm-1644	96	6	an	an	DET
ajlm-1644	96	7	excellent	excellent	ADJ
ajlm-1644	96	8	diagnostic	diagnostic	ADJ
ajlm-1644	96	9	marker	marker	NOUN
ajlm-1644	96	10	for	for	ADP
ajlm-1644	96	11	scd	scd	NOUN
ajlm-1644	96	12	and	and	CCONJ
ajlm-1644	96	13	haemoglobin	haemoglobin	PROPN
ajlm-1644	96	14	f	f	PROPN
ajlm-1644	96	15	at	at	ADP
ajlm-1644	96	16	20.8	20.8	NUM
ajlm-1644	96	17	roc	roc	PROPN
ajlm-1644	96	18	curve	curve	NOUN
ajlm-1644	96	19	coordinate	coordinate	NOUN
ajlm-1644	96	20	where	where	SCONJ
ajlm-1644	96	21	a	a	DET
ajlm-1644	96	22	sensitivity	sensitivity	NOUN
ajlm-1644	96	23	of	of	ADP
ajlm-1644	96	24	70.0	70.0	NUM
ajlm-1644	96	25	%	%	NOUN
ajlm-1644	96	26	and	and	CCONJ
ajlm-1644	96	27	a	a	DET
ajlm-1644	96	28	specificity	specificity	NOUN
ajlm-1644	96	29	of	of	ADP
ajlm-1644	96	30	67.6	67.6	NUM
ajlm-1644	96	31	%	%	NOUN
ajlm-1644	96	32	were	be	AUX
ajlm-1644	96	33	obtained	obtain	VERB
ajlm-1644	96	34	with	with	ADP
ajlm-1644	96	35	a	a	DET
ajlm-1644	96	36	high	high	ADJ
ajlm-1644	96	37	accuracy	accuracy	NOUN
ajlm-1644	96	38	of	of	ADP
ajlm-1644	96	39	0.766	0.766	NUM
ajlm-1644	96	40	.	.	PUNCT
ajlm-1644	97	1	the	the	DET
ajlm-1644	97	2	roc	roc	PROPN
ajlm-1644	97	3	curve	curve	NOUN
ajlm-1644	97	4	demonstrated	demonstrate	VERB
ajlm-1644	97	5	that	that	SCONJ
ajlm-1644	97	6	the	the	DET
ajlm-1644	97	7	rdw	rdw	NOUN
ajlm-1644	97	8	was	be	AUX
ajlm-1644	97	9	an	an	DET
ajlm-1644	97	10	excellent	excellent	ADJ
ajlm-1644	97	11	diagnostic	diagnostic	ADJ
ajlm-1644	97	12	marker	marker	NOUN
ajlm-1644	97	13	(	(	PUNCT
ajlm-1644	97	14	p	p	X
ajlm-1644	97	15	<	<	X
ajlm-1644	97	16	0.001	0.001	NUM
ajlm-1644	97	17	)	)	PUNCT
ajlm-1644	97	18	in	in	ADP
ajlm-1644	97	19	detecting	detect	VERB
ajlm-1644	97	20	scd+β	scd+β	NOUN
ajlm-1644	97	21	-	-	PUNCT
ajlm-1644	97	22	thalassaemia	thalassaemia	NOUN
ajlm-1644	97	23	with	with	ADP
ajlm-1644	97	24	an	an	DET
ajlm-1644	97	25	accuracy	accuracy	NOUN
ajlm-1644	97	26	of	of	ADP
ajlm-1644	97	27	0.805	0.805	NUM
ajlm-1644	97	28	.	.	PUNCT
ajlm-1644	98	1	the	the	DET
ajlm-1644	98	2	β	β	NOUN
ajlm-1644	98	3	-	-	ADJ
ajlm-1644	98	4	thalassaemia	thalassaemia	NOUN
ajlm-1644	98	5	roc	roc	PROPN
ajlm-1644	98	6	curve	curve	NOUN
ajlm-1644	98	7	flowed	flow	VERB
ajlm-1644	98	8	along	along	ADP
ajlm-1644	98	9	the	the	DET
ajlm-1644	98	10	diagonal	diagonal	ADJ
ajlm-1644	98	11	line	line	NOUN
ajlm-1644	98	12	with	with	ADP
ajlm-1644	98	13	poor	poor	ADJ
ajlm-1644	98	14	diagnostic	diagnostic	ADJ
ajlm-1644	98	15	significance	significance	NOUN
ajlm-1644	98	16	(	(	PUNCT
ajlm-1644	98	17	p	p	X
ajlm-1644	98	18	=	=	NOUN
ajlm-1644	98	19	0.706	0.706	NUM
ajlm-1644	98	20	)	)	PUNCT
ajlm-1644	98	21	similar	similar	ADJ
ajlm-1644	98	22	to	to	ADP
ajlm-1644	98	23	qurtom	qurtom	PROPN
ajlm-1644	98	24	et	et	PROPN
ajlm-1644	98	25	al	al	PROPN
ajlm-1644	98	26	’s	’s	PART
ajlm-1644	98	27	report33	report33	NOUN
ajlm-1644	98	28	of	of	ADP
ajlm-1644	98	29	β	β	NOUN
ajlm-1644	98	30	-	-	NOUN
ajlm-1644	98	31	thalassaemia	thalassaemia	NOUN
ajlm-1644	98	32	having	have	VERB
ajlm-1644	98	33	a	a	DET
ajlm-1644	98	34	normal	normal	ADJ
ajlm-1644	98	35	or	or	CCONJ
ajlm-1644	98	36	mildly	mildly	ADV
ajlm-1644	98	37	elevated	elevate	VERB
ajlm-1644	98	38	rdw	rdw	NOUN
ajlm-1644	98	39	at	at	ADP
ajlm-1644	98	40	a	a	DET
ajlm-1644	98	41	mean	mean	NOUN
ajlm-1644	98	42	of	of	ADP
ajlm-1644	98	43	15.4	15.4	NUM
ajlm-1644	98	44	±	±	NUM
ajlm-1644	98	45	1.21	1.21	NUM
ajlm-1644	98	46	,	,	PUNCT
ajlm-1644	98	47	meaning	mean	VERB
ajlm-1644	98	48	it	it	PRON
ajlm-1644	98	49	is	be	AUX
ajlm-1644	98	50	not	not	PART
ajlm-1644	98	51	possible	possible	ADJ
ajlm-1644	98	52	to	to	PART
ajlm-1644	98	53	use	use	VERB
ajlm-1644	98	54	the	the	DET
ajlm-1644	98	55	rdw	rdw	NOUN
ajlm-1644	98	56	to	to	PART
ajlm-1644	98	57	differentiate	differentiate	VERB
ajlm-1644	98	58	β	β	NOUN
ajlm-1644	98	59	-	-	NOUN
ajlm-1644	98	60	thalassemia	thalassemia	NOUN
ajlm-1644	98	61	from	from	ADP
ajlm-1644	98	62	the	the	DET
ajlm-1644	98	63	healthy	healthy	ADJ
ajlm-1644	98	64	population	population	NOUN
ajlm-1644	98	65	.	.	PUNCT
ajlm-1644	99	1	the	the	DET
ajlm-1644	99	2	rdw	rdw	PROPN
ajlm-1644	99	3	roc	roc	PROPN
ajlm-1644	99	4	curves	curve	NOUN
ajlm-1644	99	5	were	be	AUX
ajlm-1644	99	6	able	able	ADJ
ajlm-1644	99	7	to	to	PART
ajlm-1644	99	8	discriminate	discriminate	VERB
ajlm-1644	99	9	(	(	PUNCT
ajlm-1644	99	10	p	p	X
ajlm-1644	99	11	<	<	X
ajlm-1644	99	12	0.001	0.001	NUM
ajlm-1644	99	13	)	)	PUNCT
ajlm-1644	99	14	scd	scd	NOUN
ajlm-1644	99	15	phenotypes	phenotype	NOUN
ajlm-1644	99	16	from	from	ADP
ajlm-1644	99	17	the	the	DET
ajlm-1644	99	18	healthy	healthy	ADJ
ajlm-1644	99	19	population	population	NOUN
ajlm-1644	99	20	but	but	CCONJ
ajlm-1644	99	21	could	could	AUX
ajlm-1644	99	22	not	not	PART
ajlm-1644	99	23	diagnose	diagnose	VERB
ajlm-1644	99	24	sct	sct	PROPN
ajlm-1644	99	25	phenotypes	phenotype	NOUN
ajlm-1644	99	26	and	and	CCONJ
ajlm-1644	99	27	β	β	NOUN
ajlm-1644	99	28	-	-	NOUN
ajlm-1644	99	29	thalassaemia	thalassaemia	NOUN
ajlm-1644	99	30	.	.	PUNCT
ajlm-1644	100	1	the	the	DET
ajlm-1644	100	2	optimal	optimal	ADJ
ajlm-1644	100	3	rdw	rdw	ADJ
ajlm-1644	100	4	value	value	NOUN
ajlm-1644	100	5	for	for	ADP
ajlm-1644	100	6	the	the	DET
ajlm-1644	100	7	overall	overall	ADJ
ajlm-1644	100	8	efficacy	efficacy	NOUN
ajlm-1644	100	9	in	in	ADP
ajlm-1644	100	10	diagnosing	diagnose	VERB
ajlm-1644	100	11	scd	scd	NOUN
ajlm-1644	100	12	phenotypes	phenotype	NOUN
ajlm-1644	100	13	was	be	AUX
ajlm-1644	100	14	21.1	21.1	NUM
ajlm-1644	100	15	(	(	PUNCT
ajlm-1644	100	16	sensitivity	sensitivity	NOUN
ajlm-1644	100	17	=	=	NUM
ajlm-1644	100	18	67.7	67.7	NUM
ajlm-1644	100	19	%	%	NOUN
ajlm-1644	100	20	;	;	PUNCT
ajlm-1644	100	21	specificity	specificity	NOUN
ajlm-1644	100	22	=	=	SYM
ajlm-1644	100	23	90.0	90.0	NUM
ajlm-1644	100	24	%	%	NOUN
ajlm-1644	100	25	;	;	PUNCT
ajlm-1644	100	26	accuracy	accuracy	NOUN
ajlm-1644	100	27	=	=	NOUN
ajlm-1644	100	28	0.789	0.789	NUM
ajlm-1644	100	29	)	)	PUNCT
ajlm-1644	100	30	.	.	PUNCT
ajlm-1644	101	1	this	this	PRON
ajlm-1644	101	2	means	mean	VERB
ajlm-1644	101	3	that	that	SCONJ
ajlm-1644	101	4	in	in	ADP
ajlm-1644	101	5	a	a	DET
ajlm-1644	101	6	population	population	NOUN
ajlm-1644	101	7	,	,	PUNCT
ajlm-1644	101	8	an	an	DET
ajlm-1644	101	9	rdw	rdw	NOUN
ajlm-1644	101	10	>	>	X
ajlm-1644	101	11	21.1	21.1	NUM
ajlm-1644	101	12	can	can	AUX
ajlm-1644	101	13	identify	identify	VERB
ajlm-1644	101	14	67.7	67.7	NUM
ajlm-1644	101	15	%	%	NOUN
ajlm-1644	101	16	of	of	ADP
ajlm-1644	101	17	the	the	DET
ajlm-1644	101	18	individuals	individual	NOUN
ajlm-1644	101	19	as	as	ADP
ajlm-1644	101	20	having	have	VERB
ajlm-1644	101	21	scd	scd	NOUN
ajlm-1644	101	22	while	while	SCONJ
ajlm-1644	101	23	an	an	DET
ajlm-1644	101	24	rdw	rdw	NOUN
ajlm-1644	101	25	of	of	ADP
ajlm-1644	101	26	<	<	X
ajlm-1644	101	27	21.1	21.1	NUM
ajlm-1644	101	28	will	will	AUX
ajlm-1644	101	29	identify	identify	VERB
ajlm-1644	101	30	90	90	NUM
ajlm-1644	101	31	%	%	NOUN
ajlm-1644	101	32	of	of	ADP
ajlm-1644	101	33	individuals	individual	NOUN
ajlm-1644	101	34	who	who	PRON
ajlm-1644	101	35	would	would	AUX
ajlm-1644	101	36	test	test	VERB
ajlm-1644	101	37	negative	negative	ADJ
ajlm-1644	101	38	for	for	ADP
ajlm-1644	101	39	scd	scd	PROPN
ajlm-1644	101	40	.	.	PUNCT
ajlm-1644	102	1	this	this	PRON
ajlm-1644	102	2	implies	imply	VERB
ajlm-1644	102	3	that	that	SCONJ
ajlm-1644	102	4	at	at	ADP
ajlm-1644	102	5	21.1	21.1	NUM
ajlm-1644	102	6	,	,	PUNCT
ajlm-1644	102	7	the	the	DET
ajlm-1644	102	8	rdw	rdw	NOUN
ajlm-1644	102	9	can	can	AUX
ajlm-1644	102	10	be	be	AUX
ajlm-1644	102	11	used	use	VERB
ajlm-1644	102	12	as	as	ADP
ajlm-1644	102	13	an	an	DET
ajlm-1644	102	14	optimal	optimal	ADJ
ajlm-1644	102	15	diagnostic	diagnostic	ADJ
ajlm-1644	102	16	biomarker	biomarker	NOUN
ajlm-1644	102	17	for	for	ADP
ajlm-1644	102	18	scd	scd	NOUN
ajlm-1644	102	19	phenotypes	phenotype	NOUN
ajlm-1644	102	20	in	in	ADP
ajlm-1644	102	21	western	western	ADJ
ajlm-1644	102	22	kenya	kenya	PROPN
ajlm-1644	102	23	.	.	PUNCT
ajlm-1644	103	1	a	a	DET
ajlm-1644	103	2	positive	positive	ADJ
ajlm-1644	103	3	predictive	predictive	ADJ
ajlm-1644	103	4	value	value	NOUN
ajlm-1644	103	5	tells	tell	VERB
ajlm-1644	103	6	how	how	SCONJ
ajlm-1644	103	7	likely	likely	ADJ
ajlm-1644	103	8	an	an	DET
ajlm-1644	103	9	individual	individual	NOUN
ajlm-1644	103	10	will	will	AUX
ajlm-1644	103	11	test	test	VERB
ajlm-1644	103	12	positive	positive	ADJ
ajlm-1644	103	13	for	for	ADP
ajlm-1644	103	14	a	a	DET
ajlm-1644	103	15	given	give	VERB
ajlm-1644	103	16	disease	disease	NOUN
ajlm-1644	103	17	.	.	PUNCT
ajlm-1644	104	1	in	in	ADP
ajlm-1644	104	2	regard	regard	NOUN
ajlm-1644	104	3	to	to	ADP
ajlm-1644	104	4	the	the	DET
ajlm-1644	104	5	present	present	ADJ
ajlm-1644	104	6	study	study	NOUN
ajlm-1644	104	7	,	,	PUNCT
ajlm-1644	104	8	patients	patient	NOUN
ajlm-1644	104	9	with	with	ADP
ajlm-1644	104	10	rdw	rdw	PROPN
ajlm-1644	104	11	>	>	X
ajlm-1644	104	12	21.1	21.1	NUM
ajlm-1644	104	13	were	be	AUX
ajlm-1644	104	14	70.5	70.5	NUM
ajlm-1644	104	15	%	%	NOUN
ajlm-1644	104	16	likely	likely	ADJ
ajlm-1644	104	17	to	to	PART
ajlm-1644	104	18	test	test	VERB
ajlm-1644	104	19	positive	positive	ADJ
ajlm-1644	104	20	for	for	ADP
ajlm-1644	104	21	scd	scd	NOUN
ajlm-1644	104	22	indicating	indicate	VERB
ajlm-1644	104	23	29.5	29.5	NUM
ajlm-1644	104	24	%	%	NOUN
ajlm-1644	104	25	would	would	AUX
ajlm-1644	104	26	still	still	ADV
ajlm-1644	104	27	test	test	VERB
ajlm-1644	104	28	negative	negative	ADJ
ajlm-1644	104	29	for	for	ADP
ajlm-1644	104	30	scd	scd	NOUN
ajlm-1644	104	31	even	even	ADV
ajlm-1644	104	32	when	when	SCONJ
ajlm-1644	104	33	the	the	DET
ajlm-1644	104	34	rdw	rdw	NOUN
ajlm-1644	104	35	was	be	AUX
ajlm-1644	104	36	>	>	X
ajlm-1644	104	37	21.1	21.1	NUM
ajlm-1644	104	38	.	.	PUNCT
ajlm-1644	105	1	negative	negative	ADJ
ajlm-1644	105	2	predictive	predictive	ADJ
ajlm-1644	105	3	value	value	NOUN
ajlm-1644	105	4	tells	tell	VERB
ajlm-1644	105	5	how	how	SCONJ
ajlm-1644	105	6	likely	likely	ADJ
ajlm-1644	105	7	an	an	DET
ajlm-1644	105	8	individual	individual	NOUN
ajlm-1644	105	9	will	will	AUX
ajlm-1644	105	10	be	be	AUX
ajlm-1644	105	11	to	to	PART
ajlm-1644	105	12	test	test	VERB
ajlm-1644	105	13	negative	negative	ADJ
ajlm-1644	105	14	for	for	ADP
ajlm-1644	105	15	a	a	DET
ajlm-1644	105	16	particular	particular	ADJ
ajlm-1644	105	17	disease	disease	NOUN
ajlm-1644	105	18	meaning	mean	VERB
ajlm-1644	105	19	88.1	88.1	NUM
ajlm-1644	105	20	%	%	NOUN
ajlm-1644	105	21	of	of	ADP
ajlm-1644	105	22	patients	patient	NOUN
ajlm-1644	105	23	with	with	ADP
ajlm-1644	105	24	rdw	rdw	ADJ
ajlm-1644	105	25	<	<	X
ajlm-1644	105	26	21.1	21.1	NUM
ajlm-1644	105	27	would	would	AUX
ajlm-1644	105	28	be	be	AUX
ajlm-1644	105	29	free	free	ADJ
ajlm-1644	105	30	from	from	ADP
ajlm-1644	105	31	scd	scd	NOUN
ajlm-1644	105	32	while	while	SCONJ
ajlm-1644	105	33	11.9	11.9	NUM
ajlm-1644	105	34	%	%	NOUN
ajlm-1644	105	35	would	would	AUX
ajlm-1644	105	36	still	still	ADV
ajlm-1644	105	37	test	test	VERB
ajlm-1644	105	38	positive	positive	ADJ
ajlm-1644	105	39	.	.	PUNCT
ajlm-1644	106	1	therefore	therefore	ADV
ajlm-1644	106	2	,	,	PUNCT
ajlm-1644	106	3	the	the	DET
ajlm-1644	106	4	rdw	rdw	NOUN
ajlm-1644	106	5	is	be	AUX
ajlm-1644	106	6	proving	prove	VERB
ajlm-1644	106	7	to	to	PART
ajlm-1644	106	8	be	be	AUX
ajlm-1644	106	9	a	a	DET
ajlm-1644	106	10	good	good	ADJ
ajlm-1644	106	11	diagnostic	diagnostic	ADJ
ajlm-1644	106	12	biomarker	biomarker	NOUN
ajlm-1644	106	13	for	for	ADP
ajlm-1644	106	14	scd	scd	NOUN
ajlm-1644	106	15	phenotypes	phenotype	NOUN
ajlm-1644	106	16	among	among	ADP
ajlm-1644	106	17	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	106	18	listed	list	VERB
ajlm-1644	106	19	in	in	ADP
ajlm-1644	106	20	the	the	DET
ajlm-1644	106	21	present	present	ADJ
ajlm-1644	106	22	study	study	NOUN
ajlm-1644	106	23	.	.	PUNCT
ajlm-1644	107	1	to	to	ADP
ajlm-1644	107	2	this	this	DET
ajlm-1644	107	3	end	end	NOUN
ajlm-1644	107	4	,	,	PUNCT
ajlm-1644	107	5	this	this	PRON
ajlm-1644	107	6	is	be	AUX
ajlm-1644	107	7	the	the	DET
ajlm-1644	107	8	first	first	ADJ
ajlm-1644	107	9	-	-	PUNCT
ajlm-1644	107	10	ever	ever	ADV
ajlm-1644	107	11	attempt	attempt	NOUN
ajlm-1644	107	12	to	to	PART
ajlm-1644	107	13	determine	determine	VERB
ajlm-1644	107	14	the	the	DET
ajlm-1644	107	15	likelihood	likelihood	NOUN
ajlm-1644	107	16	of	of	ADP
ajlm-1644	107	17	using	use	VERB
ajlm-1644	107	18	the	the	DET
ajlm-1644	107	19	rdw	rdw	ADJ
ajlm-1644	107	20	value	value	NOUN
ajlm-1644	107	21	to	to	PART
ajlm-1644	107	22	diagnose	diagnose	VERB
ajlm-1644	107	23	scd	scd	NOUN
ajlm-1644	107	24	phenotype	phenotype	NOUN
ajlm-1644	107	25	in	in	ADP
ajlm-1644	107	26	western	western	ADJ
ajlm-1644	107	27	kenya	kenya	PROPN
ajlm-1644	107	28	.	.	PUNCT
ajlm-1644	108	1	likelihood	likelihood	NOUN
ajlm-1644	108	2	ratios	ratio	NOUN
ajlm-1644	108	3	are	be	AUX
ajlm-1644	108	4	clinically	clinically	ADV
ajlm-1644	108	5	more	more	ADV
ajlm-1644	108	6	useful	useful	ADJ
ajlm-1644	108	7	than	than	ADP
ajlm-1644	108	8	sensitivity	sensitivity	NOUN
ajlm-1644	108	9	and	and	CCONJ
ajlm-1644	108	10	specificity	specificity	NOUN
ajlm-1644	108	11	in	in	ADP
ajlm-1644	108	12	determining	determine	VERB
ajlm-1644	108	13	the	the	DET
ajlm-1644	108	14	usefulness	usefulness	NOUN
ajlm-1644	108	15	of	of	ADP
ajlm-1644	108	16	diagnostic	diagnostic	ADJ
ajlm-1644	108	17	tests	test	NOUN
ajlm-1644	108	18	.	.	PUNCT
ajlm-1644	109	1	the	the	DET
ajlm-1644	109	2	positive	positive	ADJ
ajlm-1644	109	3	likelihood	likelihood	NOUN
ajlm-1644	109	4	ratio	ratio	NOUN
ajlm-1644	109	5	(	(	PUNCT
ajlm-1644	109	6	lr+	lr+	ADJ
ajlm-1644	109	7	)	)	PUNCT
ajlm-1644	109	8	expresses	express	VERB
ajlm-1644	109	9	how	how	SCONJ
ajlm-1644	109	10	likely	likely	ADJ
ajlm-1644	109	11	a	a	DET
ajlm-1644	109	12	test	test	NOUN
ajlm-1644	109	13	is	be	AUX
ajlm-1644	109	14	going	go	VERB
ajlm-1644	109	15	to	to	PART
ajlm-1644	109	16	correctly	correctly	ADV
ajlm-1644	109	17	diagnose	diagnose	VERB
ajlm-1644	109	18	the	the	DET
ajlm-1644	109	19	presence	presence	NOUN
ajlm-1644	109	20	of	of	ADP
ajlm-1644	109	21	the	the	DET
ajlm-1644	109	22	condition	condition	NOUN
ajlm-1644	109	23	where	where	SCONJ
ajlm-1644	109	24	the	the	PRON
ajlm-1644	109	25	greater	great	ADJ
ajlm-1644	109	26	the	the	DET
ajlm-1644	109	27	lr+	lr+	NOUN
ajlm-1644	109	28	,	,	PUNCT
ajlm-1644	109	29	the	the	PRON
ajlm-1644	109	30	more	more	ADV
ajlm-1644	109	31	likely	likely	ADJ
ajlm-1644	109	32	the	the	DET
ajlm-1644	109	33	test	test	NOUN
ajlm-1644	109	34	is	be	AUX
ajlm-1644	109	35	going	go	VERB
ajlm-1644	109	36	to	to	PART
ajlm-1644	109	37	give	give	VERB
ajlm-1644	109	38	a	a	DET
ajlm-1644	109	39	true	true	ADJ
ajlm-1644	109	40	positive	positive	ADJ
ajlm-1644	109	41	diagnosis	diagnosis	NOUN
ajlm-1644	109	42	.	.	PUNCT
ajlm-1644	110	1	the	the	DET
ajlm-1644	110	2	rdw	rdw	PROPN
ajlm-1644	110	3	>	>	X
ajlm-1644	110	4	21.1	21.1	NUM
ajlm-1644	110	5	had	have	VERB
ajlm-1644	110	6	a	a	DET
ajlm-1644	110	7	lr+	lr+	NOUN
ajlm-1644	110	8	of	of	ADP
ajlm-1644	110	9	6.77	6.77	NUM
ajlm-1644	110	10	,	,	PUNCT
ajlm-1644	110	11	meaning	mean	VERB
ajlm-1644	110	12	any	any	DET
ajlm-1644	110	13	individual	individual	NOUN
ajlm-1644	110	14	having	have	VERB
ajlm-1644	110	15	the	the	DET
ajlm-1644	110	16	rdw	rdw	PROPN
ajlm-1644	110	17	>	>	X
ajlm-1644	110	18	21.1	21.1	NUM
ajlm-1644	110	19	is	be	AUX
ajlm-1644	110	20	6.77	6.77	NUM
ajlm-1644	110	21	times	time	NOUN
ajlm-1644	110	22	more	more	ADV
ajlm-1644	110	23	likely	likely	ADJ
ajlm-1644	110	24	to	to	PART
ajlm-1644	110	25	test	test	VERB
ajlm-1644	110	26	positive	positive	ADJ
ajlm-1644	110	27	for	for	ADP
ajlm-1644	110	28	scd	scd	PROPN
ajlm-1644	110	29	.	.	PUNCT
ajlm-1644	111	1	negative	negative	ADJ
ajlm-1644	111	2	likelihood	likelihood	NOUN
ajlm-1644	111	3	ratio	ratio	NOUN
ajlm-1644	111	4	(	(	PUNCT
ajlm-1644	111	5	lr	lr	NOUN
ajlm-1644	111	6	–	–	PUNCT
ajlm-1644	111	7	)	)	PUNCT
ajlm-1644	111	8	is	be	AUX
ajlm-1644	111	9	defined	define	VERB
ajlm-1644	111	10	by	by	ADP
ajlm-1644	111	11	akobeng34	akobeng34	NOUN
ajlm-1644	111	12	as	as	ADP
ajlm-1644	111	13	the	the	DET
ajlm-1644	111	14	ratio	ratio	NOUN
ajlm-1644	111	15	of	of	ADP
ajlm-1644	111	16	how	how	SCONJ
ajlm-1644	111	17	likely	likely	ADJ
ajlm-1644	111	18	a	a	DET
ajlm-1644	111	19	test	test	NOUN
ajlm-1644	111	20	will	will	AUX
ajlm-1644	111	21	correctly	correctly	ADV
ajlm-1644	111	22	diagnose	diagnose	VERB
ajlm-1644	111	23	the	the	DET
ajlm-1644	111	24	absence	absence	NOUN
ajlm-1644	111	25	of	of	ADP
ajlm-1644	111	26	a	a	DET
ajlm-1644	111	27	condition	condition	NOUN
ajlm-1644	111	28	whose	whose	DET
ajlm-1644	111	29	value	value	NOUN
ajlm-1644	111	30	is	be	AUX
ajlm-1644	111	31	usually	usually	ADV
ajlm-1644	111	32	<	<	X
ajlm-1644	111	33	1	1	NUM
ajlm-1644	111	34	;	;	PUNCT
ajlm-1644	111	35	the	the	PRON
ajlm-1644	111	36	closer	close	ADV
ajlm-1644	111	37	the	the	DET
ajlm-1644	111	38	value	value	NOUN
ajlm-1644	111	39	gets	get	VERB
ajlm-1644	111	40	to	to	ADP
ajlm-1644	111	41	zero	zero	NUM
ajlm-1644	111	42	,	,	PUNCT
ajlm-1644	111	43	the	the	PRON
ajlm-1644	111	44	better	well	ADJ
ajlm-1644	111	45	the	the	DET
ajlm-1644	111	46	test	test	NOUN
ajlm-1644	111	47	is	be	AUX
ajlm-1644	111	48	correctly	correctly	ADV
ajlm-1644	111	49	indicating	indicate	VERB
ajlm-1644	111	50	the	the	DET
ajlm-1644	111	51	absence	absence	NOUN
ajlm-1644	111	52	of	of	ADP
ajlm-1644	111	53	the	the	DET
ajlm-1644	111	54	condition	condition	NOUN
ajlm-1644	111	55	.	.	PUNCT
ajlm-1644	112	1	regarding	regard	VERB
ajlm-1644	112	2	the	the	DET
ajlm-1644	112	3	present	present	ADJ
ajlm-1644	112	4	study	study	NOUN
ajlm-1644	112	5	,	,	PUNCT
ajlm-1644	112	6	lr	lr	PROPN
ajlm-1644	112	7	–	–	PUNCT
ajlm-1644	112	8	was	be	AUX
ajlm-1644	112	9	0.36	0.36	NUM
ajlm-1644	112	10	,	,	PUNCT
ajlm-1644	112	11	meaning	mean	VERB
ajlm-1644	112	12	the	the	DET
ajlm-1644	112	13	probability	probability	NOUN
ajlm-1644	112	14	of	of	ADP
ajlm-1644	112	15	a	a	DET
ajlm-1644	112	16	person	person	NOUN
ajlm-1644	112	17	with	with	ADP
ajlm-1644	112	18	the	the	DET
ajlm-1644	112	19	rdw	rdw	NOUN
ajlm-1644	112	20	<	<	X
ajlm-1644	112	21	21.1	21.1	NUM
ajlm-1644	112	22	,	,	PUNCT
ajlm-1644	112	23	is	be	AUX
ajlm-1644	112	24	0.36	0.36	NUM
ajlm-1644	112	25	times	time	NOUN
ajlm-1644	112	26	less	less	ADV
ajlm-1644	112	27	likely	likely	ADJ
ajlm-1644	112	28	to	to	PART
ajlm-1644	112	29	be	be	AUX
ajlm-1644	112	30	free	free	ADJ
ajlm-1644	112	31	from	from	ADP
ajlm-1644	112	32	scd	scd	PROPN
ajlm-1644	112	33	.	.	PUNCT
ajlm-1644	113	1	it	it	PRON
ajlm-1644	113	2	is	be	AUX
ajlm-1644	113	3	important	important	ADJ
ajlm-1644	113	4	to	to	PART
ajlm-1644	113	5	note	note	VERB
ajlm-1644	113	6	a	a	DET
ajlm-1644	113	7	test	test	NOUN
ajlm-1644	113	8	having	have	VERB
ajlm-1644	113	9	both	both	CCONJ
ajlm-1644	113	10	lr+	lr+	ADJ
ajlm-1644	113	11	and	and	CCONJ
ajlm-1644	113	12	lr	lr	NOUN
ajlm-1644	113	13	–	–	PUNCT
ajlm-1644	113	14	close	close	ADJ
ajlm-1644	113	15	to	to	PART
ajlm-1644	113	16	1	1	NUM
ajlm-1644	113	17	has	have	VERB
ajlm-1644	113	18	little	little	ADJ
ajlm-1644	113	19	influence	influence	NOUN
ajlm-1644	113	20	to	to	PART
ajlm-1644	113	21	predict	predict	VERB
ajlm-1644	113	22	the	the	DET
ajlm-1644	113	23	presence	presence	NOUN
ajlm-1644	113	24	or	or	CCONJ
ajlm-1644	113	25	absence	absence	NOUN
ajlm-1644	113	26	of	of	ADP
ajlm-1644	113	27	a	a	DET
ajlm-1644	113	28	disease	disease	NOUN
ajlm-1644	113	29	and	and	CCONJ
ajlm-1644	113	30	is	be	AUX
ajlm-1644	113	31	,	,	PUNCT
ajlm-1644	113	32	therefore	therefore	ADV
ajlm-1644	113	33	,	,	PUNCT
ajlm-1644	113	34	worthless	worthless	ADJ
ajlm-1644	113	35	in	in	ADP
ajlm-1644	113	36	clinical	clinical	ADJ
ajlm-1644	113	37	practice	practice	NOUN
ajlm-1644	113	38	.	.	PUNCT
ajlm-1644	114	1	on	on	ADP
ajlm-1644	114	2	the	the	DET
ajlm-1644	114	3	same	same	ADJ
ajlm-1644	114	4	optimal	optimal	ADJ
ajlm-1644	114	5	value	value	NOUN
ajlm-1644	114	6	,	,	PUNCT
ajlm-1644	114	7	an	an	PRON
ajlm-1644	114	8	or	or	CCONJ
ajlm-1644	114	9	of	of	ADP
ajlm-1644	114	10	18.9	18.9	NUM
ajlm-1644	114	11	was	be	AUX
ajlm-1644	114	12	obtained	obtain	VERB
ajlm-1644	114	13	meaning	mean	VERB
ajlm-1644	114	14	that	that	SCONJ
ajlm-1644	114	15	individuals	individual	NOUN
ajlm-1644	114	16	with	with	ADP
ajlm-1644	114	17	the	the	DET
ajlm-1644	114	18	rdw	rdw	PROPN
ajlm-1644	114	19	>	>	X
ajlm-1644	114	20	21.1	21.1	NUM
ajlm-1644	114	21	were	be	AUX
ajlm-1644	114	22	18.9	18.9	NUM
ajlm-1644	114	23	times	time	NOUN
ajlm-1644	114	24	at	at	ADP
ajlm-1644	114	25	greater	great	ADJ
ajlm-1644	114	26	risk	risk	NOUN
ajlm-1644	114	27	of	of	ADP
ajlm-1644	114	28	having	have	VERB
ajlm-1644	114	29	scd	scd	NOUN
ajlm-1644	114	30	haemoglobinopathy	haemoglobinopathy	ADJ
ajlm-1644	114	31	compared	compare	VERB
ajlm-1644	114	32	to	to	ADP
ajlm-1644	114	33	those	those	PRON
ajlm-1644	114	34	with	with	ADP
ajlm-1644	114	35	the	the	DET
ajlm-1644	114	36	rdw	rdw	NOUN
ajlm-1644	114	37	<	<	X
ajlm-1644	114	38	21.1	21.1	NUM
ajlm-1644	114	39	.	.	PUNCT
ajlm-1644	115	1	limitations	limitation	NOUN
ajlm-1644	115	2	sickle	sickle	NOUN
ajlm-1644	115	3	cell	cell	NOUN
ajlm-1644	115	4	traits	trait	NOUN
ajlm-1644	116	1	+	+	ADP
ajlm-1644	116	2	haemoglobin	haemoglobin	NOUN
ajlm-1644	116	3	f	f	PROPN
ajlm-1644	116	4	and	and	CCONJ
ajlm-1644	116	5	+	+	ADJ
ajlm-1644	116	6	β	β	NOUN
ajlm-1644	116	7	-	-	ADJ
ajlm-1644	116	8	thalassaemia	thalassaemia	NOUN
ajlm-1644	116	9	recorded	record	VERB
ajlm-1644	116	10	abnormally	abnormally	ADV
ajlm-1644	116	11	elevated	elevate	VERB
ajlm-1644	116	12	rdw	rdw	ADJ
ajlm-1644	116	13	that	that	PRON
ajlm-1644	116	14	did	do	AUX
ajlm-1644	116	15	not	not	PART
ajlm-1644	116	16	have	have	VERB
ajlm-1644	116	17	statistical	statistical	ADJ
ajlm-1644	116	18	significance	significance	NOUN
ajlm-1644	116	19	due	due	ADP
ajlm-1644	116	20	to	to	ADP
ajlm-1644	116	21	the	the	DET
ajlm-1644	116	22	small	small	ADJ
ajlm-1644	116	23	sample	sample	NOUN
ajlm-1644	116	24	size	size	NOUN
ajlm-1644	116	25	.	.	PUNCT
ajlm-1644	117	1	conclusion	conclusion	NOUN
ajlm-1644	117	2	these	these	DET
ajlm-1644	117	3	findings	finding	NOUN
ajlm-1644	117	4	indicate	indicate	VERB
ajlm-1644	117	5	that	that	SCONJ
ajlm-1644	117	6	the	the	DET
ajlm-1644	117	7	rdw	rdw	NOUN
ajlm-1644	117	8	is	be	AUX
ajlm-1644	117	9	a	a	DET
ajlm-1644	117	10	promising	promising	ADJ
ajlm-1644	117	11	diagnostic	diagnostic	ADJ
ajlm-1644	117	12	marker	marker	NOUN
ajlm-1644	117	13	for	for	ADP
ajlm-1644	117	14	scd	scd	NOUN
ajlm-1644	117	15	phenotypes	phenotype	NOUN
ajlm-1644	117	16	;	;	PUNCT
ajlm-1644	117	17	thus	thus	ADV
ajlm-1644	117	18	,	,	PUNCT
ajlm-1644	117	19	rdw	rdw	NOUN
ajlm-1644	117	20	of	of	ADP
ajlm-1644	117	21	21.1	21.1	NUM
ajlm-1644	117	22	should	should	AUX
ajlm-1644	117	23	be	be	AUX
ajlm-1644	117	24	included	include	VERB
ajlm-1644	117	25	in	in	ADP
ajlm-1644	117	26	the	the	DET
ajlm-1644	117	27	haematology	haematology	NOUN
ajlm-1644	117	28	policy	policy	NOUN
ajlm-1644	117	29	screening	screen	VERB
ajlm-1644	117	30	algorithm	algorithm	NOUN
ajlm-1644	117	31	as	as	ADP
ajlm-1644	117	32	a	a	DET
ajlm-1644	117	33	critical	critical	ADJ
ajlm-1644	117	34	value	value	NOUN
ajlm-1644	117	35	above	above	ADP
ajlm-1644	117	36	which	which	PRON
ajlm-1644	117	37	the	the	DET
ajlm-1644	117	38	unknown	unknown	ADJ
ajlm-1644	117	39	cases	case	NOUN
ajlm-1644	117	40	qualify	qualify	VERB
ajlm-1644	117	41	to	to	PART
ajlm-1644	117	42	be	be	AUX
ajlm-1644	117	43	investigated	investigate	VERB
ajlm-1644	117	44	for	for	ADP
ajlm-1644	117	45	sickle	sickle	NOUN
ajlm-1644	117	46	cell	cell	NOUN
ajlm-1644	117	47	haemoglobinopathy	haemoglobinopathy	ADJ
ajlm-1644	117	48	.	.	PUNCT
ajlm-1644	118	1	however	however	ADV
ajlm-1644	118	2	,	,	PUNCT
ajlm-1644	118	3	the	the	DET
ajlm-1644	118	4	data	datum	NOUN
ajlm-1644	118	5	used	use	VERB
ajlm-1644	118	6	were	be	AUX
ajlm-1644	118	7	retrospective	retrospective	ADJ
ajlm-1644	118	8	and	and	CCONJ
ajlm-1644	118	9	hence	hence	ADV
ajlm-1644	118	10	the	the	DET
ajlm-1644	118	11	diagnostic	diagnostic	ADJ
ajlm-1644	118	12	utility	utility	NOUN
ajlm-1644	118	13	of	of	ADP
ajlm-1644	118	14	this	this	DET
ajlm-1644	118	15	haematological	haematological	ADJ
ajlm-1644	118	16	index	index	NOUN
ajlm-1644	118	17	for	for	ADP
ajlm-1644	118	18	haemoglobinopathy	haemoglobinopathy	ADJ
ajlm-1644	118	19	should	should	AUX
ajlm-1644	118	20	be	be	AUX
ajlm-1644	118	21	explored	explore	VERB
ajlm-1644	118	22	further	far	ADV
ajlm-1644	118	23	using	use	VERB
ajlm-1644	118	24	prospective	prospective	ADJ
ajlm-1644	118	25	data	datum	NOUN
ajlm-1644	118	26	.	.	PUNCT
ajlm-1644	119	1	a	a	DET
ajlm-1644	119	2	confirmatory	confirmatory	NOUN
ajlm-1644	119	3	test	test	NOUN
ajlm-1644	119	4	would	would	AUX
ajlm-1644	119	5	still	still	ADV
ajlm-1644	119	6	be	be	AUX
ajlm-1644	119	7	needed	need	VERB
ajlm-1644	119	8	and	and	CCONJ
ajlm-1644	119	9	therefore	therefore	ADV
ajlm-1644	119	10	provision	provision	NOUN
ajlm-1644	119	11	and	and	CCONJ
ajlm-1644	119	12	use	use	NOUN
ajlm-1644	119	13	of	of	ADP
ajlm-1644	119	14	powered	powered	ADJ
ajlm-1644	119	15	mini	mini	ADJ
ajlm-1644	119	16	-	-	ADJ
ajlm-1644	119	17	electrophoretic	electrophoretic	ADJ
ajlm-1644	119	18	equipment	equipment	NOUN
ajlm-1644	119	19	will	will	AUX
ajlm-1644	119	20	be	be	AUX
ajlm-1644	119	21	appropriate	appropriate	ADJ
ajlm-1644	119	22	in	in	ADP
ajlm-1644	119	23	low	low	ADJ
ajlm-1644	119	24	-	-	PUNCT
ajlm-1644	119	25	resource	resource	NOUN
ajlm-1644	119	26	settings	setting	NOUN
ajlm-1644	119	27	.	.	PUNCT
ajlm-1644	120	1	acknowledgements	acknowledgement	NOUN
ajlm-1644	120	2	we	we	PRON
ajlm-1644	120	3	are	be	AUX
ajlm-1644	120	4	grateful	grateful	ADJ
ajlm-1644	120	5	to	to	ADP
ajlm-1644	120	6	mr	mr	PROPN
ajlm-1644	120	7	.	.	PROPN
ajlm-1644	120	8	raphael	raphael	PROPN
ajlm-1644	120	9	kitonga	kitonga	PROPN
ajlm-1644	120	10	for	for	ADP
ajlm-1644	120	11	allowing	allow	VERB
ajlm-1644	120	12	us	we	PRON
ajlm-1644	120	13	to	to	PART
ajlm-1644	120	14	use	use	VERB
ajlm-1644	120	15	his	his	PRON
ajlm-1644	120	16	home	home	NOUN
ajlm-1644	120	17	-	-	PUNCT
ajlm-1644	120	18	based	base	VERB
ajlm-1644	120	19	library	library	NOUN
ajlm-1644	120	20	and	and	CCONJ
ajlm-1644	120	21	its	its	PRON
ajlm-1644	120	22	accessories	accessory	NOUN
ajlm-1644	120	23	in	in	ADP
ajlm-1644	120	24	addition	addition	NOUN
ajlm-1644	120	25	to	to	ADP
ajlm-1644	120	26	steadfast	steadfast	ADJ
ajlm-1644	120	27	moral	moral	ADJ
ajlm-1644	120	28	support	support	NOUN
ajlm-1644	120	29	.	.	PUNCT
ajlm-1644	121	1	we	we	PRON
ajlm-1644	121	2	appreciate	appreciate	VERB
ajlm-1644	121	3	the	the	DET
ajlm-1644	121	4	aga	aga	PROPN
ajlm-1644	121	5	khan	khan	PROPN
ajlm-1644	121	6	hospital	hospital	PROPN
ajlm-1644	121	7	,	,	PUNCT
ajlm-1644	121	8	kisumu	kisumu	PROPN
ajlm-1644	121	9	laboratory	laboratory	NOUN
ajlm-1644	121	10	manager	manager	NOUN
ajlm-1644	121	11	lucy	lucy	PROPN
ajlm-1644	121	12	mathenge	mathenge	PROPN
ajlm-1644	121	13	and	and	CCONJ
ajlm-1644	121	14	dr	dr	PROPN
ajlm-1644	121	15	simon	simon	PROPN
ajlm-1644	121	16	onsongo	onsongo	PROPN
ajlm-1644	121	17	head	head	NOUN
ajlm-1644	121	18	of	of	ADP
ajlm-1644	121	19	the	the	DET
ajlm-1644	121	20	pathology	pathology	NOUN
ajlm-1644	121	21	department	department	NOUN
ajlm-1644	121	22	for	for	ADP
ajlm-1644	121	23	supporting	support	VERB
ajlm-1644	121	24	us	we	PRON
ajlm-1644	121	25	during	during	ADP
ajlm-1644	121	26	data	data	NOUN
ajlm-1644	121	27	collection	collection	NOUN
ajlm-1644	121	28	.	.	PUNCT
ajlm-1644	122	1	competing	compete	VERB
ajlm-1644	122	2	interests	interest	NOUN
ajlm-1644	122	3	the	the	DET
ajlm-1644	122	4	authors	author	NOUN
ajlm-1644	122	5	declare	declare	VERB
ajlm-1644	122	6	that	that	SCONJ
ajlm-1644	122	7	they	they	PRON
ajlm-1644	122	8	have	have	VERB
ajlm-1644	122	9	no	no	DET
ajlm-1644	122	10	financial	financial	ADJ
ajlm-1644	122	11	or	or	CCONJ
ajlm-1644	122	12	personal	personal	ADJ
ajlm-1644	122	13	relationships	relationship	NOUN
ajlm-1644	122	14	that	that	PRON
ajlm-1644	122	15	may	may	AUX
ajlm-1644	122	16	have	have	AUX
ajlm-1644	122	17	inappropriately	inappropriately	ADV
ajlm-1644	122	18	influenced	influence	VERB
ajlm-1644	122	19	them	they	PRON
ajlm-1644	122	20	in	in	ADP
ajlm-1644	122	21	writing	write	VERB
ajlm-1644	122	22	this	this	DET
ajlm-1644	122	23	article	article	NOUN
ajlm-1644	122	24	.	.	PUNCT
ajlm-1644	123	1	authors	author	NOUN
ajlm-1644	123	2	’	’	PART
ajlm-1644	123	3	contributions	contribution	NOUN
ajlm-1644	123	4	b.m.m	b.m.m	VERB
ajlm-1644	123	5	.	.	PROPN
ajlm-1644	123	6	conceptualised	conceptualise	VERB
ajlm-1644	123	7	the	the	DET
ajlm-1644	123	8	study	study	NOUN
ajlm-1644	123	9	,	,	PUNCT
ajlm-1644	123	10	analysed	analyse	VERB
ajlm-1644	123	11	data	datum	NOUN
ajlm-1644	123	12	,	,	PUNCT
ajlm-1644	123	13	wrote	write	VERB
ajlm-1644	123	14	the	the	DET
ajlm-1644	123	15	original	original	ADJ
ajlm-1644	123	16	draft	draft	NOUN
ajlm-1644	123	17	of	of	ADP
ajlm-1644	123	18	the	the	DET
ajlm-1644	123	19	manuscript	manuscript	NOUN
ajlm-1644	123	20	and	and	CCONJ
ajlm-1644	123	21	critical	critical	ADJ
ajlm-1644	123	22	reviews	review	NOUN
ajlm-1644	123	23	.	.	PUNCT
ajlm-1644	124	1	g.s	g.s	PROPN
ajlm-1644	124	2	.	.	PROPN
ajlm-1644	124	3	conceptualised	conceptualise	VERB
ajlm-1644	124	4	the	the	DET
ajlm-1644	124	5	study	study	NOUN
ajlm-1644	124	6	,	,	PUNCT
ajlm-1644	124	7	and	and	CCONJ
ajlm-1644	124	8	contributed	contribute	VERB
ajlm-1644	124	9	to	to	ADP
ajlm-1644	124	10	the	the	DET
ajlm-1644	124	11	validation	validation	NOUN
ajlm-1644	124	12	and	and	CCONJ
ajlm-1644	124	13	critical	critical	ADJ
ajlm-1644	124	14	reviews	review	NOUN
ajlm-1644	124	15	.	.	PUNCT
ajlm-1644	125	1	p.o	p.o	PROPN
ajlm-1644	125	2	.	.	PROPN
ajlm-1644	125	3	conceptualised	conceptualise	VERB
ajlm-1644	125	4	the	the	DET
ajlm-1644	125	5	study	study	NOUN
ajlm-1644	125	6	,	,	PUNCT
ajlm-1644	125	7	gave	give	VERB
ajlm-1644	125	8	critical	critical	ADJ
ajlm-1644	125	9	technical	technical	ADJ
ajlm-1644	125	10	expert	expert	NOUN
ajlm-1644	125	11	advice	advice	NOUN
ajlm-1644	125	12	on	on	ADP
ajlm-1644	125	13	the	the	DET
ajlm-1644	125	14	study	study	NOUN
ajlm-1644	125	15	,	,	PUNCT
ajlm-1644	125	16	validation	validation	NOUN
ajlm-1644	125	17	and	and	CCONJ
ajlm-1644	125	18	gave	give	VERB
ajlm-1644	125	19	critical	critical	ADJ
ajlm-1644	125	20	reviews	review	NOUN
ajlm-1644	125	21	on	on	ADP
ajlm-1644	125	22	the	the	DET
ajlm-1644	125	23	manuscript	manuscript	NOUN
ajlm-1644	125	24	.	.	PUNCT
ajlm-1644	126	1	sources	source	NOUN
ajlm-1644	126	2	of	of	ADP
ajlm-1644	126	3	support	support	NOUN
ajlm-1644	126	4	the	the	DET
ajlm-1644	126	5	authors	author	NOUN
ajlm-1644	126	6	received	receive	VERB
ajlm-1644	126	7	no	no	DET
ajlm-1644	126	8	financial	financial	ADJ
ajlm-1644	126	9	support	support	NOUN
ajlm-1644	126	10	for	for	ADP
ajlm-1644	126	11	the	the	DET
ajlm-1644	126	12	research	research	NOUN
ajlm-1644	126	13	,	,	PUNCT
ajlm-1644	126	14	authorship	authorship	NOUN
ajlm-1644	126	15	,	,	PUNCT
ajlm-1644	126	16	or	or	CCONJ
ajlm-1644	126	17	publication	publication	NOUN
ajlm-1644	126	18	of	of	ADP
ajlm-1644	126	19	this	this	DET
ajlm-1644	126	20	article	article	NOUN
ajlm-1644	126	21	.	.	PUNCT
ajlm-1644	127	1	data	data	PROPN
ajlm-1644	127	2	availability	availability	NOUN
ajlm-1644	127	3	data	datum	NOUN
ajlm-1644	127	4	supporting	support	VERB
ajlm-1644	127	5	the	the	DET
ajlm-1644	127	6	findings	finding	NOUN
ajlm-1644	127	7	of	of	ADP
ajlm-1644	127	8	this	this	DET
ajlm-1644	127	9	study	study	NOUN
ajlm-1644	127	10	is	be	AUX
ajlm-1644	127	11	available	available	ADJ
ajlm-1644	127	12	upon	upon	SCONJ
ajlm-1644	127	13	request	request	NOUN
ajlm-1644	127	14	from	from	ADP
ajlm-1644	127	15	the	the	DET
ajlm-1644	127	16	corresponding	corresponding	ADJ
ajlm-1644	127	17	author	author	NOUN
ajlm-1644	127	18	,	,	PUNCT
ajlm-1644	127	19	b.m.m	b.m.m	NOUN
ajlm-1644	127	20	.	.	PUNCT
ajlm-1644	127	21	disclaimer	disclaimer	VERB
ajlm-1644	127	22	the	the	DET
ajlm-1644	127	23	views	view	NOUN
ajlm-1644	127	24	and	and	CCONJ
ajlm-1644	127	25	opinions	opinion	NOUN
ajlm-1644	127	26	expressed	express	VERB
ajlm-1644	127	27	in	in	ADP
ajlm-1644	127	28	this	this	DET
ajlm-1644	127	29	article	article	NOUN
ajlm-1644	127	30	are	be	AUX
ajlm-1644	127	31	those	those	PRON
ajlm-1644	127	32	of	of	ADP
ajlm-1644	127	33	the	the	DET
ajlm-1644	127	34	authors	author	NOUN
ajlm-1644	127	35	and	and	CCONJ
ajlm-1644	127	36	do	do	AUX
ajlm-1644	127	37	not	not	PART
ajlm-1644	127	38	necessarily	necessarily	ADV
ajlm-1644	127	39	reflect	reflect	VERB
ajlm-1644	127	40	the	the	DET
ajlm-1644	127	41	official	official	ADJ
ajlm-1644	127	42	policy	policy	NOUN
ajlm-1644	127	43	or	or	CCONJ
ajlm-1644	127	44	position	position	NOUN
ajlm-1644	127	45	of	of	ADP
ajlm-1644	127	46	any	any	DET
ajlm-1644	127	47	affiliated	affiliated	ADJ
ajlm-1644	127	48	agency	agency	NOUN
ajlm-1644	127	49	of	of	ADP
ajlm-1644	127	50	the	the	DET
ajlm-1644	127	51	authors	author	NOUN
ajlm-1644	127	52	.	.	PUNCT
ajlm-1644	128	1	references	reference	NOUN
ajlm-1644	128	2	weatherall	weatherall	PROPN
ajlm-1644	128	3	d.	d.	PROPN
ajlm-1644	128	4	the	the	DET
ajlm-1644	128	5	inherited	inherit	VERB
ajlm-1644	128	6	disorders	disorder	NOUN
ajlm-1644	128	7	of	of	ADP
ajlm-1644	128	8	haemoglobin	haemoglobin	NOUN
ajlm-1644	128	9	:	:	PUNCT
ajlm-1644	128	10	an	an	DET
ajlm-1644	128	11	increasingly	increasingly	ADV
ajlm-1644	128	12	neglected	neglect	VERB
ajlm-1644	128	13	global	global	ADJ
ajlm-1644	128	14	health	health	NOUN
ajlm-1644	128	15	burden	burden	NOUN
ajlm-1644	128	16	.	.	PUNCT
ajlm-1644	129	1	indian	indian	PROPN
ajlm-1644	129	2	j	j	PROPN
ajlm-1644	129	3	med	med	PROPN
ajlm-1644	129	4	res	re	NOUN
ajlm-1644	129	5	.	.	PUNCT
ajlm-1644	130	1	2011;134(4):493	2011;134(4):493	NUM
ajlm-1644	130	2	.	.	PUNCT
ajlm-1644	131	1	ilesanmi	ilesanmi	PROPN
ajlm-1644	131	2	oo	oo	INTJ
ajlm-1644	131	3	.	.	PUNCT
ajlm-1644	132	1	pathological	pathological	ADJ
ajlm-1644	132	2	basis	basis	NOUN
ajlm-1644	132	3	of	of	ADP
ajlm-1644	132	4	symptoms	symptom	NOUN
ajlm-1644	132	5	and	and	CCONJ
ajlm-1644	132	6	crises	crisis	NOUN
ajlm-1644	132	7	in	in	ADP
ajlm-1644	132	8	sickle	sickle	NOUN
ajlm-1644	132	9	cell	cell	NOUN
ajlm-1644	132	10	disorder	disorder	NOUN
ajlm-1644	132	11	:	:	PUNCT
ajlm-1644	132	12	implications	implication	NOUN
ajlm-1644	132	13	for	for	ADP
ajlm-1644	132	14	counseling	counseling	NOUN
ajlm-1644	132	15	and	and	CCONJ
ajlm-1644	132	16	psychotherapy	psychotherapy	NOUN
ajlm-1644	132	17	.	.	PUNCT
ajlm-1644	133	1	hematol	hematol	PROPN
ajlm-1644	133	2	rep	rep	PROPN
ajlm-1644	133	3	.	.	PROPN
ajlm-1644	133	4	2010;2(1):e2	2010;2(1):e2	NUM
ajlm-1644	133	5	.	.	PUNCT
ajlm-1644	134	1	https://doi.org/10.4081/hr.2010.e2	https://doi.org/10.4081/hr.2010.e2	PROPN
ajlm-1644	134	2	piety	piety	NOUN
ajlm-1644	134	3	nz	nz	PROPN
ajlm-1644	134	4	,	,	PUNCT
ajlm-1644	134	5	yang	yang	PROPN
ajlm-1644	134	6	x	x	PROPN
ajlm-1644	134	7	,	,	PUNCT
ajlm-1644	134	8	kanter	kanter	PROPN
ajlm-1644	134	9	j	j	PROPN
ajlm-1644	134	10	,	,	PUNCT
ajlm-1644	134	11	vignes	vignes	PROPN
ajlm-1644	134	12	sm	sm	PROPN
ajlm-1644	134	13	,	,	PUNCT
ajlm-1644	134	14	george	george	PROPN
ajlm-1644	134	15	a	a	X
ajlm-1644	134	16	,	,	PUNCT
ajlm-1644	134	17	shevkoplyas	shevkoplyas	PROPN
ajlm-1644	134	18	ss	ss	PROPN
ajlm-1644	134	19	.	.	PUNCT
ajlm-1644	135	1	validation	validation	NOUN
ajlm-1644	135	2	of	of	ADP
ajlm-1644	135	3	a	a	DET
ajlm-1644	135	4	low	low	ADJ
ajlm-1644	135	5	-	-	PUNCT
ajlm-1644	135	6	cost	cost	NOUN
ajlm-1644	135	7	paper	paper	NOUN
ajlm-1644	135	8	-	-	PUNCT
ajlm-1644	135	9	based	base	VERB
ajlm-1644	135	10	screening	screening	NOUN
ajlm-1644	135	11	test	test	NOUN
ajlm-1644	135	12	for	for	ADP
ajlm-1644	135	13	sickle	sickle	NOUN
ajlm-1644	135	14	cell	cell	NOUN
ajlm-1644	135	15	anemia	anemia	NOUN
ajlm-1644	135	16	.	.	PUNCT
ajlm-1644	136	1	plos	plos	PROPN
ajlm-1644	136	2	one	one	NUM
ajlm-1644	136	3	.	.	PUNCT
ajlm-1644	137	1	2016;11(1):e0144901	2016;11(1):e0144901	X
ajlm-1644	137	2	.	.	PUNCT
ajlm-1644	138	1	https://doi.org/10.1371/journal.pone.0144901	https://doi.org/10.1371/journal.pone.0144901	PROPN
ajlm-1644	138	2	debaun	debaun	PROPN
ajlm-1644	138	3	mr	mr	PROPN
ajlm-1644	138	4	,	,	PUNCT
ajlm-1644	138	5	galadanci	galadanci	PROPN
ajlm-1644	138	6	na	na	NOUN
ajlm-1644	138	7	,	,	PUNCT
ajlm-1644	138	8	vichinsky	vichinsky	ADJ
ajlm-1644	138	9	ep	ep	PROPN
ajlm-1644	138	10	.	.	PUNCT
ajlm-1644	139	1	sickle	sickle	PROPN
ajlm-1644	139	2	cell	cell	NOUN
ajlm-1644	139	3	disease	disease	NOUN
ajlm-1644	139	4	in	in	ADP
ajlm-1644	139	5	sub	sub	ADJ
ajlm-1644	139	6	-	-	ADJ
ajlm-1644	139	7	saharan	saharan	ADJ
ajlm-1644	139	8	africa	africa	PROPN
ajlm-1644	139	9	.	.	PUNCT
ajlm-1644	140	1	alphen	alphen	PROPN
ajlm-1644	140	2	aan	aan	PROPN
ajlm-1644	140	3	den	den	PROPN
ajlm-1644	140	4	rijn	rijn	PROPN
ajlm-1644	140	5	:	:	PUNCT
ajlm-1644	140	6	wolters	wolters	PROPN
ajlm-1644	140	7	kluwer	kluwer	PROPN
ajlm-1644	140	8	uptodate;2019	uptodate;2019	PROPN
ajlm-1644	140	9	.	.	PROPN
ajlm-1644	141	1	makani	makani	PROPN
ajlm-1644	141	2	j	j	PROPN
ajlm-1644	141	3	,	,	PUNCT
ajlm-1644	141	4	cox	cox	PROPN
ajlm-1644	141	5	se	se	X
ajlm-1644	141	6	,	,	PUNCT
ajlm-1644	141	7	soka	soka	PROPN
ajlm-1644	141	8	d	d	PROPN
ajlm-1644	141	9	,	,	PUNCT
ajlm-1644	141	10	et	et	PROPN
ajlm-1644	141	11	al	al	PROPN
ajlm-1644	141	12	.	.	PUNCT
ajlm-1644	141	13	mortality	mortality	NOUN
ajlm-1644	141	14	in	in	ADP
ajlm-1644	141	15	sickle	sickle	PROPN
ajlm-1644	141	16	cell	cell	NOUN
ajlm-1644	141	17	anemia	anemia	NOUN
ajlm-1644	141	18	in	in	ADP
ajlm-1644	141	19	africa	africa	PROPN
ajlm-1644	141	20	:	:	PUNCT
ajlm-1644	141	21	a	a	DET
ajlm-1644	141	22	prospective	prospective	ADJ
ajlm-1644	141	23	cohort	cohort	NOUN
ajlm-1644	141	24	study	study	NOUN
ajlm-1644	141	25	in	in	ADP
ajlm-1644	141	26	tanzania	tanzania	PROPN
ajlm-1644	141	27	.	.	PUNCT
ajlm-1644	142	1	plos	plos	PROPN
ajlm-1644	142	2	one	one	NUM
ajlm-1644	142	3	.	.	PUNCT
ajlm-1644	143	1	2011;6(2):e14699	2011;6(2):e14699	NUM
ajlm-1644	143	2	.	.	PUNCT
ajlm-1644	144	1	https://doi.org/10.1371/journal.pone.0014699	https://doi.org/10.1371/journal.pone.0014699	PROPN
ajlm-1644	144	2	arishi	arishi	PROPN
ajlm-1644	144	3	wa	wa	PROPN
ajlm-1644	144	4	,	,	PUNCT
ajlm-1644	144	5	al	al	PROPN
ajlm-1644	144	6	-	-	PUNCT
ajlm-1644	144	7	hadrami	hadrami	PROPN
ajlm-1644	144	8	ha	ha	INTJ
ajlm-1644	144	9	,	,	PUNCT
ajlm-1644	144	10	zourob	zourob	PROPN
ajlm-1644	144	11	m.	m.	NOUN
ajlm-1644	144	12	techniques	technique	NOUN
ajlm-1644	144	13	for	for	ADP
ajlm-1644	144	14	the	the	DET
ajlm-1644	144	15	detection	detection	NOUN
ajlm-1644	144	16	of	of	ADP
ajlm-1644	144	17	sickle	sickle	NOUN
ajlm-1644	144	18	cell	cell	NOUN
ajlm-1644	144	19	disease	disease	NOUN
ajlm-1644	144	20	:	:	PUNCT
ajlm-1644	144	21	a	a	DET
ajlm-1644	144	22	review	review	NOUN
ajlm-1644	144	23	.	.	PUNCT
ajlm-1644	145	1	micromachines	micromachine	NOUN
ajlm-1644	145	2	.	.	PUNCT
ajlm-1644	146	1	2021;12(5):519	2021;12(5):519	NOUN
ajlm-1644	146	2	.	.	PUNCT
ajlm-1644	147	1	https://doi.org/10.3390/mi12050519	https://doi.org/10.3390/mi12050519	PROPN
ajlm-1644	147	2	uyoga	uyoga	PROPN
ajlm-1644	147	3	s	s	PROPN
ajlm-1644	147	4	,	,	PUNCT
ajlm-1644	147	5	macharia	macharia	PROPN
ajlm-1644	147	6	aw	aw	INTJ
ajlm-1644	147	7	,	,	PUNCT
ajlm-1644	147	8	mochamah	mochamah	PROPN
ajlm-1644	147	9	g	g	PROPN
ajlm-1644	147	10	,	,	PUNCT
ajlm-1644	147	11	et	et	PROPN
ajlm-1644	147	12	al	al	PROPN
ajlm-1644	147	13	.	.	PUNCT
ajlm-1644	148	1	the	the	DET
ajlm-1644	148	2	epidemiology	epidemiology	NOUN
ajlm-1644	148	3	of	of	ADP
ajlm-1644	148	4	sickle	sickle	NOUN
ajlm-1644	148	5	cell	cell	NOUN
ajlm-1644	148	6	disease	disease	NOUN
ajlm-1644	148	7	in	in	ADP
ajlm-1644	148	8	children	child	NOUN
ajlm-1644	148	9	recruited	recruit	VERB
ajlm-1644	148	10	in	in	ADP
ajlm-1644	148	11	infancy	infancy	NOUN
ajlm-1644	148	12	in	in	ADP
ajlm-1644	148	13	kilifi	kilifi	PROPN
ajlm-1644	148	14	,	,	PUNCT
ajlm-1644	148	15	kenya	kenya	PROPN
ajlm-1644	148	16	:	:	PUNCT
ajlm-1644	148	17	a	a	DET
ajlm-1644	148	18	prospective	prospective	ADJ
ajlm-1644	148	19	cohort	cohort	NOUN
ajlm-1644	148	20	study	study	NOUN
ajlm-1644	148	21	.	.	PUNCT
ajlm-1644	149	1	the	the	DET
ajlm-1644	149	2	lancet	lancet	PROPN
ajlm-1644	149	3	global	global	PROPN
ajlm-1644	149	4	health	health	NOUN
ajlm-1644	149	5	.	.	PUNCT
ajlm-1644	150	1	2019;7(10):e1458	2019;7(10):e1458	X
ajlm-1644	150	2	–	–	PUNCT
ajlm-1644	150	3	e1466	e1466	PROPN
ajlm-1644	150	4	.	.	NOUN
ajlm-1644	150	5	https://doi.org/10.1016/s2214-109x(19)30328-6	https://doi.org/10.1016/s2214-109x(19)30328-6	NOUN
ajlm-1644	150	6	chakravorty	chakravorty	NOUN
ajlm-1644	150	7	s	s	PROPN
ajlm-1644	150	8	,	,	PUNCT
ajlm-1644	150	9	williams	williams	PROPN
ajlm-1644	150	10	tn	tn	PROPN
ajlm-1644	150	11	.	.	PUNCT
ajlm-1644	150	12	sickle	sickle	PROPN
ajlm-1644	150	13	cell	cell	NOUN
ajlm-1644	150	14	disease	disease	NOUN
ajlm-1644	150	15	:	:	PUNCT
ajlm-1644	150	16	a	a	DET
ajlm-1644	150	17	neglected	neglect	VERB
ajlm-1644	150	18	chronic	chronic	ADJ
ajlm-1644	150	19	disease	disease	NOUN
ajlm-1644	150	20	of	of	ADP
ajlm-1644	150	21	increasing	increase	VERB
ajlm-1644	150	22	global	global	ADJ
ajlm-1644	150	23	health	health	NOUN
ajlm-1644	150	24	importance	importance	NOUN
ajlm-1644	150	25	.	.	PUNCT
ajlm-1644	151	1	arch	arch	PROPN
ajlm-1644	151	2	dis	dis	PROPN
ajlm-1644	151	3	child	child	NOUN
ajlm-1644	151	4	.	.	PUNCT
ajlm-1644	152	1	2015;100(1):48–53	2015;100(1):48–53	X
ajlm-1644	152	2	.	.	PUNCT
ajlm-1644	152	3	https://doi.org/10.1136/archdischild-2013-303773	https://doi.org/10.1136/archdischild-2013-303773	PROPN
ajlm-1644	152	4	grosse	grosse	PROPN
ajlm-1644	152	5	sd	sd	PROPN
ajlm-1644	152	6	,	,	PUNCT
ajlm-1644	152	7	odame	odame	VERB
ajlm-1644	152	8	i	i	PRON
ajlm-1644	152	9	,	,	PUNCT
ajlm-1644	152	10	atrash	atrash	PROPN
ajlm-1644	152	11	hk	hk	PROPN
ajlm-1644	152	12	,	,	PUNCT
ajlm-1644	152	13	amendah	amendah	PROPN
ajlm-1644	152	14	dd	dd	PROPN
ajlm-1644	152	15	,	,	PUNCT
ajlm-1644	152	16	piel	piel	NOUN
ajlm-1644	152	17	fb	fb	PROPN
ajlm-1644	152	18	,	,	PUNCT
ajlm-1644	152	19	williams	williams	PROPN
ajlm-1644	152	20	tn	tn	PROPN
ajlm-1644	152	21	.	.	PUNCT
ajlm-1644	152	22	sickle	sickle	PROPN
ajlm-1644	152	23	cell	cell	NOUN
ajlm-1644	152	24	disease	disease	NOUN
ajlm-1644	152	25	in	in	ADP
ajlm-1644	152	26	africa	africa	PROPN
ajlm-1644	152	27	:	:	PUNCT
ajlm-1644	152	28	a	a	DET
ajlm-1644	152	29	neglected	neglect	VERB
ajlm-1644	152	30	cause	cause	NOUN
ajlm-1644	152	31	of	of	ADP
ajlm-1644	152	32	early	early	ADJ
ajlm-1644	152	33	childhood	childhood	NOUN
ajlm-1644	152	34	mortality	mortality	NOUN
ajlm-1644	152	35	.	.	PUNCT
ajlm-1644	153	1	am	be	AUX
ajlm-1644	153	2	j	j	PROPN
ajlm-1644	153	3	prev	prev	X
ajlm-1644	153	4	med	med	PROPN
ajlm-1644	153	5	.	.	PUNCT
ajlm-1644	154	1	2011;41(6):s398	2011;41(6):s398	PROPN
ajlm-1644	154	2	–	–	PUNCT
ajlm-1644	154	3	s405	s405	PROPN
ajlm-1644	154	4	.	.	PUNCT
ajlm-1644	155	1	https://doi.org/10.1016/j.amepre.2011.09.013	https://doi.org/10.1016/j.amepre.2011.09.013	PROPN
ajlm-1644	155	2	modell	modell	PROPN
ajlm-1644	155	3	b	b	PROPN
ajlm-1644	155	4	,	,	PUNCT
ajlm-1644	155	5	darlison	darlison	PROPN
ajlm-1644	155	6	m.	m.	NOUN
ajlm-1644	155	7	global	global	ADJ
ajlm-1644	155	8	epidemiology	epidemiology	NOUN
ajlm-1644	155	9	of	of	ADP
ajlm-1644	155	10	haemoglobin	haemoglobin	PROPN
ajlm-1644	155	11	disorders	disorder	NOUN
ajlm-1644	155	12	and	and	CCONJ
ajlm-1644	155	13	derived	derived	ADJ
ajlm-1644	155	14	service	service	NOUN
ajlm-1644	155	15	indicators	indicator	NOUN
ajlm-1644	155	16	.	.	PUNCT
ajlm-1644	156	1	bulletin	bulletin	NOUN
ajlm-1644	156	2	of	of	ADP
ajlm-1644	156	3	the	the	DET
ajlm-1644	156	4	world	world	PROPN
ajlm-1644	156	5	health	health	NOUN
ajlm-1644	156	6	organization	organization	NOUN
ajlm-1644	156	7	.	.	PUNCT
ajlm-1644	157	1	2008;86:480–487	2008;86:480–487	PROPN
ajlm-1644	157	2	.	.	PUNCT
ajlm-1644	158	1	https://doi.org/10.2471/blt.06.036673	https://doi.org/10.2471/blt.06.036673	PROPN
ajlm-1644	158	2	suchdev	suchdev	PROPN
ajlm-1644	158	3	ps	ps	PROPN
ajlm-1644	158	4	,	,	PUNCT
ajlm-1644	158	5	ruth	ruth	PROPN
ajlm-1644	158	6	lj	lj	PROPN
ajlm-1644	158	7	,	,	PUNCT
ajlm-1644	158	8	earley	earley	PROPN
ajlm-1644	158	9	m	m	PROPN
ajlm-1644	158	10	,	,	PUNCT
ajlm-1644	158	11	macharia	macharia	PROPN
ajlm-1644	158	12	a	a	PROPN
ajlm-1644	158	13	,	,	PUNCT
ajlm-1644	158	14	williams	williams	PROPN
ajlm-1644	158	15	tn	tn	PROPN
ajlm-1644	158	16	.	.	PUNCT
ajlm-1644	159	1	the	the	DET
ajlm-1644	159	2	burden	burden	NOUN
ajlm-1644	159	3	and	and	CCONJ
ajlm-1644	159	4	consequences	consequence	NOUN
ajlm-1644	159	5	of	of	ADP
ajlm-1644	159	6	inherited	inherit	VERB
ajlm-1644	159	7	blood	blood	NOUN
ajlm-1644	159	8	disorders	disorder	NOUN
ajlm-1644	159	9	among	among	ADP
ajlm-1644	159	10	young	young	ADJ
ajlm-1644	159	11	children	child	NOUN
ajlm-1644	159	12	in	in	ADP
ajlm-1644	159	13	western	western	ADJ
ajlm-1644	159	14	kenya	kenya	PROPN
ajlm-1644	159	15	.	.	PUNCT
ajlm-1644	160	1	matern	matern	PROPN
ajlm-1644	160	2	child	child	PROPN
ajlm-1644	160	3	nutr	nutr	PROPN
ajlm-1644	160	4	.	.	PUNCT
ajlm-1644	161	1	2014;10(1):135–144	2014;10(1):135–144	NUM
ajlm-1644	161	2	.	.	PUNCT
ajlm-1644	161	3	https://doi.org/10.1111/j.1740-8709.2012.00454.x	https://doi.org/10.1111/j.1740-8709.2012.00454.x	PROPN
ajlm-1644	161	4	sawaimul	sawaimul	PROPN
ajlm-1644	161	5	kd	kd	PROPN
ajlm-1644	161	6	,	,	PUNCT
ajlm-1644	161	7	iqbal	iqbal	PROPN
ajlm-1644	161	8	mb	mb	PROPN
ajlm-1644	161	9	,	,	PUNCT
ajlm-1644	161	10	sawaimul	sawaimul	ADJ
ajlm-1644	161	11	vd	vd	NOUN
ajlm-1644	161	12	,	,	PUNCT
ajlm-1644	161	13	kambale	kambale	PROPN
ajlm-1644	161	14	t	t	PROPN
ajlm-1644	161	15	,	,	PUNCT
ajlm-1644	161	16	hanmante	hanmante	PROPN
ajlm-1644	161	17	r.	r.	PROPN
ajlm-1644	161	18	study	study	PROPN
ajlm-1644	161	19	to	to	PART
ajlm-1644	161	20	identify	identify	VERB
ajlm-1644	161	21	the	the	DET
ajlm-1644	161	22	role	role	NOUN
ajlm-1644	161	23	of	of	ADP
ajlm-1644	161	24	high	high	ADJ
ajlm-1644	161	25	-	-	PUNCT
ajlm-1644	161	26	performance	performance	NOUN
ajlm-1644	161	27	liquid	liquid	ADJ
ajlm-1644	161	28	chromatography	chromatography	NOUN
ajlm-1644	161	29	in	in	ADP
ajlm-1644	161	30	detecting	detect	VERB
ajlm-1644	161	31	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	161	32	in	in	ADP
ajlm-1644	161	33	antenatal	antenatal	ADJ
ajlm-1644	161	34	patients	patient	NOUN
ajlm-1644	161	35	.	.	PUNCT
ajlm-1644	162	1	indian	indian	PROPN
ajlm-1644	162	2	j	j	PROPN
ajlm-1644	162	3	pathol	pathol	VERB
ajlm-1644	162	4	oncol	oncol	ADJ
ajlm-1644	162	5	.	.	PUNCT
ajlm-1644	163	1	2018;5(1):6–11	2018;5(1):6–11	NUM
ajlm-1644	163	2	.	.	PUNCT
ajlm-1644	164	1	https://doi.org/10.18231/2394-6792.2018.0002	https://doi.org/10.18231/2394-6792.2018.0002	PROPN
ajlm-1644	164	2	trent	trent	PROPN
ajlm-1644	164	3	rj	rj	PROPN
ajlm-1644	164	4	.	.	PUNCT
ajlm-1644	164	5	diagnosis	diagnosis	NOUN
ajlm-1644	164	6	of	of	ADP
ajlm-1644	164	7	the	the	DET
ajlm-1644	164	8	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-1644	164	9	.	.	PUNCT
ajlm-1644	165	1	clin	clin	PROPN
ajlm-1644	165	2	biochemist	biochemist	NOUN
ajlm-1644	165	3	rev	rev	VERB
ajlm-1644	165	4	.	.	PUNCT
ajlm-1644	166	1	2006;27(1):27	2006;27(1):27	NUM
ajlm-1644	166	2	.	.	PUNCT
ajlm-1644	166	3	tluway	tluway	PROPN
ajlm-1644	167	1	f	f	PROPN
ajlm-1644	167	2	,	,	PUNCT
ajlm-1644	167	3	makani	makani	PROPN
ajlm-1644	167	4	j.	j.	PROPN
ajlm-1644	167	5	sickle	sickle	PROPN
ajlm-1644	167	6	cell	cell	PROPN
ajlm-1644	167	7	disease	disease	NOUN
ajlm-1644	167	8	in	in	ADP
ajlm-1644	167	9	africa	africa	PROPN
ajlm-1644	167	10	:	:	PUNCT
ajlm-1644	167	11	an	an	DET
ajlm-1644	167	12	overview	overview	NOUN
ajlm-1644	167	13	of	of	ADP
ajlm-1644	167	14	the	the	DET
ajlm-1644	167	15	integrated	integrate	VERB
ajlm-1644	167	16	approach	approach	NOUN
ajlm-1644	167	17	to	to	ADP
ajlm-1644	167	18	health	health	NOUN
ajlm-1644	167	19	,	,	PUNCT
ajlm-1644	167	20	research	research	NOUN
ajlm-1644	167	21	,	,	PUNCT
ajlm-1644	167	22	education	education	NOUN
ajlm-1644	167	23	,	,	PUNCT
ajlm-1644	167	24	and	and	CCONJ
ajlm-1644	167	25	advocacy	advocacy	NOUN
ajlm-1644	167	26	in	in	ADP
ajlm-1644	167	27	tanzania	tanzania	PROPN
ajlm-1644	167	28	,	,	PUNCT
ajlm-1644	167	29	2004–2016	2004–2016	NUM
ajlm-1644	167	30	.	.	PUNCT
ajlm-1644	168	1	br	br	PROPN
ajlm-1644	168	2	j	j	PROPN
ajlm-1644	168	3	haematol	haematol	NOUN
ajlm-1644	168	4	.	.	PUNCT
ajlm-1644	169	1	2017;177(6):919–929	2017;177(6):919–929	NOUN
ajlm-1644	169	2	.	.	PUNCT
ajlm-1644	170	1	https://doi.org/10.1111/bjh.14594	https://doi.org/10.1111/bjh.14594	PROPN
ajlm-1644	170	2	kosiyo	kosiyo	VERB
ajlm-1644	170	3	p	p	X
ajlm-1644	170	4	,	,	PUNCT
ajlm-1644	170	5	otieno	otieno	ADJ
ajlm-1644	170	6	w	w	PROPN
ajlm-1644	170	7	,	,	PUNCT
ajlm-1644	170	8	gitaka	gitaka	PROPN
ajlm-1644	170	9	j	j	PROPN
ajlm-1644	170	10	,	,	PUNCT
ajlm-1644	170	11	munde	munde	PROPN
ajlm-1644	170	12	eo	eo	PROPN
ajlm-1644	170	13	,	,	PUNCT
ajlm-1644	170	14	ouma	ouma	PROPN
ajlm-1644	170	15	c.	c.	PROPN
ajlm-1644	170	16	association	association	PROPN
ajlm-1644	170	17	between	between	ADP
ajlm-1644	170	18	haematological	haematological	ADJ
ajlm-1644	170	19	parameters	parameter	NOUN
ajlm-1644	170	20	and	and	CCONJ
ajlm-1644	170	21	sickle	sickle	NOUN
ajlm-1644	170	22	cell	cell	NOUN
ajlm-1644	170	23	genotypes	genotype	NOUN
ajlm-1644	170	24	in	in	ADP
ajlm-1644	170	25	children	child	NOUN
ajlm-1644	170	26	with	with	ADP
ajlm-1644	170	27	plasmodium	plasmodium	NOUN
ajlm-1644	170	28	falciparum	falciparum	ADJ
ajlm-1644	170	29	malaria	malaria	NOUN
ajlm-1644	170	30	resident	resident	NOUN
ajlm-1644	170	31	in	in	ADP
ajlm-1644	170	32	kisumu	kisumu	PROPN
ajlm-1644	170	33	county	county	PROPN
ajlm-1644	170	34	in	in	ADP
ajlm-1644	170	35	western	western	ADJ
ajlm-1644	170	36	kenya	kenya	PROPN
ajlm-1644	170	37	.	.	PUNCT
ajlm-1644	171	1	bmc	bmc	PROPN
ajlm-1644	171	2	infect	infect	PROPN
ajlm-1644	171	3	dis	dis	PROPN
ajlm-1644	171	4	.	.	PUNCT
ajlm-1644	172	1	2020;20(1):1–1	2020;20(1):1–1	X
ajlm-1644	172	2	.	.	PUNCT
ajlm-1644	173	1	https://doi.org/10.1186/s12879-020-05625-z	https://doi.org/10.1186/s12879-020-05625-z	PRON
ajlm-1644	173	2	kifude	kifude	VERB
ajlm-1644	173	3	cm	cm	PROPN
ajlm-1644	173	4	.	.	PUNCT
ajlm-1644	174	1	prevalence	prevalence	NOUN
ajlm-1644	174	2	of	of	ADP
ajlm-1644	174	3	sickle	sickle	NOUN
ajlm-1644	174	4	cell	cell	NOUN
ajlm-1644	174	5	and	and	CCONJ
ajlm-1644	174	6	α	α	NOUN
ajlm-1644	174	7	-	-	PUNCT
ajlm-1644	174	8	thalassemia	thalassemia	NOUN
ajlm-1644	174	9	traits	trait	NOUN
ajlm-1644	174	10	in	in	ADP
ajlm-1644	174	11	children	child	NOUN
ajlm-1644	174	12	enrolled	enrol	VERB
ajlm-1644	174	13	in	in	ADP
ajlm-1644	174	14	a	a	DET
ajlm-1644	174	15	malaria	malaria	NOUN
ajlm-1644	174	16	vaccine	vaccine	NOUN
ajlm-1644	174	17	clinical	clinical	ADJ
ajlm-1644	174	18	trial	trial	NOUN
ajlm-1644	174	19	,	,	PUNCT
ajlm-1644	174	20	in	in	ADP
ajlm-1644	174	21	kombewa	kombewa	PROPN
ajlm-1644	174	22	,	,	PUNCT
ajlm-1644	174	23	western	western	ADJ
ajlm-1644	174	24	kenya	kenya	PROPN
ajlm-1644	174	25	.	.	PUNCT
ajlm-1644	175	1	doctoral	doctoral	ADJ
ajlm-1644	175	2	dissertation	dissertation	NOUN
ajlm-1644	175	3	.	.	PUNCT
ajlm-1644	176	1	nairobi	nairobi	PROPN
ajlm-1644	176	2	:	:	PUNCT
ajlm-1644	176	3	jesuit	jesuit	PROPN
ajlm-1644	176	4	historical	historical	PROPN
ajlm-1644	176	5	institute	institute	PROPN
ajlm-1644	176	6	in	in	ADP
ajlm-1644	176	7	africa	africa	PROPN
ajlm-1644	176	8	,	,	PUNCT
ajlm-1644	176	9	kenyatta	kenyatta	PROPN
ajlm-1644	176	10	university;2007	university;2007	PROPN
ajlm-1644	176	11	.	.	PROPN
ajlm-1644	176	12	available	available	ADJ
ajlm-1644	176	13	from	from	ADP
ajlm-1644	176	14	:	:	PUNCT
ajlm-1644	176	15	http://thesisbank.jhia.ac.ke/id/eprint/2505	http://thesisbank.jhia.ac.ke/id/eprint/2505	PROPN
ajlm-1644	176	16	sarah	sarah	PROPN
ajlm-1644	176	17	b	b	PROPN
ajlm-1644	176	18	,	,	PUNCT
ajlm-1644	176	19	sheikh	sheikh	PROPN
ajlm-1644	176	20	k	k	PROPN
ajlm-1644	176	21	,	,	PUNCT
ajlm-1644	176	22	shah	shah	PROPN
ajlm-1644	176	23	t.	t.	PROPN
ajlm-1644	176	24	red	red	ADJ
ajlm-1644	176	25	cell	cell	NOUN
ajlm-1644	176	26	distribution	distribution	NOUN
ajlm-1644	176	27	width	width	NOUN
ajlm-1644	176	28	is	be	AUX
ajlm-1644	176	29	early	early	ADJ
ajlm-1644	176	30	marker	marker	NOUN
ajlm-1644	176	31	for	for	ADP
ajlm-1644	176	32	detection	detection	NOUN
ajlm-1644	176	33	of	of	ADP
ajlm-1644	176	34	iron	iron	NOUN
ajlm-1644	176	35	deficiency	deficiency	NOUN
ajlm-1644	176	36	anemia	anemia	NOUN
ajlm-1644	176	37	during	during	ADP
ajlm-1644	176	38	pregnancy	pregnancy	NOUN
ajlm-1644	176	39	.	.	PUNCT
ajlm-1644	177	1	j	j	PROPN
ajlm-1644	177	2	liaquat	liaquat	PROPN
ajlm-1644	177	3	university	university	PROPN
ajlm-1644	177	4	med	med	PROPN
ajlm-1644	177	5	health	health	PROPN
ajlm-1644	177	6	sci	sci	PROPN
ajlm-1644	177	7	.	.	PUNCT
ajlm-1644	178	1	2018;17(3):165–169	2018;17(3):165–169	PROPN
ajlm-1644	178	2	.	.	PUNCT
ajlm-1644	178	3	https://doi.org/10.22442/jlumhs.181730571	https://doi.org/10.22442/jlumhs.181730571	PROPN
ajlm-1644	179	1	aulakh	aulakh	PROPN
ajlm-1644	179	2	r	r	PROPN
ajlm-1644	179	3	,	,	PUNCT
ajlm-1644	179	4	sohi	sohi	NOUN
ajlm-1644	179	5	i	i	PRON
ajlm-1644	179	6	,	,	PUNCT
ajlm-1644	179	7	singh	singh	PROPN
ajlm-1644	179	8	t	t	PROPN
ajlm-1644	179	9	,	,	PUNCT
ajlm-1644	179	10	kakkar	kakkar	PROPN
ajlm-1644	179	11	n.	n.	PROPN
ajlm-1644	179	12	red	red	ADJ
ajlm-1644	179	13	cell	cell	NOUN
ajlm-1644	179	14	distribution	distribution	NOUN
ajlm-1644	179	15	width	width	NOUN
ajlm-1644	179	16	(	(	PUNCT
ajlm-1644	179	17	rdw	rdw	NOUN
ajlm-1644	179	18	)	)	PUNCT
ajlm-1644	179	19	in	in	ADP
ajlm-1644	179	20	the	the	DET
ajlm-1644	179	21	diagnosis	diagnosis	NOUN
ajlm-1644	179	22	of	of	ADP
ajlm-1644	179	23	iron	iron	NOUN
ajlm-1644	179	24	deficiency	deficiency	NOUN
ajlm-1644	179	25	with	with	ADP
ajlm-1644	179	26	microcytic	microcytic	ADJ
ajlm-1644	179	27	hypochromic	hypochromic	ADJ
ajlm-1644	179	28	anemia	anemia	NOUN
ajlm-1644	179	29	.	.	PUNCT
ajlm-1644	180	1	indian	indian	PROPN
ajlm-1644	180	2	j	j	PROPN
ajlm-1644	180	3	pediatr	pediatr	PROPN
ajlm-1644	180	4	.	.	PUNCT
ajlm-1644	181	1	2009;76(3):265–268	2009;76(3):265–268	NUM
ajlm-1644	181	2	.	.	X
ajlm-1644	181	3	https://doi.org/10.1007/s12098-009-0014-4	https://doi.org/10.1007/s12098-009-0014-4	NUM
ajlm-1644	181	4	eldibany	eldibany	NOUN
ajlm-1644	181	5	mm	mm	PROPN
ajlm-1644	181	6	,	,	PUNCT
ajlm-1644	181	7	totonchi	totonchi	PROPN
ajlm-1644	181	8	kf	kf	PROPN
ajlm-1644	181	9	,	,	PUNCT
ajlm-1644	181	10	joseph	joseph	PROPN
ajlm-1644	181	11	nj	nj	PROPN
ajlm-1644	181	12	,	,	PUNCT
ajlm-1644	181	13	rhone	rhone	PROPN
ajlm-1644	181	14	d.	d.	PROPN
ajlm-1644	181	15	usefulness	usefulness	NOUN
ajlm-1644	181	16	of	of	ADP
ajlm-1644	181	17	certain	certain	ADJ
ajlm-1644	181	18	red	red	ADJ
ajlm-1644	181	19	blood	blood	NOUN
ajlm-1644	181	20	cell	cell	NOUN
ajlm-1644	181	21	indices	indice	VERB
ajlm-1644	181	22	in	in	ADP
ajlm-1644	181	23	diagnosing	diagnose	VERB
ajlm-1644	181	24	and	and	CCONJ
ajlm-1644	181	25	differentiating	differentiate	VERB
ajlm-1644	181	26	thalassemia	thalassemia	NOUN
ajlm-1644	181	27	trait	trait	NOUN
ajlm-1644	181	28	from	from	ADP
ajlm-1644	181	29	iron	iron	NOUN
ajlm-1644	181	30	-	-	PUNCT
ajlm-1644	181	31	deficiency	deficiency	NOUN
ajlm-1644	181	32	anemia	anemia	NOUN
ajlm-1644	181	33	.	.	PUNCT
ajlm-1644	182	1	am	be	AUX
ajlm-1644	182	2	j	j	PROPN
ajlm-1644	182	3	clin	clin	PROPN
ajlm-1644	182	4	pathol	pathol	NOUN
ajlm-1644	182	5	.	.	PUNCT
ajlm-1644	183	1	1999;111(5):676–682	1999;111(5):676–682	X
ajlm-1644	183	2	.	.	PUNCT
ajlm-1644	183	3	https://doi.org/10.1093/ajcp/111.5.676	https://doi.org/10.1093/ajcp/111.5.676	PROPN
ajlm-1644	183	4	matos	matos	PROPN
ajlm-1644	183	5	jf	jf	PROPN
ajlm-1644	183	6	,	,	PUNCT
ajlm-1644	183	7	dusse	dusse	PROPN
ajlm-1644	183	8	l	l	PROPN
ajlm-1644	183	9	,	,	PUNCT
ajlm-1644	183	10	borges	borges	PROPN
ajlm-1644	183	11	kb	kb	PROPN
ajlm-1644	183	12	,	,	PUNCT
ajlm-1644	183	13	de	de	PROPN
ajlm-1644	183	14	castro	castro	PROPN
ajlm-1644	183	15	rl	rl	PROPN
ajlm-1644	183	16	,	,	PUNCT
ajlm-1644	183	17	coura	coura	NOUN
ajlm-1644	183	18	-	-	ADJ
ajlm-1644	183	19	vital	vital	ADJ
ajlm-1644	183	20	w	w	PROPN
ajlm-1644	183	21	,	,	PUNCT
ajlm-1644	183	22	carvalho	carvalho	PROPN
ajlm-1644	183	23	md	md	PROPN
ajlm-1644	183	24	.	.	PUNCT
ajlm-1644	184	1	a	a	DET
ajlm-1644	184	2	new	new	ADJ
ajlm-1644	184	3	index	index	NOUN
ajlm-1644	184	4	to	to	PART
ajlm-1644	184	5	discriminate	discriminate	VERB
ajlm-1644	184	6	between	between	ADP
ajlm-1644	184	7	iron	iron	NOUN
ajlm-1644	184	8	deficiency	deficiency	NOUN
ajlm-1644	184	9	anemia	anemia	NOUN
ajlm-1644	184	10	and	and	CCONJ
ajlm-1644	184	11	thalassemia	thalassemia	NOUN
ajlm-1644	184	12	trait	trait	PROPN
ajlm-1644	184	13	.	.	PUNCT
ajlm-1644	185	1	revista	revista	PROPN
ajlm-1644	185	2	brasileira	brasileira	PROPN
ajlm-1644	185	3	de	de	PROPN
ajlm-1644	185	4	hematologia	hematologia	PROPN
ajlm-1644	185	5	e	e	PROPN
ajlm-1644	185	6	hemoterapia	hemoterapia	PROPN
ajlm-1644	185	7	.	.	PUNCT
ajlm-1644	186	1	2016;38(3):214–219	2016;38(3):214–219	X
ajlm-1644	186	2	.	.	PUNCT
ajlm-1644	187	1	https://doi.org/10.1016/j.bjhh.2016.05.011	https://doi.org/10.1016/j.bjhh.2016.05.011	NUM
ajlm-1644	187	2	miri	miri	PROPN
ajlm-1644	187	3	-	-	PUNCT
ajlm-1644	187	4	moghaddam	moghaddam	PROPN
ajlm-1644	187	5	e	e	NOUN
ajlm-1644	187	6	,	,	PUNCT
ajlm-1644	187	7	sargolzaie	sargolzaie	PROPN
ajlm-1644	187	8	n.	n.	PROPN
ajlm-1644	187	9	cut	cut	VERB
ajlm-1644	187	10	off	off	ADP
ajlm-1644	187	11	determination	determination	NOUN
ajlm-1644	187	12	of	of	ADP
ajlm-1644	187	13	discrimination	discrimination	NOUN
ajlm-1644	187	14	indices	index	NOUN
ajlm-1644	187	15	in	in	ADP
ajlm-1644	187	16	differential	differential	ADJ
ajlm-1644	187	17	diagnosis	diagnosis	NOUN
ajlm-1644	187	18	between	between	ADP
ajlm-1644	187	19	iron	iron	NOUN
ajlm-1644	187	20	deficiency	deficiency	NOUN
ajlm-1644	187	21	anemia	anemia	NOUN
ajlm-1644	187	22	and	and	CCONJ
ajlm-1644	187	23	β	β	NOUN
ajlm-1644	187	24	-	-	PUNCT
ajlm-1644	187	25	thalassemia	thalassemia	ADJ
ajlm-1644	187	26	minor	minor	ADJ
ajlm-1644	187	27	.	.	PUNCT
ajlm-1644	188	1	int	int	PROPN
ajlm-1644	188	2	j	j	PROPN
ajlm-1644	188	3	hematol	hematol	NOUN
ajlm-1644	188	4	oncol	oncol	ADJ
ajlm-1644	188	5	stem	stem	NOUN
ajlm-1644	188	6	cell	cell	NOUN
ajlm-1644	188	7	res	re	NOUN
ajlm-1644	188	8	.	.	PUNCT
ajlm-1644	189	1	2014;8(2):27	2014;8(2):27	NUM
ajlm-1644	189	2	.	.	PUNCT
ajlm-1644	190	1	sharma	sharma	PROPN
ajlm-1644	190	2	a	a	PROPN
ajlm-1644	190	3	,	,	PUNCT
ajlm-1644	190	4	sharma	sharma	PROPN
ajlm-1644	190	5	m	m	PROPN
ajlm-1644	190	6	,	,	PUNCT
ajlm-1644	190	7	sharma	sharma	PROPN
ajlm-1644	190	8	v.	v.	ADP
ajlm-1644	190	9	evaluation	evaluation	NOUN
ajlm-1644	190	10	of	of	ADP
ajlm-1644	190	11	red	red	ADJ
ajlm-1644	190	12	cell	cell	NOUN
ajlm-1644	190	13	distribution	distribution	NOUN
ajlm-1644	190	14	width	width	NOUN
ajlm-1644	190	15	in	in	ADP
ajlm-1644	190	16	the	the	DET
ajlm-1644	190	17	diagnosis	diagnosis	NOUN
ajlm-1644	190	18	of	of	ADP
ajlm-1644	190	19	iron	iron	NOUN
ajlm-1644	190	20	deficiency	deficiency	NOUN
ajlm-1644	190	21	anemia	anemia	NOUN
ajlm-1644	190	22	.	.	PUNCT
ajlm-1644	191	1	int	int	PROPN
ajlm-1644	191	2	j	j	PROPN
ajlm-1644	191	3	res	res	PROPN
ajlm-1644	191	4	med	med	PROPN
ajlm-1644	191	5	sci	sci	PROPN
ajlm-1644	191	6	.	.	PROPN
ajlm-1644	191	7	2016;4(9):3733–3736	2016;4(9):3733–3736	NUM
ajlm-1644	191	8	.	.	PUNCT
ajlm-1644	192	1	https://doi.org/10.18203/2320-6012.ijrms20162603	https://doi.org/10.18203/2320-6012.ijrms20162603	PROPN
ajlm-1644	192	2	okwi	okwi	VERB
ajlm-1644	192	3	al	al	PROPN
ajlm-1644	192	4	,	,	PUNCT
ajlm-1644	192	5	byarugaba	byarugaba	PROPN
ajlm-1644	192	6	w	w	PROPN
ajlm-1644	192	7	,	,	PUNCT
ajlm-1644	192	8	parkes	park	VERB
ajlm-1644	192	9	a	a	DET
ajlm-1644	192	10	,	,	PUNCT
ajlm-1644	192	11	ocaido	ocaido	ADJ
ajlm-1644	192	12	m.	m.	NOUN
ajlm-1644	192	13	the	the	DET
ajlm-1644	192	14	reliability	reliability	NOUN
ajlm-1644	192	15	of	of	ADP
ajlm-1644	192	16	sickling	sickling	NOUN
ajlm-1644	192	17	and	and	CCONJ
ajlm-1644	192	18	solubility	solubility	NOUN
ajlm-1644	192	19	tests	test	NOUN
ajlm-1644	192	20	and	and	CCONJ
ajlm-1644	192	21	peripheral	peripheral	ADJ
ajlm-1644	192	22	blood	blood	NOUN
ajlm-1644	192	23	film	film	NOUN
ajlm-1644	192	24	method	method	NOUN
ajlm-1644	192	25	for	for	ADP
ajlm-1644	192	26	sickle	sickle	NOUN
ajlm-1644	192	27	cell	cell	NOUN
ajlm-1644	192	28	disease	disease	NOUN
ajlm-1644	192	29	screening	screen	VERB
ajlm-1644	192	30	at	at	ADP
ajlm-1644	192	31	district	district	NOUN
ajlm-1644	192	32	health	health	NOUN
ajlm-1644	192	33	centers	center	NOUN
ajlm-1644	192	34	in	in	ADP
ajlm-1644	192	35	uganda	uganda	PROPN
ajlm-1644	192	36	.	.	PUNCT
ajlm-1644	193	1	clin	clin	PROPN
ajlm-1644	193	2	mother	mother	PROPN
ajlm-1644	193	3	child	child	PROPN
ajlm-1644	193	4	health	health	NOUN
ajlm-1644	193	5	.	.	PUNCT
ajlm-1644	194	1	2010;7(1)1–5	2010;7(1)1–5	X
ajlm-1644	194	2	.	.	PUNCT
ajlm-1644	195	1	https://doi.org/10.4303/cmch/c101947	https://doi.org/10.4303/cmch/c101947	PROPN
ajlm-1644	195	2	ramby	ramby	PROPN
ajlm-1644	195	3	al	al	PROPN
ajlm-1644	195	4	,	,	PUNCT
ajlm-1644	195	5	goodman	goodman	PROPN
ajlm-1644	195	6	dm	dm	PROPN
ajlm-1644	195	7	,	,	PUNCT
ajlm-1644	195	8	wald	wald	PROPN
ajlm-1644	195	9	el	el	PROPN
ajlm-1644	195	10	,	,	PUNCT
ajlm-1644	195	11	weiss	weiss	PROPN
ajlm-1644	195	12	sl	sl	PROPN
ajlm-1644	195	13	.	.	PROPN
ajlm-1644	195	14	red	red	ADJ
ajlm-1644	195	15	blood	blood	NOUN
ajlm-1644	195	16	cell	cell	NOUN
ajlm-1644	195	17	distribution	distribution	NOUN
ajlm-1644	195	18	width	width	NOUN
ajlm-1644	195	19	as	as	ADP
ajlm-1644	195	20	a	a	DET
ajlm-1644	195	21	pragmatic	pragmatic	ADJ
ajlm-1644	195	22	marker	marker	NOUN
ajlm-1644	195	23	for	for	ADP
ajlm-1644	195	24	outcome	outcome	NOUN
ajlm-1644	195	25	in	in	ADP
ajlm-1644	195	26	pediatric	pediatric	ADJ
ajlm-1644	195	27	critical	critical	ADJ
ajlm-1644	195	28	illness	illness	NOUN
ajlm-1644	195	29	.	.	PUNCT
ajlm-1644	196	1	plos	plos	PROPN
ajlm-1644	196	2	one	one	NUM
ajlm-1644	196	3	.	.	PUNCT
ajlm-1644	197	1	2015;10(6):e0129258	2015;10(6):e0129258	X
ajlm-1644	197	2	.	.	PUNCT
ajlm-1644	198	1	https://doi.org/10.1371/journal.pone.0129258	https://doi.org/10.1371/journal.pone.0129258	PROPN
ajlm-1644	198	2	nishad	nishad	VERB
ajlm-1644	198	3	an	an	PRON
ajlm-1644	198	4	,	,	PUNCT
ajlm-1644	198	5	de	de	X
ajlm-1644	198	6	silva	silva	NOUN
ajlm-1644	198	7	is	be	AUX
ajlm-1644	198	8	,	,	PUNCT
ajlm-1644	198	9	perera	perera	PROPN
ajlm-1644	198	10	hl	hl	NOUN
ajlm-1644	198	11	,	,	PUNCT
ajlm-1644	198	12	pathmeswaran	pathmeswaran	VERB
ajlm-1644	198	13	a	a	PRON
ajlm-1644	198	14	,	,	PUNCT
ajlm-1644	198	15	kastutiratne	kastutiratne	PROPN
ajlm-1644	198	16	ka	ka	PROPN
ajlm-1644	198	17	,	,	PUNCT
ajlm-1644	198	18	premawardhena	premawardhena	PROPN
ajlm-1644	198	19	ap	ap	PROPN
ajlm-1644	198	20	.	.	PUNCT
ajlm-1644	199	1	role	role	NOUN
ajlm-1644	199	2	of	of	ADP
ajlm-1644	199	3	red	red	ADJ
ajlm-1644	199	4	cell	cell	NOUN
ajlm-1644	199	5	distribution	distribution	NOUN
ajlm-1644	199	6	width	width	NOUN
ajlm-1644	199	7	in	in	ADP
ajlm-1644	199	8	screening	screen	VERB
ajlm-1644	199	9	for	for	ADP
ajlm-1644	199	10	hb	hb	PROPN
ajlm-1644	199	11	e	e	PROPN
ajlm-1644	199	12	trait	trait	NOUN
ajlm-1644	199	13	in	in	ADP
ajlm-1644	199	14	population	population	NOUN
ajlm-1644	199	15	screening	screen	VERB
ajlm-1644	199	16	for	for	ADP
ajlm-1644	199	17	hemoglobin	hemoglobin	NOUN
ajlm-1644	199	18	disorders	disorder	NOUN
ajlm-1644	199	19	.	.	PUNCT
ajlm-1644	200	1	j	j	PROPN
ajlm-1644	200	2	pediatr	pediatr	PROPN
ajlm-1644	200	3	hematol	hematol	PROPN
ajlm-1644	200	4	oncol	oncol	ADJ
ajlm-1644	200	5	.	.	PUNCT
ajlm-1644	201	1	2014;36(8):e490	2014;36(8):e490	NUM
ajlm-1644	201	2	–	–	PUNCT
ajlm-1644	201	3	e492	e492	NUM
ajlm-1644	201	4	.	.	PUNCT
ajlm-1644	202	1	https://doi.org/10.1097/mph.0000000000000052	https://doi.org/10.1097/mph.0000000000000052	PROPN
ajlm-1644	202	2	thame	thame	PROPN
ajlm-1644	202	3	m	m	PROPN
ajlm-1644	202	4	,	,	PUNCT
ajlm-1644	202	5	grandison	grandison	PROPN
ajlm-1644	202	6	y	y	PROPN
ajlm-1644	202	7	,	,	PUNCT
ajlm-1644	202	8	mason	mason	PROPN
ajlm-1644	202	9	k	k	PROPN
ajlm-1644	202	10	,	,	PUNCT
ajlm-1644	202	11	et	et	PROPN
ajlm-1644	202	12	al	al	PROPN
ajlm-1644	202	13	.	.	PUNCT
ajlm-1644	203	1	the	the	DET
ajlm-1644	203	2	red	red	ADJ
ajlm-1644	203	3	cell	cell	NOUN
ajlm-1644	203	4	distribution	distribution	NOUN
ajlm-1644	203	5	width	width	NOUN
ajlm-1644	203	6	in	in	ADP
ajlm-1644	203	7	sickle	sickle	NOUN
ajlm-1644	203	8	cell	cell	NOUN
ajlm-1644	203	9	disease	disease	NOUN
ajlm-1644	203	10	–	–	PUNCT
ajlm-1644	203	11	is	be	AUX
ajlm-1644	203	12	it	it	PRON
ajlm-1644	203	13	of	of	ADP
ajlm-1644	203	14	clinical	clinical	ADJ
ajlm-1644	203	15	value	value	NOUN
ajlm-1644	203	16	?	?	PUNCT
ajlm-1644	204	1	clin	clin	PROPN
ajlm-1644	204	2	lab	lab	NOUN
ajlm-1644	204	3	haematol	haematol	NOUN
ajlm-1644	204	4	.	.	PUNCT
ajlm-1644	205	1	1991;13(3):229–237	1991;13(3):229–237	X
ajlm-1644	205	2	.	.	PUNCT
ajlm-1644	206	1	https://doi.org/10.1111/j.1365-2257.1991.tb00277.x	https://doi.org/10.1111/j.1365-2257.1991.tb00277.x	PROPN
ajlm-1644	206	2	saulnier	saulnier	PROPN
ajlm-1644	206	3	km	km	PROPN
ajlm-1644	206	4	,	,	PUNCT
ajlm-1644	206	5	dupras	dupras	PROPN
ajlm-1644	206	6	c.	c.	PROPN
ajlm-1644	206	7	race	race	NOUN
ajlm-1644	206	8	in	in	ADP
ajlm-1644	206	9	the	the	DET
ajlm-1644	206	10	postgenomic	postgenomic	ADJ
ajlm-1644	206	11	era	era	NOUN
ajlm-1644	206	12	:	:	PUNCT
ajlm-1644	206	13	social	social	ADJ
ajlm-1644	206	14	epigenetics	epigenetic	NOUN
ajlm-1644	206	15	calling	call	VERB
ajlm-1644	206	16	for	for	ADP
ajlm-1644	206	17	interdisciplinary	interdisciplinary	ADJ
ajlm-1644	206	18	ethical	ethical	ADJ
ajlm-1644	206	19	safeguards	safeguard	NOUN
ajlm-1644	206	20	.	.	PUNCT
ajlm-1644	206	21	am	be	AUX
ajlm-1644	206	22	j	j	PROPN
ajlm-1644	206	23	bioeth	bioeth	ADJ
ajlm-1644	206	24	.	.	PUNCT
ajlm-1644	207	1	2017;17(9):58–60	2017;17(9):58–60	X
ajlm-1644	207	2	.	.	PUNCT
ajlm-1644	207	3	https://doi.org/10.1080/15265161.2017.1353182	https://doi.org/10.1080/15265161.2017.1353182	PROPN
ajlm-1644	208	1	nam	nam	PROPN
ajlm-1644	208	2	jm	jm	PROPN
ajlm-1644	208	3	.	.	PROPN
ajlm-1644	208	4	sample	sample	PROPN
ajlm-1644	208	5	size	size	NOUN
ajlm-1644	208	6	determination	determination	NOUN
ajlm-1644	208	7	for	for	ADP
ajlm-1644	208	8	case	case	NOUN
ajlm-1644	208	9	-	-	PUNCT
ajlm-1644	208	10	control	control	NOUN
ajlm-1644	208	11	studies	study	NOUN
ajlm-1644	208	12	and	and	CCONJ
ajlm-1644	208	13	the	the	DET
ajlm-1644	208	14	comparison	comparison	NOUN
ajlm-1644	208	15	of	of	ADP
ajlm-1644	208	16	stratified	stratified	ADJ
ajlm-1644	208	17	and	and	CCONJ
ajlm-1644	208	18	unstratified	unstratified	ADJ
ajlm-1644	208	19	analyses	analysis	NOUN
ajlm-1644	208	20	.	.	PUNCT
ajlm-1644	209	1	biometrics	biometric	NOUN
ajlm-1644	209	2	.	.	PUNCT
ajlm-1644	210	1	1992;48(2):389–395	1992;48(2):389–395	NUM
ajlm-1644	210	2	.	.	PUNCT
ajlm-1644	210	3	https://doi.org/10.2307/2532298	https://doi.org/10.2307/2532298	PROPN
ajlm-1644	210	4	wacholder	wacholder	PROPN
ajlm-1644	210	5	s	s	PROPN
ajlm-1644	210	6	,	,	PUNCT
ajlm-1644	210	7	mclaughlin	mclaughlin	PROPN
ajlm-1644	210	8	jk	jk	PROPN
ajlm-1644	210	9	,	,	PUNCT
ajlm-1644	210	10	silverman	silverman	PROPN
ajlm-1644	210	11	dt	dt	PROPN
ajlm-1644	210	12	,	,	PUNCT
ajlm-1644	210	13	mandel	mandel	PROPN
ajlm-1644	210	14	js	js	PROPN
ajlm-1644	210	15	.	.	PUNCT
ajlm-1644	211	1	selection	selection	NOUN
ajlm-1644	211	2	of	of	ADP
ajlm-1644	211	3	controls	control	NOUN
ajlm-1644	211	4	in	in	ADP
ajlm-1644	211	5	case	case	NOUN
ajlm-1644	211	6	-	-	PUNCT
ajlm-1644	211	7	control	control	NOUN
ajlm-1644	211	8	studies	study	NOUN
ajlm-1644	211	9	:	:	PUNCT
ajlm-1644	211	10	i.	i.	NOUN
ajlm-1644	211	11	principles	principle	NOUN
ajlm-1644	211	12	.	.	PUNCT
ajlm-1644	212	1	am	be	AUX
ajlm-1644	212	2	j	j	PROPN
ajlm-1644	212	3	epidemiol	epidemiol	PROPN
ajlm-1644	212	4	.	.	PUNCT
ajlm-1644	213	1	1992;135(9):1019–1028	1992;135(9):1019–1028	NUM
ajlm-1644	213	2	.	.	PUNCT
ajlm-1644	213	3	https://doi.org/10.1093/oxfordjournals.aje.a116396	https://doi.org/10.1093/oxfordjournals.aje.a116396	PROPN
ajlm-1644	213	4	nahm	nahm	PROPN
ajlm-1644	213	5	fs	fs	PROPN
ajlm-1644	213	6	.	.	PROPN
ajlm-1644	213	7	nonparametric	nonparametric	NOUN
ajlm-1644	213	8	statistical	statistical	ADJ
ajlm-1644	213	9	tests	test	NOUN
ajlm-1644	213	10	for	for	ADP
ajlm-1644	213	11	the	the	DET
ajlm-1644	213	12	continuous	continuous	ADJ
ajlm-1644	213	13	data	datum	NOUN
ajlm-1644	213	14	:	:	PUNCT
ajlm-1644	213	15	the	the	DET
ajlm-1644	213	16	basic	basic	ADJ
ajlm-1644	213	17	concept	concept	NOUN
ajlm-1644	213	18	and	and	CCONJ
ajlm-1644	213	19	the	the	DET
ajlm-1644	213	20	practical	practical	ADJ
ajlm-1644	213	21	use	use	NOUN
ajlm-1644	213	22	.	.	PUNCT
ajlm-1644	214	1	korean	korean	PROPN
ajlm-1644	214	2	j	j	PROPN
ajlm-1644	214	3	anesthesiol	anesthesiol	NOUN
ajlm-1644	214	4	.	.	PUNCT
ajlm-1644	215	1	2016;69(1):8	2016;69(1):8	NUM
ajlm-1644	215	2	.	.	PUNCT
ajlm-1644	216	1	https://doi.org/10.4097/kjae.2016.69.1.8	https://doi.org/10.4097/kjae.2016.69.1.8	PROPN
ajlm-1644	216	2	ruopp	ruopp	PROPN
ajlm-1644	216	3	md	md	PROPN
ajlm-1644	216	4	,	,	PUNCT
ajlm-1644	216	5	perkins	perkins	PROPN
ajlm-1644	216	6	nj	nj	PROPN
ajlm-1644	216	7	,	,	PUNCT
ajlm-1644	216	8	whitcomb	whitcomb	PROPN
ajlm-1644	216	9	bw	bw	PROPN
ajlm-1644	216	10	,	,	PUNCT
ajlm-1644	216	11	schisterman	schisterman	PROPN
ajlm-1644	216	12	ef	ef	PROPN
ajlm-1644	216	13	.	.	PROPN
ajlm-1644	216	14	youden	youden	PROPN
ajlm-1644	216	15	index	index	NOUN
ajlm-1644	216	16	and	and	CCONJ
ajlm-1644	216	17	optimal	optimal	ADJ
ajlm-1644	216	18	cut	cut	NOUN
ajlm-1644	216	19	-	-	PUNCT
ajlm-1644	216	20	point	point	NOUN
ajlm-1644	216	21	estimated	estimate	VERB
ajlm-1644	216	22	from	from	ADP
ajlm-1644	216	23	observations	observation	NOUN
ajlm-1644	216	24	affected	affect	VERB
ajlm-1644	216	25	by	by	ADP
ajlm-1644	216	26	a	a	DET
ajlm-1644	216	27	lower	low	ADJ
ajlm-1644	216	28	limit	limit	NOUN
ajlm-1644	216	29	of	of	ADP
ajlm-1644	216	30	detection	detection	NOUN
ajlm-1644	216	31	.	.	PUNCT
ajlm-1644	217	1	biom	biom	PROPN
ajlm-1644	217	2	j.	j.	PROPN
ajlm-1644	217	3	2008;50(3):419–430	2008;50(3):419–430	PROPN
ajlm-1644	217	4	.	.	PUNCT
ajlm-1644	218	1	https://doi.org/10.1002/bimj.200710415	https://doi.org/10.1002/bimj.200710415	NOUN
ajlm-1644	218	2	webster	webster	PROPN
ajlm-1644	218	3	pa	pa	PROPN
ajlm-1644	218	4	,	,	PUNCT
ajlm-1644	218	5	castro	castro	VERB
ajlm-1644	218	6	os	os	PROPN
ajlm-1644	218	7	.	.	PUNCT
ajlm-1644	218	8	red	red	ADJ
ajlm-1644	218	9	cell	cell	NOUN
ajlm-1644	218	10	distribution	distribution	NOUN
ajlm-1644	218	11	width	width	NOUN
ajlm-1644	218	12	in	in	ADP
ajlm-1644	218	13	sickle	sickle	NOUN
ajlm-1644	218	14	cell	cell	NOUN
ajlm-1644	218	15	disease	disease	NOUN
ajlm-1644	218	16	.	.	PUNCT
ajlm-1644	219	1	ann	ann	PROPN
ajlm-1644	219	2	clin	clin	PROPN
ajlm-1644	219	3	lab	lab	PROPN
ajlm-1644	219	4	sci	sci	PROPN
ajlm-1644	219	5	.	.	PUNCT
ajlm-1644	220	1	1986;16(4):274–277	1986;16(4):274–277	PROPN
ajlm-1644	220	2	.	.	PUNCT
ajlm-1644	221	1	qurtom	qurtom	PROPN
ajlm-1644	221	2	ha	ha	INTJ
ajlm-1644	221	3	,	,	PUNCT
ajlm-1644	221	4	al	al	PROPN
ajlm-1644	221	5	-	-	PUNCT
ajlm-1644	221	6	saleh	saleh	PROPN
ajlm-1644	221	7	qa	qa	PROPN
ajlm-1644	221	8	,	,	PUNCT
ajlm-1644	221	9	lubani	lubani	PROPN
ajlm-1644	221	10	mm	mm	PROPN
ajlm-1644	221	11	,	,	PUNCT
ajlm-1644	221	12	et	et	PROPN
ajlm-1644	221	13	al	al	PROPN
ajlm-1644	221	14	.	.	PUNCT
ajlm-1644	222	1	the	the	DET
ajlm-1644	222	2	value	value	NOUN
ajlm-1644	222	3	of	of	ADP
ajlm-1644	222	4	red	red	ADJ
ajlm-1644	222	5	cell	cell	NOUN
ajlm-1644	222	6	distribution	distribution	NOUN
ajlm-1644	222	7	width	width	NOUN
ajlm-1644	222	8	in	in	ADP
ajlm-1644	222	9	the	the	DET
ajlm-1644	222	10	diagnosis	diagnosis	NOUN
ajlm-1644	222	11	of	of	ADP
ajlm-1644	222	12	anaemia	anaemia	NOUN
ajlm-1644	222	13	in	in	ADP
ajlm-1644	222	14	children	child	NOUN
ajlm-1644	222	15	.	.	PUNCT
ajlm-1644	223	1	eur	eur	PROPN
ajlm-1644	223	2	j	j	PROPN
ajlm-1644	223	3	pediatrics	pediatric	NOUN
ajlm-1644	223	4	.	.	PUNCT
ajlm-1644	224	1	1989;148(8):745–748	1989;148(8):745–748	X
ajlm-1644	224	2	.	.	PUNCT
ajlm-1644	224	3	https://doi.org/10.1007/bf00443100	https://doi.org/10.1007/bf00443100	PROPN
ajlm-1644	224	4	akobeng	akobeng	PROPN
ajlm-1644	224	5	ak	ak	AUX
ajlm-1644	224	6	.	.	PROPN
ajlm-1644	224	7	understanding	understand	VERB
ajlm-1644	224	8	diagnostic	diagnostic	ADJ
ajlm-1644	224	9	tests	test	NOUN
ajlm-1644	224	10	2	2	NUM
ajlm-1644	224	11	:	:	PUNCT
ajlm-1644	224	12	likelihood	likelihood	NOUN
ajlm-1644	224	13	ratios	ratio	NOUN
ajlm-1644	224	14	,	,	PUNCT
ajlm-1644	224	15	pre	pre	ADJ
ajlm-1644	224	16	-	-	ADJ
ajlm-1644	224	17	and	and	CCONJ
ajlm-1644	224	18	post	post	ADJ
ajlm-1644	224	19	-	-	ADJ
ajlm-1644	224	20	test	test	NOUN
ajlm-1644	224	21	probabilities	probability	NOUN
ajlm-1644	224	22	,	,	PUNCT
ajlm-1644	224	23	and	and	CCONJ
ajlm-1644	224	24	their	their	PRON
ajlm-1644	224	25	use	use	NOUN
ajlm-1644	224	26	in	in	ADP
ajlm-1644	224	27	clinical	clinical	ADJ
ajlm-1644	224	28	practice	practice	NOUN
ajlm-1644	224	29	.	.	PUNCT
ajlm-1644	225	1	acta	acta	PROPN
ajlm-1644	225	2	paediatr	paediatr	NOUN
ajlm-1644	225	3	.	.	PUNCT
ajlm-1644	226	1	2007;96(4):487–491	2007;96(4):487–491	X
ajlm-1644	226	2	.	.	PUNCT
ajlm-1644	226	3	https://doi.org/10.1111/j.1651-2227.2006.00179.x	https://doi.org/10.1111/j.1651-2227.2006.00179.x	PROPN